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Joint modelling techniques for the analysis of longitudinal and survival data are
a relatively recent statistical development, employed to appropriately account for the
possible association which can exist between these two processes. Since their develop-
ment at the end of the 20th century, joint models have become increasingly popular
within statistical literature due to their broad applicability across many areas of sta-
tistical research. Within a joint modelling framework, each process is represented by
its own submodel, where most often a linear mixed effects (LME) model is employed
for the longitudinal process and a proportional hazards model for the survival out-
come. The parameters of both submodels are estimated simultaneously from a single
joint likelihood, therefore overcoming the bias which can occur when the processes are
modelled independently.
Within this thesis, the Coxian phase-type regression model is explored as a novel
approach to represent the survival process within a joint model. Phase-type distribu-
tions, in general, are a diverse family of distributions which describe the absorption
times of a continuous time Markov process with a single absorbing state, formulated
by a convolution of exponential distributions, either in series or parallel. Employing
phase-type distributions to model failure times can potentially uncover latent stages of
the process under investigation, and insight can be gained from the estimated param-
eters regarding the rates of flow through these uncovered phases. Within a medical
context, mapping the uncovered states onto distinct stages of a disease’s progression,
for example, allows predictions to be made regarding the time spent within the differ-
ent stages of the disease, and inferences can be drawn from these predictions on the
individuals’ expected quality of life for their remaining survival time.
Whilst previous research has explored the use of phase-type distributions to repre-
sent typical survival analysis problems, there are a number of limitations which have
hindered their popularity, particularly with regards to the fitting of the models. Con-
sequently, the first portion of this research is concerned with investigating the Coxian
phase-type regression model so as to improve its suitability at representing typical
survival processes. To this end, a new expectation-maximisation (EM) algorithm ap-
proach to fitting phase-type distributions is developed, shown through a simulation
study to improve upon alternative algorithm approaches, employed within the current
literature, in terms of both the accuracy of the parameter estimates and the rate of
convergence. Due to its increased stability, this approach is then extended to allow
for the effect of a covariate to vary across the transitions of the model, as opposed to
remaining fixed, as is the common assumption within the literature.
Subsequently, a joint modelling framework is developed, within which the longitu-
dinal process is represented by a LME model and the survival process by the Coxian
phase-type regression model. This new methodology is shown to be beneficial to
both areas of research. For instance, previously the Coxian was limited to modelling
time-invariant covariates, greatly limiting its scope, whereas it can now be employed
within the new joint modelling framework to model the association between longitu-
dinal biomarkers and survival outcome, extending its applicability, particularly within
the medical field.
Further, employing the Coxian to represent the survival process offers a number
of advantages over alternative parametric models; the Coxian phase-type distribution
can represent any positive distribution to an arbitrary degree of accuracy, overcoming
the noted limitations of survival models which assume more restrictive distributions,
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Both the fields of longitudinal and survival analysis have undergone significant statis-
tical advancements within the last 50 years. Key methodological developments, such
as the linear mixed effects (LME) model [1] for the analysis of unbalanced repeated
measures data, and the Cox proportional hazards (PH) model [2] for the analysis of
time-to-event processes, have had a profound impact upon these fields of research,
within which they have come to dominate. By the end of the 20th century, a greater
emphasis could be observed within the literature on the association which can ex-
ist between these two processes, culminating in the development of joint modelling
techniques [3, 4]. Within a joint modelling framework, the longitudinal and survival
processes are estimated simultaneously, through a single joint likelihood, allowing the
effect of each process on the other to be appropriately taken into consideration, re-
moving the bias which is well noted to contaminate parameter estimation within inde-
pendent models [5,6]. Despite their ever-increasing popularity, there still exists many
areas of joint modelling which have not yet been fully explored, with much scope
to both improve upon current estimation techniques and to investigate alternative
representations of the two processes within the single joint likelihood.
This research explores the use of the Coxian phase-type regression model as a
novel approach to represent typical survival data, initially as an independent model
and subsequently within a joint modelling framework, offering a number of advan-
tages when compared to standard survival representations. Namely, as phase-type
distributions assume an underlying Markov process, applying such models to survival
data can uncover latent states, or ‘phases’, of the failure process, and inferences can
be made from the estimated parameters of the distribution on the rates of flow of
individuals through these phases. This can be extremely useful within medical statis-
tics, for instance, where the uncovered phases can be mapped onto distinct stages of
the survival process, meaning greater insight can be gained regarding how individuals
behave before experiencing their event of interest. For example, for chronic and degen-
erative conditions, where the uncovered states can represent increasingly severe stages
of the disease, the models can provide insight into the quality of life an individual will
experience during the remainder of their survival time by estimating how long they
will spend within each state. Such information can be utilised by clinicians to inform
treatment plans and target interventions towards patients when they are most in need
and when the intervention will yield optimal results.
Incorporating such models within a joint framework, as is detailed within this re-
search, significantly advances the theory of phase-type regression models, extending
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their applicability to scenarios where time-varying covariates are of interest, not pre-
viously explored within the literature. Further, the field of joint modelling is similarly
advanced, benefiting from additional features of phase-type distributions which over-
come some well documented limitations of alternative distributional representations of
the survival process [7]. Consequently, the research presented within this thesis con-
tributes significantly to both the research areas of phase-type distributions and joint
modelling.
A more detailed background of joint models and phase-type distributions is pre-
sented within Section 1.2, before a motivating example is briefly introduced within
Section 1.3. Finally, the contributions of this research are detailed within Section 1.4,
and an outline of the remainder of the thesis is given in Section 1.5.
1.2 Background
1.2.1 Joint Modelling of Longitudinal and Survival Data
The joint analysis of longitudinal and survival data is a relatively recent statistical tech-
nique, developed to take into consideration the association which often exists between
these two processes. For instance, within survival analysis, it is often of interest to
incorporate some dynamic, endogenous biomarker as a predictor of failure, where stan-
dard independent PH and acceleration failure time (AFT) models are ill-equipped to
appropriately handle the time-varying nature of such covariates. Conversely, dropout
from a longitudinal study due to an associated event process can result in underrepre-
sentation of certain subpopulations, introducing bias to the estimated population-level
parameters.
By 1995, it had been well established within both longitudinal and survival lit-
erature that the independent analysis of either process, in the presence of such an
association, results in biased inferences [5, 6, 8]. Shortly thereafter, pioneering papers
by Faucett and Thomas [3] in 1996, Wulfsohn and Tsiatis [4] in 1997, and Henderson
et al. [9] in 2000, outlined new joint modelling methodology, where the two process are
estimated simultaneously through a single joint likelihood. Within this initial mod-
elling framework, the longitudinal process was represented by a LME model and the
survival process by a Cox PH model, where the association between the two processes
was represented by latent random effects.
Since the publication of these critical methodological developments, the area of
joint modelling has grown rapidly, as illustrated by Figure 1.1, which shows an in-
creasing trend in the number of citations for two key publications within the research
3
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Figure 1.1: Graph showing the increasing number of citations for Wulfsohn and
Tsiatis’s pioneering paper [4] and the JM package within R software [14]. Data
obtained from Web of Science, accessed September 2018 [15].
area. As such, many extensions to the methodology have been explored within the
literature. For example, parametric AFT models have been incorporated within the
joint modelling framework to represent the survival process [10], applicable in scenarios
where the PH assumption does not hold. Similarly, fully parametric PH models have
also been explored to represent the survival process, assuming, for example, an un-
derlying exponential or Weibull distribution. Such fully parametric representations of
the survival process, whilst successfully overcoming issues in estimating the standard
errors which are experienced when employing the semi-parametric Cox PH model [11],
are not without their limitations. As noted by Gould et al. [12], the exponential and
Weibull distributions are limited in terms of the hazard shapes which they can repre-
sent, introducing error to the parameter estimates if the data does not truly observe
the assumed distribution. This issue constitutes one of the targets within this re-
search, where the Coxian phase-type distribution is advantageous due to its ability to
represent any positive distribution to an arbitrary degree of accuracy [13], overcoming
this well documented limitation of alternative survival representations within a joint
framework.
Despite the conceptual simplicity of joint models, the fitting procedure involved
to estimate the unknown parameters of the two processes can be computationally in-
tensive, primarily due to the numerical approximations required within the likelihood.
Indeed, as noted by Rizopoulos [16], these numerical approximations “constitute the
4
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main reason why joint models have not yet found their rightful place in the tool-
box of modern applied statisticians.” More recent contributions to the field of joint
modelling have, however, investigated approaches to improve the numerical approxi-
mations within the likelihood, where the standard Gauss-Hermite quadrature has been
replaced with a pseudo-adaptive Gauss-Hermite approach [17], and the use of Laplace
approximations to estimate these integrals has also been investigated [16].
Perhaps partially due to these computational difficulties, as well as their being
a relatively recent statistical development, there exists only a limited number of ap-
proaches to fit joint models within modern statistical software, the most popular of
which is the ‘JM’ package [14] within R [18]. First published in 2008, this package
is designed to model the ‘true longitudinal response’ (TLR) parameterisation of the
joint likelihood, where interest lies in the direct relationship between the true value of
the longitudinal response and survival outcome. Within the package, the longitudinal
process is represented by a LME model, and the survival process can be represented
by a selection of submodels, such as: (i) a Cox PH model, (ii) an exponential or
Weibull PH model, (iii) an exponential or Weibull AFT model, (iv) a PH model with
a piecewise-constant baseline risk function, and (v) a PH model in which the log
cumulative baseline hazard is approximated using B-splines. The piecewise-constant
baseline formulation, along with the spline based approach, are suggested within the
literature as suitable methods to overcome the limited distributional shapes which can
be represented by the fully parametric PH models [19], however no equivalent AFT
approaches are currently available within the software, limiting the choice to only an
exponential or Weibull AFT model. Within this research, an AFT formulation of the
Coxian phase-type regression model is incorporated within a joint framework, fulfilling
the need for alternative representations of the baseline survival distribution when the
Weibull does not suitably fit the shape of the data. This overcomes potential errors
in the estimation of the survival parameters which can result from misspecifying the
underlying distribution.
The TLR parameterisation can also be fitted using a Bayesian approach, by the
R package ‘JMBayes’ [20]. However, the survival process can only be represented,
thus far, by a proportional hazards model where the baseline hazard is approximated
using splines. The ‘joineR’ package [21], also within R software, fits an alternative
parameterisation of the joint model, referred to as the ‘random effects’ (RE) parame-
terisation, where interest lies in modelling the association between the survival process
and the latent random effects of the longitudinal process, representing deviations from
the population average trajectory, as opposed to the true longitudinal response itself.




Detailed theory of longitudinal, survival, and joint modelling techniques is explored
further within Chapter 2 of this thesis, where current limitations found within the
literature, which this research alleviates, are highlighted throughout.
1.2.2 The Coxian Phase-type Distribution
The absorption times of any continuous time Markov process, with a single absorbing
state, can be regarded as being phase-type distributed [22], where the distribution is
defined by the transition intensity matrix of the Markov process which it represents.
As such, the family of phase-type distributions is diverse; so much so that it can
represent any positive distribution to an arbitrary degree of accuracy [13].
The practice of fitting phase-type distributions can be dated back to 1917, when
Erlang [23], who was concerned with modelling the service times within a telephone
exchange system, hypothesised that the total time spent within a queue could be
considered to consist of a series of underlying states, through which individuals tran-
sitioned according to an exponential distribution before being served. This idea is
often cited as the basis of modern queueing theory [24], and the practice of utilis-
ing a convolution of exponential distributions in this way, either in series or parallel,
has been generalised to define a diverse family of distributions which are referred to
as phase-type. The Coxian phase-type distribution is one such generalisation, which
allows absorption to occur from any of the underlying transient states of the queue.
Phase-type distributions have previously been utilised to represent flow through
various systems, such as patient flow through hospital [25,26] and students progression
through university [27]. More recently, however, they have also been considered as a
potential approach to model more typical survival analysis problems [28], where they
can be employed to represent, for example, patients’ ‘flow’ or progression through
the states of a chronic disease [29]. Such applications, whilst novel, have motivated
renewed activity within this research area. For instance, extensions to the phase-type
methodology to allow for the incorporation of covariates within what is referred to as
the phase-type regression model [30], as well as extensions for the inclusion of censored
individuals [31], not typically encountered within standard queueing applications, have
occurred relatively recently within the history of phase-type distributions.
Previous research has exhibited success at mapping the uncovered latent states
from a fitted phase-type distribution onto distinct stages of the process which it rep-
resents. This is particularly true for the Coxian phase-type distribution, a popular
6
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choice within the literature due to its underlying Markov process representing typical
flow patterns. In doing so, inferences can be made from the estimated transition pa-
rameters on the rates of flow of individuals through the uncovered phases, providing
further insight into the survival process, not ascertainable when utilising alternative
distributions. This is advantageous when analysing survival data which is assumed to
have an underlying Markov process, but where repeated measures were not collected
on the individuals’ transitions through the process.
At present, there exists only a small number of available approaches to fit phase-
type distributions using standard statistical software, no doubt limiting their widespread
application to survival analysis problems. A Bayesian approach to fit phase-type dis-
tributions is detailed within the R package ‘PhaseType’ [32], which is not capable of
incorporating either covariate effects or censored individuals, reducing their applica-
bility. EMpht [33] is another software approach which can be utilised to fit phase-type
distributions which is capable of handling censored individuals but similarly cannot
evaluate the effect of covariates on the system which the phase-type distribution rep-
resents. Indeed, there are currently no publicly available software packages which can
handle both covariates and censored individuals.
Phase-type distributions are discussed in more depth within Chapter 3 of this
thesis, where a number of methodological developments are also detailed to improve
the suitability of phase-type distributions to represent typical survival processes.
1.3 Motivating Example
The research presented within this thesis is motivated, at least partially, by a study
of individuals suffering from chronic kidney disease (CKD); a degenerative condition
whereby an individual’s kidney function gradually deteriorates over time. CKD often
culminates in kidney failure, where haemodialysis (HD) treatment is necessary to fulfil
the role of the ailing kidneys, before an eventual transplant is required.
Due to increasing incidence rates, where, for example, it has been estimated that
8.3% of individuals in England aged 16 or over will suffer from CKD by 2036, compared
to 6.1% in 2011 [34], CKD is considered to be a prevailing challenge for healthcare
providers [35]. Further, the disease has been observed to be particularly prominent
amongst older individuals, where it is estimated that one in four women and one in five
men aged between 64 and 75 are diagnosed with the disease [36,37], meaning incidents
rates are increasing due to an ageing population [38].
Within this research, the novel joint modelling approach, which utilises the Coxian
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phase-type regression model to represent the survival process, is used to analyse data
collected from eight HD treatment centres across Northern Ireland. The aim of the
analysis is to model the association between repeated measures collected on individu-
als’ haemoglobin (Hb) levels, an emerging CKD biomarker, and their survival times.
Within this analysis, the Coxian provides additional insight into the underlying stages
of progression of end-stage renal patients, whilst also overcoming the aforementioned
bias which can occur in survival parameter estimation by misspecifying the survival
distribution.
1.4 Contributions
Throughout this research, a number of methodological developments are made, both
to the area of phase-type distributions and to the area of joint modelling, significantly
advancing each of the fields. The key advancements explored within this thesis are
summarised below:
i A novel EM algorithm approach to fitting phase-type regression models is derived,
with the aim of establishing a more stable method to fit such models and allevi-
ate the identifiability issues which are well noted within the literature to impede
current fitting procedures [39,40]. This approach, in comparison to standard Quasi-
Newton (QN) and Nelder-Mead (NM) algorithm approaches, is advantageous as
it also estimates what proportion of an individual’s survival time is spent within
each of the underlying states, allowing inferences to be made regarding quality of
life; key information for both patients and clinicians.
ii The increased stability of this EM algorithm approach to fitting phase-type re-
gression models is leveraged so as to relax the routinely imposed assumption that
a covariate will have a constant effect across all transition intensities within the
model. A new formulation of the standard Coxian regression model is presented,
which instead allows (a) state-specific, (b) direction-specific and (c) transition-
specific inferences to be made regarding the covariates’ effects. In doing so, more
information can be ascertained relating to how a covariate affects the system rep-
resented by the phase-type distribution.
iii The novel EM algorithm approach is also extended to allow for the inclusion
of time-varying covariates, not considered within any phase-type model formu-
lation within current literature. This advancement significantly extends the scope
of phase-type distributions, as time-varying covariates are of increasing interest
within many fields, particularly within medical statistics and epidemiology.
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iv As detailed in Donnelly et al. [29], a two-stage approach to the joint analysis of lon-
gitudinal and survival data is preliminarily developed, utilising the Coxian phase-
type regression model to represent the survival process. Within stage one of the
model fitting procedure, a LME model is employed to overcome the measurement
error which exists amongst the repeated measures of the longitudinal response,
allowing an estimate of the ‘true’ response to be generated for each individual at
their event time. Within stage two, these unbiased estimates are incorporated as
predictors within the Coxian phase-type regression model, allowing the effect of
the longitudinal process on the rates of transition through the underlying stages
of the survival process to be quantified.
v Finally, a single joint likelihood approach to fit the new joint modelling speci-
fication, which utilises the Coxian phase-type regression model to represent the
survival process, is derived for both the TLR and RE parameterisations of the
joint model. Due to the flexibility of the Coxian phase-type distribution, in terms
of its ability to represent any positive distribution, this new model overcomes pre-
vious limitations associated with fully parametric representations of the survival
process, where bias can be introduced to the estimates of the survival parameters
if the underlying distribution is misspecified. Further, the additional insight into
the survival process provided by the Coxian, by way of the uncovered states, is not
available from alternative survival representations and is a key advantage of the
novel joint models presented within this work.
1.5 Thesis Outline
The remainder of this thesis is outlined as follows:
Chapter 2 presents a review of the literature within the areas of longitudinal, survival
and joint modelling, as well as detailing the significant methodological develop-
ments which have been made within these fields of research. Throughout this
review, limitations of standard joint models, which are subsequently targeted
within this research, are highlighted.
Chapter 3 begins with a review of previous literature pertaining to phase-type dis-
tributions and phase-type regression models, where the limitations of the models
which are addressed within this research are discussed. Subsequently, the de-
velopment of the new EM algorithm approach to fitting phase-type regression
models is presented in full. This new model is then extended to allow the effect
of the covariates to vary across the transitions, increasing the information which
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can be obtained regarding the survival process under investigation. Within this
Chapter, the phase-type regression model is also extended to an inhomogeneous
case, allowing time-varying covariates to be included within the model, neces-
sary to incorporate the longitudinal response within the joint likelihood. Two
simulation studies are presented throughout, validating the new methodological
advancements which are introduced.
Chapter 4 details the development of the new joint model formulation which em-
ployes the Coxian phase-type regression model to represent the survival pro-
cess. A preliminary two stage approach is first explored, before the single joint
likelihood approach is detailed in full for both parameterisations. The chapter
concludes with a simulation study, validating the new joint modelling framework
and illustrating its advantages over the standard joint models currently available
within published software.
Chapter 5 explores the application of the newly developed joint model which incor-
porates the Coxian phase-type distribution to represent the survival process to
data collected from Northern Ireland renal patients suffering from chronic kidney
disease.
Chapter 6 concludes the thesis by providing a summary of the main findings of this
research, as well as presenting some potential points of further work.
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Chapter 2
Joint Modelling of Longitudinal and
Survival Data
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2.2. Longitudinal Data Analysis
2.1 Overview
The analysis of longitudinal and survival data, both independently and simultaneously
within a joint modelling context, constitutes a widely discussed topic within statistical
literature. This chapter reviews both the techniques for independent analysis of the
two processes, alongside the more sophisticated joint likelihood approach for the simul-
taneous estimation of both processes. With regard to joint modelling techniques, some
limitations of the standard procedures, subsequently addressed within this research,
are discussed throughout.
2.2 Longitudinal Data Analysis
Over the last 40 years, significant developments have been made to the area of longi-
tudinal data analysis, motivated partially by the more frequent collection of repeated
measures data within an increasingly digitalised society. For example, the more regu-
lar use of computers to compile and store patient health records has meant that the
collection of longitudinal data within the medical field happens almost inadvertently.
Longitudinal studies, in comparison to cross-sectional studies, are favourable due to
their increased statistical power; they have the capability to model change over time
at both an individual and population level [41, 42], as well as the capacity to distin-
guish between ageing and cohort effects, which can otherwise become confounded [43],
making longitudinal studies advantageous in terms of the type of statistical questions
they can address.
On the other hand, the analysis of longitudinal data can prove challenging; such
studies possess a number of unique features which make typical regression techniques
redundant, and instead require specialist approaches in order to insure that valid
inferences can be drawn [44]. Along with the improved capacity to collect and store
repeated measures data, computational advancements have also aided the evolution of
more sophisticated methodological techniques, necessary to draw such valid inferences
from repeated measures data, meaning longitudinal studies have become increasingly
popular within the fields of medicine, epidemiology and public health over the last 30
years [45].
2.2.1 Challenges Inherent to Longitudinal Data
Many of the problems faced when analysing longitudinal data stem from its multi-
level hierarchical structure [46], which introduces naturally occurring heterogeneity
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to the data meaning it can no longer be assumed independent and identically dis-
tributed. The repeated measures are instead clustered by individual as, intuitively,
the observations collected on one individual are more alike to each other than to the
observations collected on a second individual; this is due to the effect of unobserved,
individual-specific characteristics which act upon the observed response.
Commonly, therefore, two sources of variation are considered when modelling lon-
gitudinal data: the between-individual variation, which represents the extent of the
differences between individuals, and the within-individual variation, which represents
how alike the observations made on a single individual are [46]. Figure 2.1 illustrates
the multilevel nature of longitudinal data. As the independence assumption of or-
dinary linear regression is violated, techniques based upon the analysis of variance





























Figure 2.1: Diagram illustrating the multilevel nature of longitudinal data
Another frequent complication encountered within the analysis of longitudinal data
is missingness. Missing data occurs when, for any reason, some individuals within a
study do not have a complete set of observations. This can be due to either an indi-
vidual skipping a scheduled observation appointment or, more commonly (and with
a more significant impact), an individual dropping out of a study altogether before
its completion. With regards to the former, ‘skipped observation’ missingness, it is
instinctive that it is more straightforward to compare individuals’ rates of change over
time when all individuals have the same number of observations recorded at the same
time points which, indeed, is a requirement for some of the less sophisticated historical
approaches discussed in Section 2.2.2. When such a condition is not satisfied, bias can
be introduced if the missingness problem is ignored, or individuals (and potentially in-
formative data) can be omitted from the study if the problem is incorrectly addressed,
possibly rendering the retained sample unrepresentative of the true population.
Missingness due to dropout can pose a more significant challenge to the analysis
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of longitudinal data, particularly when the missingness is not at random [48]. For
example, in a clinical trial to test the effect of a new drug intervention compared
to a placebo on some repeatedly observed disease marker, if individuals who receive
the drug are more likely to experience some negative reaction, causing them to drop
out of the study, then those who received the treatment (and experience the negative
side-effect) become under represented within the sample, introducing bias.
Missingness is closely related to the final prominent feature of longitudinal studies:
unbalanced data. Whilst in theory it may seem beneficial to make the same number of
observations, at the same time points, with equal time-gaps between observations, for
all individuals within a study, this is difficult to enforce. In practice, it is inevitable
that some observations shall be postponed, or missed entirely, for reasons beyond
control, causing unbalanced and unstructured data. More drastically, if interested in
conducting a retrospective analysis on data that was not collected as part of a trial
with a strict structure, methods of analysis which require balanced data cannot be
relied upon to produce unbiased parameter estimates.
2.2.2 Historical Methods of Analysis
Historically, a number of approaches have been considered to overcome the problems
inherent to longitudinal data and, as shall be discussed, the path to developing the
modern techniques used today has been a long one. Indeed, a review of the litera-
ture reveals a haphazard timeline within which different modelling frameworks were
developed synchronously, each contributing to the advancement of the methodological
framework towards the development of the linear mixed effects model (LME) model [1];
one of the most sophisticated approaches employed today to analyse longitudinal data.
2.2.2.1 Derived Variable Analysis
Derived variable analysis is the most simplistic approach which can be employed to
handle the intercorrelation that exists amongst the repeated measures collected per
individual within a longitudinal study. It involves compiling the information pro-
vided by the multiple observations into a single summary variable, meaning that more
straightforward analytical approaches can be employed to the now uncorrelated sum-
mary variables, of which there is only one per individual [49]. That is to say, the
approach is based upon modifying the data so as to suit the standard cross-sectional
methods of analysis, rather than changing the method of analysis itself. Common
derived variables include: (a) an ‘average across time’ variable, whereby the repeated
measures are used to generate an average for each individual [50], (b) a ‘change-score’
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variable, where the change in response between the individuals’ first and last obser-
vations is calculated, and (c) an ‘average rate of change’ variable, giving the average
change between successive observations of each individuals’ response.
There are a number of disadvantages associated with the derived variable approach.
Firstly, summarising the repeated measures into a single observation can sacrifice the
validity of the model by removing potentially informative data from the analysis. For
example, an individual whose repeated measures show a negative trend over time could
generate the same overall average as an individual whose repeated measures follow a
positive trend; vastly different response profiles can generate the same derived variable.
In such scenarios, whilst sufficient data was collected through the repeated measures
to observe differences within the individuals which may be significant, the distinctions
were lost in generating the derived variables, compromising the legitimacy of the results
produced by the analysis. A similar loss of information occurs when calculating the
‘change score’ variable, as all but the first and last observations per individual are
disregarded, meaning the analysis is blind to anything that occurs within this time
interval.
Calculating a change score derived variable also presents additional challenges. The
approach relies on the observed data having a balanced structure, and is vulnerable
to missing observations and dropouts. In order to reasonably compare the change
over time for each individual, it is necessary that all individuals are observed for
the same length of time, otherwise those individuals who are observed for a shorter
period will have less of an opportunity for the change to be observed. The two most
commonly employed mechanisms to handle dropout are completer analysis, where
only those individuals who were fully observed are retained within the analysis, or last
observation carried forward (LOCF), where the last recorded observation, irregardless
of the time at which it was made, is utilised to represent the individual’s profile at study
completion. Completer analysis can yield biased results as the individuals retained
within the analysis may not represent the target population, and LOCF introduces
bias as change scores observed over different time periods are being directly compared
without considering that longer time periods allow for greater changes to occur. LOCF
can also impact estimates of the means and standard deviations when employed to
impute missing data.
The uncertainty within a derived variable is proportional to the number of repeated
measures used to derive it. This means that, in cases where the data is unbalanced
and individuals have different numbers of observations, there is a different uncertainty
for each individuals’ derived variable, thus violating the homoskedasticity assumption
for standard ANOVA techniques [47].
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The derived variable approach to longitudinal data analysis has a long history;
in 1936, for example, Woodman et al. [51] conducted an investigation into the effect
of a high protein diet on the growth rate of pigs. Within the experiment, three
feeding treatments were tested by way of both group and individual feeding, with
baseline and weekly weight measurements recorded for each pig. Within the analysis,
however, only the first and last recorded weights were utilised to calculate a change
score variable, disregarding all intermediate observations. In 1938, Wishart [52], noted
that this omission of observations may lead to potential loss of information, and instead
proposed modifying the method of analysis so as to incorporate the raw repeated
measures data, rather than the derived variables.
2.2.2.2 Repeated Measures Analysis of Variance
Repeated measures analysis of variance (rANOVA) was one of the first methods of lon-
gitudinal data analysis to consider utilising the full set of the raw repeated measures
collected in their unaltered form [41], and it does so by extending the simple ANOVA
paradigm to include a single, individual-specific, random effect. The approach is com-
parable to that of the randomised block design, described by Fisher [53], commonly
utilised within cross-sectional analysis when there exists some grouping (or “blocking”)
factor present within the experiment.
A block effect is a categorical variable which, in some way, groups together obser-
vations into similar classes which are inherent within the experimental units, rather
than imposed by experimental design; the blocks are typically of no intrinsic inter-
est but rather a nuisance variable which needs to be controlled for. That is to say,
in order for valid inferences to be drawn when such clustering exists, the source of
this between-block variation must be identified and isolated so as to prevent it from
either confounding with the parameter estimates of the model or being misidentified
as residual error. The classic example of a randomised block design, presented by
Fisher [53], was concerned with designing an experiment to compare different types of
fertiliser. Within the investigation, each of the fertilisers was tested across a number
of fields, where each field was partitioned into various plots so as multiple fertilisers
could be tested within each field. When conducting the analysis and evaluating the
performance of the fertilisers, it was considered that, naturally, there would exist in-
herent variability in the performance of the fertilisers between the fields due to the
underlying baseline fertility of the fields themselves, which additionally may contribute
to the response of interest. To overcome this, a blocking variable for each field was
introduced, representing the effect of the baseline fertility, preventing it from con-
founding with the effect of the fertilisers. Similarly, then, a blocking effect could be
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considered within a longitudinal study to represent the underlying influence of any
unobserved, individual-specific features or characteristics which also have an impact
on the response of interest [54].
The rANOVA model is a simplistic form of what is now commonly referred to as a
random intercept model, within which individuals’ trajectories are allowed to deviate
from the overall population average by some individual-specific random effect, denoted
bi, which is considered fixed over time. Consequently, the total variation within the
rANOVA model which is not explained by the covariates is considered to come from two
sources: (i) the variation caused by the individual characteristics, denoted bi, where it
is assumed bi ∼ N(0, σ2b ) and (ii) the residual error, denoted ij , where ij ∼ N(0, σ2e).
There were a number of limitations associated with the early rANOVA approach.
Firstly, it imposed a strict compound symmetric covariance structure on the data
whereby it is assumed that the variances and covariances remained fixed over time [55],
whereas intuitively it would be expected that the variance would increase and covari-
ance would decrease as the time gap between observations gets larger. This restriction
was later alleviated by Greenhouse and Geisser [56] to allow for more general covari-
ance structures. Secondly, the model, at least before later developments proposed by
Henderson [57], required a balanced data structure with an equal number of observa-
tions recorded at fixed observation points for each individual, and was vulnerable to
the effects of missing values. In fact, individuals with missing values were often omit-
ted from the analysis when employing this approach, creating bias [58] as discussed
previously. Finally, the approach does not have the flexibility to model scenarios where
individuals have unique rates of change over time, along with unique intercept values,
as is often observed in practice, limiting their applicability to real-world data.
Nevertheless, the rANOVA approach was popular due to the relative straightfor-
wardness of the calculations involved and the reliability of the results when fitted to a
balanced dataset which observed the strict assumptions made regarding the covariance
structure of the data. The scarcity of such scenarios in practice, however, meant that
alternative approaches, such as a modification of the multivariate analysis of variance
approach, were also considered and developed.
2.2.2.3 Multivariate Analysis of Variance
In order to overcome some of the limitations faced when employing an rANOVA ap-
proach, longitudinal research moved in the direction of multivariate analysis of vari-
ance; a technique historically utilised within cross-sectional analysis to model multiple,
possibly correlated, response variables of interest [59, 60]. Similarities were observed,
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for example by Box [61], between this notion, and that of modelling multiple ob-
servations per individual on the same response. Namely, that both scenarios have
correlations which must be contended with. This idea was generalised by Potthoff
and Roy [62], in 1964, who proposed a multivariate analysis of variance growth curve
model for the analysis of repeated measures data.
Whilst more computationally intensive, the multivariate approaches to growth
curve analysis are widely regarded within the statistical literature to be superior to
the univariate approach due to their increased flexibility [63–65]. For instance, they
relax the strict compound symmetric assumption from before, instead imposing no
restrictions on the covariances, allowing the model to more faithfully represent the
longitudinal process. However, there are limitations associated with these approaches
as well. Complete balanced data is required and individuals with missing observations
are often omitted from the analysis, creating bias. Also, as the multiple measures
are considered to be distinct rather than repeated observations of the same variable,
time varying covariates cannot be intuitively handled within the analysis; the model
does not explicitly consider how the distinct variables relate to each other, and so the
temporal aspect is not modelled [66].
2.2.3 Linear Mixed Effects Models
The most significant contribution to the analysis of repeated measures data came in
1982 when Laird and Ware [1] proposed what they referred to as the random effects
model for longitudinal data analysis, which forms the basis of modern linear mixed
effects (LME) models. Within their research, they extended previous methodology,
originally proposed by Harville to analyse multilevel data [67], to the specific case of
longitudinal data where observations were considered to be clustered by individuals, as
illustrated previously within Figure 2.1. LME models, now the most common approach
taken to analyse longitudinal data, have been utilised, for instance, in cancer screening
to describe longitudinal changes of cancer biomarkers [68], in AIDS clinical trials to
estimate viral decay rate parameters [69], in depression treatment studies [70] and
diabetes health management evaluation studies [71], to give just a few examples.
2.2.3.1 Background
As discussed previously, hierarchical data presents significant challenges within its
analysis due to the presence of naturally occurring heterogeneity. Whilst specific
focus is given here to the longitudinal scenario whereby observations are clustered
within individuals, in practice hierarchical clustering can occur for many reasons,
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for instance patients can be clustered within hospitals or students clustered within
schools. A significant contribution to the analysis of such clustered data came in
1977, when Harville [67] presented a maximum likelihood estimation approach for a
variance components model with both fixed and random effects, offering a number of
advantages. Namely, the approach had no requirement for balanced data and allowed
explicit modelling of the within-cluster and between-cluster effects.
The benefits of the approach can perhaps best be illustrated by looking at the spe-
cific case of students nested within schools; a common problem discussed within the
literature. Over the years, many studies have been conducted to investigate factors
which influence students’ performance, where the hierarchical clustering of students
within schools must be contended with. In 1976, before the development of Harville’s
approach to clustered data, Bennett [72] investigated the effect of different teaching
styles on pupil performance, with particular attention paid to whether there exists an
interaction between teaching style and pupils’ personality traits. Within the study,
Bennett used questionnaires to establish an idea of educators’ teaching styles and used
cluster analysis to group together teachers of similar style. Likewise, students were
assessed and clustered based on their personality traits. Subsequently, analysis of
covariance was used to determine if there existed significant differences between the
performances of students exposed to different teaching styles, with the results indicat-
ing that a ‘formal’ teaching style lead to greater academic improvement, evaluated via
aptitude tests conducted at the beginning and end of the school year.
The results, although widely referenced, were criticised by Gray and Sutterly [73]
who re-evaluated the research and instead determined that no valid conclusions could
be reached based on the published evidence. They criticised, specifically, the meth-
ods of establishing the clusters of similar teaching styles and highlighted that not
enough was done to control for external influences. Both issues, whilst presenting real
problems to the analysis of such multilevel data in 1976, can be handled in a rela-
tively straightforward manner by using the variance components approach proposed
by Harville. In fact, in 1986, Aitkin et al. [74] discussed the issues encountered within
previous school effectiveness studies and advocated for the use of the newly developed
variance component models for the analysis of studies within which observations are
clustered, referencing the earlier work on variance components models (and their es-
timation) of Laird [75], Dempster, Laird and Rubin [76] and Dempster, Rubin and
Tsutakawa [77].
As mentioned previously, Laird and Ware [1] were the first to extend this method-
ology to the case of longitudinal data, with later contributions coming from Laird [75],
who discussed the computation of the variance components utilising the newly devel-
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oped EM algorithm, and Laird, Lange and Stram [78] who, further investigating the
maximum likelihood computation, solidified the approach as a fundamental longitudi-
nal data analysis technique.
2.2.3.2 Basic Concepts
Broadly speaking, the LME approach to the analysis of longitudinal data involves the
building of a model within which the response variable of interest is defined by both
fixed effects and unobserved, individual-specific random effects. Within this context,
the fixed effects are the observed covariates within the model which are presumed to
have a constant (or ‘fixed’) effect on the rate-of-change of the response variable across
all individuals. Much like the predictor variables within an ordinary linear model,
they explain the population-level variation within the response variable of interest.
The random effects, in contrast, represent any intrinsic characteristics of the indi-
viduals which are unobserved within the data but which have an effect on the response
variable. Because the random effects are individual-specific, it is reasonable to assume
that their influence is exerted over all observations made on the same individual, thus
causing these observations to vary systematically from the overall population average
in a similar way. The random effects represent the source of the heterogeneity within
longitudinal data; observations made on the same individual are more alike to each
other than to observations made on another individual because the two subjects are
influenced by a different set of random effects. The random effects can be thought of
as random variables as they are assumed to follow some specified distribution; most
typically the normal distribution.
Considering the fixed and random effects mathematically, the observed response
for the ith individual, yi, observed at time tij , relates linearly to the fixed effects, φi,
the random effects, ωi, and the residual error, i, as given by:
yi(tij) = φi(tij) + ωi(tij) + i(tij)
= y∗i (tij) + i(tij)
(2.1)
for i = 1, . . . ,m, where m is the total number of individuals observed, and j =
1, . . . ,mi, where mi is the number of observations made on the i
th individual. The
true longitudinal response at time tij , denoted y
∗
i (tij), is given by considering only the
fixed and random effects, thus removing the residual error. The vector of residual errors
for each individual is assumed normally distributed, i ∼ N(0,Ri), and it is commonly
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assumed that Ri = σ
2Imi , where Imi is an (mi ×mi) identity matrix [1, 67].
The fixed and random effects can be defined in a number of ways to specify different
special cases of the LME model. For example, considering the fixed effects to be given
by various explanatory variables with corresponding regression parameters β, as in a
standard linear model, i.e. φi(tij) = x i(tij)β, and allowing the individuals’ intercepts
to vary from the overall population average by some individual-specific constant bi,
i.e. ωi(tij) = bi, produces the rANOVA model discussed previously in Section 2.2.2.2
and given below:
yi(tij) = x i(tij)β + bi + i(tij) (2.2)
where x i(tij) is a (1× r) row vector of r fixed effects observed at time tij , and β is an
(r × 1) vector of the corresponding fixed effects parameters.
This rANOVA formulation is the simplest form of LME model and is often referred
to as a random intercept model, within which individuals can deviate from the popula-
tion average by their intercept only, meaning that their trajectories (or rates-of-change
over time) are defined only by the population-level parameters, i.e. they are assumed
constant across the population.
Allowing individuals to be influenced by multiple random effects instead allows
for more sophisticated models to be built whereby individuals can vary from the
population average in terms of multiple covariates, not just their intercept. Setting
ωi(tij) = z i(tij)bi produces the most generalised formulation of the LME model, given
by:
yi(tij) = x i(tij)β + z i(tij)bi + i(tij) (2.3)
where z i(tij) is a (1 × p) row vector of explanatory variables observed at time tij
defining the (p × 1) vector of random effects, bi. Depending on how this design
vector of the random effects is defined, various special cases of the LME model can be
specified. For instance, allowing z i(tij) = 1 reduces the generalised LME model (2.3)
to the random intercept model (2.2). Letting z i(tij) = x i(tij) gives a special case
referred to as the random coefficients model [46, 79] in which each fixed effect has a
corresponding random effect. Most commonly within the literature two random effects
are considered, allowing individuals to deviate from the population average in terms
of their intercept and their rate of change over time, where z i(tij)bi = bi0 + bi1tij .
In matrix notation, the generalised model (2.3) for individual i, introduced by Laird
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and Ware [80], is given by:
y i = X iβ + Z ibi + i, i = 1, . . . ,m (2.4)
where
y i is an mi × 1 vector of the mi observed responses for individual i,
X i is an mi × r design matrix of the r observed covariates for individual i,







β is an r × 1 vector of the unknown population (or fixed effects) parameters,
Z i is an mi × p design matrix of the p random effects for individual i,







bi is a p× 1 vector of the unknown, individual specific random effects,
i is an mi×1 vector of the residual error terms, where it is assumed i∼N(0, σ2Imi).
Similarly to the residual errors, the random effects are assumed multivariate nor-
mally distributed, bi∼N(0,D), where D is a p× p positive-definite covariance matrix
of the individuals random effects. The observed longitudinal responses can be consid-
ered conditionally independent given random effects, y i|bi ∼ N(X iβ+Z ibi, σ2Imi),




































which has a corresponding log likelihood given by:















Alternatively, the general LME model, given by Equation (2.4), can be expressed
in its marginal form:
y i = X iβ + 
∗
i (2.8)
where ∗i denotes the total between- and within-individual variation, i.e. 
∗
i = Zibi+i,




2Imi , and allowing V i = Z iDZ
′
i + σ
2Imi means y i an be considered to
be multivariate normally distributed, y i ∼ N(X iβ,V i).
The individual random effects, bi, are latent variables; although not explicitly
observed within the data they are still of interest as they affect the individual level
variation and so are still estimated. This is done using an extension to the Gauss-
Markov theorem, developed by Harville [81] in 1976, where an estimate of bi for each





i (y i −X iβ) (2.9)
2.2.3.3 Linear Mixed Effects Models in Literature
Since its initial development in the early 1980s, the LME model has enjoyed a great deal
of advancement, with contributions and extensions coming from many different areas
of statistical interest. In 1984, for instance, Stiratelli et al. [82] generalised the LME
model for serial observations with a binary response, utilising the EM algorithm to
23
2.3. Survival Analysis
estimate the unknown parameters. The authors compared their approach favourably
to that of an earlier two step method, developed by Korn and Whittemor [83], high-
lighting the newer approach’s ability to utilise all available data to give more reliable
results, where as the earlier approach required individuals with low response rates to
be excluded from the analysis, potentially causing bias.
In 1990, Lindstrom and Bates [84] further developed the work of Harville and
Laird and Ware when they introduced non-linear mixed effects models, allowing more
complicated longitudinal trajectories to be modelled. Gibbons and Hedeker [85], in
2000, described the application of the LME model to complex residual error structures
whereby the assumption Ri = σ
2Imi does not hold. Instead they considered different
types of auto-correlated errors, defined by a parameter of autocorrelation. The stan-
dard two level LME model was extended to three levels by Gibbons and Hedeker [86],
motivated by the idea of multi-centre longitudinal clinical trial data where observa-
tions are nested within individuals and individuals within clinical centres. They also
presented a three level example of individuals nested within classrooms within schools.
2.3 Survival Analysis
Survival analysis is the area of statistical research concerned with analysing the time
from a well defined origin until an event of interest occurs [87]. Such techniques have
a wide variety of applications, where focus primarily lies in quantifying the effect
of various covariates on this time-to-event. For instance, they have been utilised
extensively within clinical trials to identify treatment interventions which significantly
improve survival time [88], within engineering to estimate the lifetime of electrical
components [89] and in addiction studies to investigate factors which affect the time
to relapse after a period of abstinence [90], to give just a few examples.
2.3.1 Features of Survival Data
There are a number of features associated with survival data which make typical meth-
ods of regression analysis redundant, and instead require specialist approaches to be
applied in order for valid inferences to be drawn. Firstly, it is commonly observed that
the event times are not normally distributed, but rather positively skewed, meaning
that methods of analysis based on the normality assumptions cannot be relied upon.
Secondly, it is typical that not all individuals within a survival study experience the
event of interest while under observation, either as a result of premature dropout from
the study, or due to the event not occurring during the pre-specified observation pe-
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riod. Ignoring such individuals can result in model mis-specification and may result
in biased parameter estimates, and so they must instead be incorporated within the
analysis in some way, despite their missing response variable. This is done through
censoring.
Consider that the true event time for individual i is given by τ∗i , and allow Ci to
represent the censoring time, i.e. the last time point at which an individual is observed
before being lost to followup. If Ci < τ
∗
i then individual i is censored and their true
event time, τ∗i , is never observed; all that is known about it is that it occurs at some
time after Ci. The observed data within a survival investigation thus consists of each
individuals final observation time, τi = min(τ
∗
i , Ci), along with an indicator variable,
δi, which takes the value 1 if the final observation time corresponds to the true event
time and 0 if it alternatively corresponds to a censoring time.
The censoring mechanism can be classified as either informative or non-informative,
depending upon whether there exists a relationship between the probability of being
censored and the survival process under investigation.
Informative censoring occurs when an individual drops out of a study for some
reason which relates to the survival process. For instance, in a survival investi-
gation which aims to evaluate the effect of a treatment intervention on the time
to death in cancer patients, informative censoring occurs if an individual pre-
maturely drops out of the study due to a negative side effect of the treatment.
When censoring is informative, the failure rates of those individuals observed
within the study are significantly different from the failure rates of those who
have dropped out [91].
Non-informative censoring occurs, in contrast, when an individual withdraws from
a study for reasons unrelated to the survival process, for example due to reloca-
tion. The failure rates of such individuals are not considered to vary significantly
from those individuals observed within the study
Much like when observations are missing not at random (MNAR) within a longi-
tudinal study, as defined by Rubin [48], the options for dealing with informative right
censoring are somewhat limited [19]; the observed data does not provide enough infor-
mation to appropriately model that information which is missing. Consequently, the
majority of literature focuses on cases where censoring is considered non-informative.
The final unique feature of survival data relates to conditioning; when estimating
individuals’ survival time, it has to be considered that the probability of survival
changes as time progresses. For example, if the average estimated survival time of
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individuals infected with some disease is seven years from the point of diagnosis, it
has to be considered that an individual who is still alive at a time point six years
after diagnosis is going to have an increased probability of surviving for seven years
than an individual who is alive at only one year after diagnosis. Therefore, it is
important to obtain survival probabilities that are conditional on the current status
of the individual.
2.3.2 Survival Distributions
An observed event time within a survival study can be thought of as a continuous
random variable drawn from some underlying distribution, defined by a probability
density function. Two additional functions are often also employed within survival
analysis to summarise the time-to-event data: the survivor and hazard functions [92],
as described below.
Hazard Function, h(t)
The hazard function, denoted h(t), represents the instantaneous risk of the event of
interest occurring within the interval [t, t+ δt), where δt represents some infinitesimal
variation in t, conditional upon the individual having survived until time t. The hazard









The survivor function, denoted S(t), represents the probability that the event of in-
terest occurs after some specified time t, and is given by:
















where f(·) denotes the probability density function, F (·) the cumulative distribution
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function and H(·) is referred to as the cumulative hazard function.
The survivor function is an intuitive way to consider how censored individuals can
be incorporated within the analysis; whilst their exact event time may be unobserved,
it is at least known to occur at some point beyond their censoring time i.e. τ∗i > Ci.
Density Function, f(t)
The probability density function, which can be interpreted as the rate of change of the
cumulative distribution function, is given by the product of the survivor and hazard
functions, as shown:
f(t) =




The expressions for the hazard, survivor and density functions depend upon the
assumed distribution of the event times, where the most commonly employed distri-
butions are the exponential, Weibull, gamma and log-normal due to their ability to
represent positively skewed data. However, as outlined within Chapter 1, this research
focuses instead on utilising the Coxian phase-type distribution to represent the survival
process, where the Coxian is discussed fully within Chapter 3.
2.3.3 Fully Parametric Survival Models
When fitting a survival model under the assumption that the event times follow a spec-
ified underlying distribution, the model is said to be parametric; both the distribution
of the event times and the effect of the covariates are described by parameters which
are estimated during the model fitting procedure. When employing such a parametric
approach, the likelihood function of the survival process is given by:









where the censoring process is assumed independent of the survival process and S(τi)
and h(τi) are defined according to the assumed underlying distribution. Note that
censored individuals only contribute to the likelihood through their survivor function,
S(τi), as their event time is unobserved.
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There are two common parametric approaches to the analysis of survival data;
proportional hazards (PH) models and acceleration failure time (AFT) models, which
are described briefly in Sections 2.3.3.1 and 2.3.3.2 below.
2.3.3.1 Proportional Hazards Models
Within statistical literature, PH models are perhaps the most common approach taken
to analyse time-to-event data, where they quantify the effect of various covariates on
the hazard of experiencing the event of interest. Consider, for example, a clinical trial
designed to compare the effect of two treatment interventions on individuals’ survival.
If h1(t) represents the hazard function of those individuals who receive treatment 1,
under the PH model formulation it is assumed that there exists some constant, denoted
ξ, such that the hazard function of those individuals who receive treatment 2 is given
by h2(t) = ξh1(t). As ξ is constant, this imposes a proportional hazards assumption





This constant ξ represents the ratio of the hazard of experiencing the event for
individuals in treatment group 2, relative to the hazard of individuals in treatment
group 1. The PH model can be generalised to quantify the effect of a vector of
covariates, both binary and continuous, on the hazard of experiencing the event of
interest by parameterising the hazard ratio such that ξi = exp{w ′iγ} for individual i,
where w i represents a vector of covariates with corresponding regression parameters
γ. In doing so the covariates are assumed to have a multiplicative effect on the hazard
of death, where the hazard function for individual i is given by:





where h0(t) represents the baseline hazard.
Despite their popularity within the literature, a disadvantage of PH models is
that it is common for the proportionality assumption to be violated, meaning the
inferences drawn from the models cannot be relied upon. AFT models, discussed in




2.3.3.2 Acceleration Failure Time Models
Acceleration failure time (AFT) models are an alternative to PH models which can
be employed when the PH assumption does not hold. Instead of evaluating the effect
of the explanatory variables on the hazard of experiencing the event of interest, AFT
models alternatively consider the effect of the explanatory variables directly on the
survival times.
Consider, once again, a clinical trial designed to compare the effect of two treat-
ment interventions. If S1(t) represents the survivor function of those individuals who
receive treatment 1, under the AFT model formulation it is assumed that there exists
some constant, again denoted ξ, such that the survivor function of those who receive
treatment 2 is given by S2(t) = S1(ξt).
Within this context, ξ is referred to as the acceleration factor, where:
• ξ > 1 indicates an acceleration towards death (and thus a shorter survival time)
in treatment group 2, relative to group 1,
• ξ < 1 indicates a deceleration towards death (and thus a longer survival time)
in treatment group 2, relative to group 1.
As within the PH model, the AFT model can also be generalised to quantify
the effect of various covariates, this time on the individuals’ survival times. The
generalised survivor function for the ith individual under the AFT model formulation






where S0 is the baseline survivor function and where ξ has this time been parameterised
such that ξi = exp{−w iγ}, with w i representing a vector of covariates and γ their
corresponding AFT regression parameters.
2.3.4 Semi-parametric Survival Models
When fitting a fully parametric PH model, discussed within Section 2.3.3, the effect
of the covariates, given by γ, and the baseline hazard, h0(t), are estimated separately,
with the covariate parameters being estimated first and subsequently utilised to give
an estimate of h0(t) [87]. However, it can alternatively be considered that the PH
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model, given by Equation 2.15, can be expressed as a linear model for the logarithm






= w ′iγ. (2.17)
As it is not necessary to estimate h0(t) in order to make inferences regarding the
effect of the covariates on the relative hazard ratio, hi(t)/h0(t), it is therefore not
necessary to make any assumptions regarding the distribution of the survival times.
The model is called semi-parametric as the parameters which define the underlying
distribution of the survival times are not estimated during the model fitting procedure.
Instead, the covariate parameters of this Cox PH model are estimated by maximising
the partial likelihood, given by [2]:












where R(τi) is the set of all individuals who have not experienced the event of interest
at time τi, referred to as the risk set. While fully parametric models can be limited
in terms of their scope due to the necessity of appropriately capturing the underlying
distribution of the survival times, the semi-parametric Cox PH model can be employed
to survival times according to any distribution, due to unrestricted functional form of
the hazard.
2.3.5 Time-varying Survival Models
A well noted limitation of the previously discussed PH and AFT models is that they
do not allow for time-varying covariates to be incorporated within their analysis, po-
tentially limiting their scope. Indeed, with the increased collection of longitudinal
data, as discussed within Section 2.2, it is becoming increasingly common for repeated
measures to be made on various covariates relating to an individual’s health condition
throughout the observation period of a survival study. Omitting these observations
from the survival model can result in the loss of valuable information.
The first approach to incorporate repeated measures within a survival model was
proposed by Andersen and Gill [93], who extended the Cox PH model to allow the
hazard to be defined by:
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where it can be observed that the vector of explanatory variables, w i, now depends
on time, t. The partial likelihood of this model is given in a similar form to that of
the Cox PH model by:

















A limitation of this approach is that it requires the time varying-covariates to be
fully observable for each individual during the entire time for which they were under
observation [94]. Consider, for example, that an individual q experiences the event of
interest at time τq, and that at this time there are 2 individuals, r and s, also within




















where w r(τq) and w s(τq) represent the vectors of covariate values for individuals r and
s, observed at time τq, i.e. at the event time of individual q. This means, then, that in
order to fit the time-dependent Cox model it is necessary to observe the covariate val-
ues for all individuals at each event time at which they are at risk. Whilst this may be
attainable for exogenous covariates, it is not typically possible for endogenous covari-
ates, such as individual biomarker readings. When employing the time-dependent Cox
model to such endogenous covariates there is typically a large portion of missingness
within the data. Often the LOCF approach is used to impute these missing values,
introducing bias. In addition to this, the time-dependent Cox model does not take into
consideration that the repeatedly observed covariate may be prone to measurement
error, further exacerbating this bias [95].
2.4 Joint Modelling of Longitudinal and Survival Data
In healthcare modelling, it is typical for longitudinal and survival data to be collected
simultaneously and, in such scenarios, it is often observed that there exists an asso-
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ciation between the two processes [96]. Indeed, this interrelationship has been widely
discussed within statistical literature, where previous research has shown that inde-
pendently modelling the longitudinal and survival processes, utilising the methods
discussed within Sections 2.2 and 2.3, can lead to biased results if such a relationship
exists [9, 97]. Joint modelling techniques, consequently, are a relatively recent sta-
tistical development which aim to model both processes simultaneously, utilising all
available data relating to both longitudinal progression and survival outcome, in order
to make valid inferences about the two processes.
Whilst joint modelling approaches are necessary, most obviously, when interest
lies specifically in evaluating the association between some longitudinal biomarker and
a related survival outcome (i.e. the longitudinal and survival processes are of equal
importance), they are also required when only one of the processes is the target of
investigation, but where the other has an impact which needs to be taken into consid-
eration and controlled for. That is to say, joint modelling approaches are necessary to
make valid inferences when interest lies in modelling [98]:
i. the longitudinal response, when there exists informative dropout during the ob-
servation period [99], or
ii. the survival process, when interest lies in incorporating some time-varying en-
dogenous covariate measured with error, or
iii. the extent of the latent association which is assumed to exist between both the
longitudinal and survival processes.
It is easy to envisage the potentially large scope of joint modelling techniques
within the fields of medicine and public health. Consider, as an illustrative example,
the case of an individual admitted to hospital suffering from some disease. During their
hospital stay, it is typical that repeated measures are made through time on various
biomarkers which change in a way that reflects the underlying health condition of
the patient. Intuitively, the changes in these markers may possess some predictive
potential of a related future event outcome, either through their true empirical values
or, importantly, through their rate of change over time. For example, at a certain
point in time it may be that two individuals have approximately the same level of
a biomarker covariate, indicating that they will have a similar survival experience.
However, when looking at the patients’ histories through their repeated measures, it
may be that one individual’s biomarker levels have been rapidly declining, where as the
other individual’s levels have remained fairly constant. Whilst the dynamic nature of
the marker suggests the former individual’s health condition is quickly evolving, with
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the latter’s remaining fairly constant, a cross-sectional view of the biomarker does not
incorporate this information within the model. Joint models, on the other hand, can
incorporate the informative patient history, improving the reliability of the results.
2.4.1 Two-stage Approach
Modern joint modelling techniques often reference back to research conducted by Tsi-
atis et al. [5, 100] and Self and Pawitan [6, 101], who were interested in overcoming
the bias within survival models which occurrs when dealing with time-varying covari-
ates, and De Gruttola and Tu [8, 102] who, conversely, wanted to overcome the bias
introduced to longitudinal models as a result of informative dropout. Each of these
three pioneering ideas looked specifically at modelling the association between a longi-
tudinally observed endogenous biomarker in HIV patients, alongside a corresponding
survival process. Whilst each of their approaches varied slightly, they all proposed a
two-stage methodology where, in stage one, the process which was of secondary inter-
est, but considered to introduce bias into the primary model, was fitted, and, in stage
two, an unbiased feature of this process was incorporated within the primary model,
yielding unbiased estimates of the association parameters.
Tsiatis et al. [5,100], interested in modelling the association between changing CD4
cell counts and the related survival times in HIV patients, acknowledged two common
problems when observing endogenous covariates and evaluating their relationship with
survival. Firstly, the covariates are observed intermittently and so a full covariate
history, necessary when fitting a time-dependent Cox model, is typically not available
for each individual, and, secondly, it is common for the covariates to be observed with
some degree of measurement error. As an alternative to the time-dependent Cox,
a two-stage approach was proposed whereby, in stage one, a growth curve random
coefficients model was employed to generate personalised trajectories using empirical
Bayes estimation approaches, as originally described by Laird and Ware [80]. Within
this model, each individual’s CD4 cell count was described by an individual-specific
intercept and slope and was given by:
y∗i (tij) = θi0 + θi1tij (2.22)
where θi0 represents the intercept, or initial CD4 cell count, and θi1 the slope, or rate
of change of CD4 cell count, for individual i.
In stage two, estimates of the individuals’ true covariate values for every time-
point at which they are at risk are incorporated into a time-dependent Cox model so
as to evaluate their effect on survival. Furthermore, the authors also considered the
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possibility of incorporating other features of the individuals’ repeated measures trajec-
tories as potential predictors within the survival model. For example, they examined
whether the individual-specific slopes, θi1, as well as the true CD4 cell counts, may
have a strong association with survival outcome by fitting a survival model given by:
hi(t) = h0(t) exp
{
y∗i (t)α1 + θi1α2
}
(2.23)
where α1 is the regression parameter corresponding to the individuals’ true CD4 cell
count at their death time and α2 is the regression parameter associated only with the
individuals’ slope.
Whilst it was concluded that the individuals’ unbiased CD4 cell counts were a
significant predictor of survival, in this case it was found that the individual-specific
slopes did not significantly contribute to the likelihood. However, this idea of incorpo-
rating features of the random effects within a survival model, alongside or in place of
the true longitudinal response, forms the basis of the random effects parameterisation
of modern joint likelihood approaches, discussed fully within Section 2.4.3.
Self and Pawitan [6,101], interested in modelling the association between repeated
observations on the ratio of individuals’ T4 to T8 cell counts and the time until AIDS
diagnosis in HIV patients, proposed a similar two-stage approach. This time, within
stage one, a more traditional LME-type formulation to represent the longitudinal pro-
cess was utilised, similar to Equation (2.4), where the model was fitted using the
method of least squares by conditioning on the random effects. In stage two, they
employed a survival model based on the multivariate counting processes of Ander-
son and Gill [93], modified so as to assume a linear relative risk form for the effect
of the longitudinal process on survival, due to the fewer distributional assumptions
regarding the random terms within the model, as noted by Prentice [95]. Other (pos-
sibly time-varying) covariates were also included within the survival model, where, for
these covariates, the standard multiplicative form was assumed. The resulting survival
model was of the form:




1 + y∗i (t)α
)
(2.24)
where w i is a vector of additional covariates with regression parameters γ.
Similar two-stage approaches were proposed by Dafni and Tsiatis [103], who in-
corporated empirical Bayes estimates of the time-dependent covariate at each event
time within a Cox PH model, and Boycott and Taylor [104], who used population
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smoothing methods employing a LME model with a stochastic process to generate
more accurate estimates of the longitudinal response at each event time which were
then incorporated within a time-dependent Cox model.
The primary drawback of these two-stage approaches is that they assume non-
informative dropout during the observation of the longitudinal response. If this is not
the case, as is often found in practice, then bias shall exist within the longitudinal
model fitted in stage one, compromising the validity of the results.
De Gruttola and Tu [102], also in 1992, had the similar intention of removing the
bias of one process on the other, but were instead primarily focused on modelling
the rates of change of individuals’ longitudinal response, where some observations
were missing due to informative dropout. Specifically, they noted that the number of
repeated measures made on the time-dependent covariates for each individual is related
to the individual’s survival time, whereby those individuals who survive longer will
have a greater number of repeated measures recorded. Modelling longitudinal response
in the presence of such informative censoring situations has been previously discussed
by Wu and Carroll [105], who proposed a likelihood ratio test for informativeness
and employed a probit model to derive coefficients corresponding to the informative
censoring process which could then be incorporated within a mixed effects model.
De Gruttola and Tu proposed an extension of this methodology to consider a wide
range of growth curve models where there exists a relationship between survival out-
come and longitudinal response. Focusing specifically on the association between CD4
cell count and survival outcome in HIV patients, they estimated the contribution of
each individual to the likelihood of the LME model by conditioning on their random
effects, bi, assuming that the probability of being censored was unrelated to the in-
dividual’s event time and that this conditional probability was independent of the
longitudinal process. Fitting the model parametrically, assuming normally distributed
random effects and that the joint distribution of CD4 cell counts and survival times
is multivariate normal, allowed the EM algorithm to be employed to give estimates of
parameters which describe the relationship between longitudinal response and survival.
Whilst these two-stage approaches can successfully correct for the measurement er-
ror which is commonly encountered within a repeatedly observed covariate, as well as
overcome the disadvantages associated with the periodic nature of endogenous covari-
ates’ observation scheme, where the LME model can be utilised to predict the ‘true’
covariate at any time-point, they are still prone to producing biased estimates [96,106].
For example, when fitting a LME model in stage one, the effect of the survival process
on the longitudinal process is not taken into consideration, and subsequently, the po-
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tentially informative history of the individuals’ repeated measures is not incorporated
within the survival model. As such, joint likelihood approaches were explored within
the literature.
2.4.2 Joint Likelihood Approach
In order to overcome the aforementioned sources of bias which are encountered when
employing either the independent or two-stage approaches, methodological advance-
ments have been developed to instead consider both the longitudinal and survival
processes simultaneously through a single joint likelihood [3, 4]. This technique has
been shown within the literature to yield better estimates of the longitudinal and
survival parameters by more appropriately modelling the association between both
processes [9, 97].
Depending upon the target process of interest, as well as the assumed underlying
relationship between the two processes, this joint likelihood can be factorised in dif-
ferent ways to specify different formulations of the same model. Although, as noted
by Hogan and Laird [107], the joint likelihood approach is global in the sense that all
joint formulations are valid for each process and that factorising the likelihood with
a particular target in mind does not affect the models overall likelihood, merely the
interpretation of the parameters. The three common formulations, as described by
McCrink et al. [108], are given below:
Selection Models: [Y,T ,b] = [T |Y] [Y|b] [b] (2.25)
Pattern-mixture Models: [Y,T ,b] = [Y|T ] [T |b] [b] (2.26)
Shared Parameter Models: [Y,T ,b] = [Y|b] [T |b] [b] (2.27)
where Y represents the longitudinal process, T the survival process and b the latent
random effects.
Selection models [109, 110], within which the survival process is conditional upon
the longitudinal process, which itself is dependent upon the random effects, are most
commonly employed in scenarios where the survival process is of primary interest, but
considered to be influenced or associated with a longitudinal process which must also
be taken into consideration.
Conversely, pattern-mixture models [111] assume the longitudinal process to be
conditional upon the survival process, which is dependent upon the random effects,
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making these models particularly applicable to scenarios whereby the longitudinal pro-
cess is of primary interest. They have historically been explored within the literature
to overcome missingness when analysing two continuous variables [112], and later to
model the dropout mechanism in repeated measures data [113]. Hogan and Laird [107]
and Sousa [114] provide a comprehensive overview of selection and pattern-mixture
models.
This research focuses primarily upon the shared parameter joint likelihood for-
mulation, where both the longitudinal and survival process are conditional upon the
random effects, which represent the latent association between the two process. Not-
ing the limitations of the two-stage approaches discussed within Section 2.4.1, it was
Faucett and Thomas [3] who, in 1996, first considered estimating the parameters of
both submodels simultaneously under the shared parameter formulation, where they
employed the Markov chain Monte Carlo (MCMC) method of Gibbs sampling to esti-
mate the joint posterior distribution of all the unknown parameters. The methodology
was illustrated using simulated data, where the joint approach gave unbiased estimates
of the parameters compared to the independent fitting of both models.
In 1997, Wulfsohn and Tsiatis [4] instead proposed a maximum likelihood approach
to simultaneously estimate the longitudinal and survival parameters through a single
joint likelihood utilising the EM algorithm. A LME submodel was utilised to model
the longitudinal response, and a Cox PH submodel to represent the survival process,
where only the true value of the longitudinal response, yi(t)
∗, was considered as a
possible predictor of survival in what is referred to as the true longitudinal response
(TLR) parameterisation of the joint likelihood, discussed fully in Section 2.4.4.
Henderson et al. [9], in 2000, generalised this approach of Wulfsohn and Tsiatis in
a number of ways, firstly by incorporating baseline covariates as additional predictors
within the survival model. Secondly, they considered other features of the longitudinal
trajectory which may have a strong predictive potential of the survival outcome, such
as the individuals’ deviations from the population average, represented by the random
effects, similarly to Self and Pawitan [6, 101], rather than exclusively considering the
estimated true longitudinal response, yi(t)
∗.
Within their generalised modelling framework, they proposed that the longitudinal
and survival processes be related through a subset of the individual’s random effects,
ωi(t) = {ωi1(t), ωi2(t)}, where ωi1(t) influences the longitudinal response and ωi2(t))
the survival outcome. These two subsets of random effects have a latent association
which is described by the cross correlation between ωi1(t) and ωi2(t) which constitutes
a latent bivariate Gaussian process.
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So, for example, allowing the longitudinal response to be represented by a LME
model of the form:
yi(tij) = x i(tij)β + ωi1(tij) + i(tij) (2.28)
where x i(tij)β represents the trajectory of individual i at time tij , as described by
the population-level fixed effects, and ωi1(t) represents the additional influence of
individual-specific random effects. Typically, these random effects are specified by
ωi1(tij) = bi0 + bi1tij , where bi0 represents the individual-specific intercept and bi1 the
individual-specific slope, as described in Section 2.2.3.
The hazard of individual i at time t, then, is given by:
hi(t) = h0(t) exp
{
w ′iγ + ωi2(t)α
}
(2.29)
where ωi2(t) could represent any feature of the longitudinal response and where α
represents the corresponding parameter estimate(s).
In the previous case described by Wulfsohn and Tsiatis, the true longitudinal re-





α. Additionally, however, Henderson et al.’s approach allows for increased
flexibility where ωi2(t) can be alternatively specified. For example, multiple features of





bi0α2 + bi1α3, which evaluates the effect of (i) the true longitudinal response, (ii)
the individual-specific deviation from the population-average intercept and (iii) the
baseline individual-specific deviation from the population-average slope, on survival.
Henderson et al. employed the EM algorithm approach proposed by Wulfsohn and
Tsiatis to maximise the joint likelihood and estimate the unknown parameters of both
submodels.
With Faucett and Thomas [3], Wulfsohn and Tsiatis [4] and Henderson et al. [9]
providing this joint likelihood framework, early developments focused on extending
the approach for alternative submodels. For instance, Wu [115], in 2002, motivated by
the common application of non-linear mixed effects models to represent variations in
viral load of HIV patients, and wishing to overcome the potential measurement error
and informative dropout which can occur therewithin, proposed a joint likelihood
approach within which the non-linear mixed effects model was used to represent the
longitudinal process and a Monte Carlo EM approach was utilised to estimate the
unknown parameters.
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Alternatively, consideration has been given to modelling the longitudinal process
utilising a LME model with a stochastic component. Henderson et al. [9], alongside
their generalisation of Wulfsohn and Tsiatis’s joint likelihood approach, also considered
incorporating a stationary Gaussian process within the longitudinal submodel, where
an EM algorithm approach was used to maximise the likelihood. Similarly, Salah et al.
[116] incorporated an integrated Ornstein-Uhlenbeck process within the longitudinal
submodel, utilising a Bayesian approach to estimate the unknown parameters due to
the complexity of the model. Spline based approaches to representing the longitudinal
process have also been explored within a joint model framework; Brown et al. [117]
utilised non-parametric cubic B-splines to model the longitudinal process, where the
joint likelihood was maximised using the MCMC algorithm. A similar approach was
explored by Rizopoulos et al. [16] who instead estimated the parameters using a ML
formulation.
With regard to the survival process, whilst it is convention within standard survival
analysis to leave the baseline of a Cox PH model unspecified, this can lead to an
underestimation of the standard errors within a joint modelling framework [11]. In
order to overcome this, a fully parametric survival model can alternatively be utilised to
represent the survival process, such as those described within Section 2.3.3. It is noted
within the literature, however, that this can potentially limit the range of baseline
hazards which can be accurately represented [12]. Rizopoulos [19] proposed that the
step function approach of Whittemore and Killer [118] could instead be employed to
generate non-parametric estimates of the baseline, or spline based approaches such as
those proposed by Rosenberg [119] and Herndon and Harrell [120] could similarly be
implemented.
Within this research, the survival process shall be represented by the Coxian phase-
type distribution; a fully parametric approach, described in full within Chapter 4.
It is well noted within the literature that phase-type distributions can be utilised
to approximate any positive distribution arbitrarily closely [121], therefore making
them more robust than the standard parametric survival approaches more commonly
utilised.
Another common focus within the literature relates to the Gauss-Hermite quadra-
ture approach to numerically approximate the (typically multi-dimensional) integral
of the joint likelihood with respect to the random effects. Rizopoulos [19] noted that
the computational difficulty of this numerical integration “constitutes the main reason
why joint models have not yet found their rightful place in the toolbox of modern ap-
plied statisticians.” In an attempt to improve the model fitting procedure, Rizopoulos
et al. [16] and Lin et al. [122] have explored the use of Lapalace approximations, due
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to their being more computationally efficient, particularly in cases with high dimen-
sionality of the random effects. Rizopoulos [17] has also proposed a pseudo-adaptive
Gauss-Hermite approach to improve the computation time of the standard Gauss-
Hermite.
2.4.3 Random Effects Parameterisation
Under the random effects (RE) parameterisation of the joint likelihood, the association
between the two processes is represented solely by the random effects, bi, which are
present within both submodels. Joint models which observe this RE parameterisation
can be fitted using the ‘joineR’ package within R Software [21], where the longitudinal
process is represented by a LME model and the survival process by a Cox PH model,
as shown below.
Longitudinal Submodel:
yi(t) = x i(t)
′β + bi0 + bi1t+ i(t) (2.30)
Survival Submodel:
hi(t) = h0(t) exp
{
w i
′γ + bi0α0 + bi1tα1
}
(2.31)
Under this parameterisation, inferences can be made on the effect of a deviation
from the population-average intercept or population-average slope on the survival pro-
cess. For example, an individual whose intercept is one unit higher than the population
average shall have a hazard which is exp{α0} times that of the hazard of the population
average, so long as all other covariates remain constant.
The joint likelihood of the longitudinal and survival processes under the RE pa-
rameterisation, marginalised over the random effects, is given by:




f(y i|bi;θy)f(τi, δi|bi;θτ )f(bi;θb) dbi (2.32)
where:
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where D is the variance-covariance matrix of the random effects.
The Gauss-Hermite quadrature, or the pseudo-adaptive quadrature, is commonly
employed to numerically approximate the integral with respect to the random ef-
fects [17, 19]. Further, for the integral with respect to time within f(τi, δi|bi;θτ ),
an analytical solution cannot be obtained and instead it is necessary to approximate
these integrals. Commonly, this is done using a 7-point or a 15-point Gauss-Kronrod
rule [123].
2.4.4 True Longitudinal Response Parameterisation
Within the true longitudinal response (TLR) parameterisation, unbiased estimates
of the true longitudinal process, denoted y∗i (t), are incorporated within the survival
submodel so as to allow explicit inferences to be made regarding the effect of the
longitudinal response directly on survival. Joint models which observe this TLR pa-
rameterisation can be fitted using the JM package within R Software [14], where
typically the longitudinal process is represented by a LME model and the survival
process by either a PH or AFT model, allowing for various underlying distributions
to be assumed. The submodels of the two processes, when survival is represented by
a Cox PH model, are shown below.
Longitudinal Submodel:
yi(t) = x i(t)β + bi0 + bi1t+ i(t)
= y∗i (t) + i(t)
(2.37)
Survival Submodel:
hi(t) = h0(t) exp
{
w i











Under this model formulation, exp{α} represents the relative increase in the hazard
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at time t as a result of a one unit increase in the longitudinal response at the same
point in time.
The joint likelihood of the longitudinal and survival processes under the TLR
parameterisation, marginalised over the random effects, is again given by Equation
2.32, where f(y i|bi;θy) and (bi;θb) are as defined previously within Section 2.4.3,
but where:






























As can be observed, the longitudinal fixed effects parameter, β, is now incorporated
within the survival submodel, complicating the maximisation of the likelihood as a
closed form expression of β cannot be obtained.
2.5 Summary
This chapter begins with a review of the independent methods of analysis for both lon-
gitudinal and survival data, before exploring the motivation behind the development
of joint modelling techniques, whereby both process are estimated simultaneously.
Alongside a review of the core developments within the theory of joint modelling, a
number of limitations of standard joint models are identified as targets within this
research. Specifically:
i. Employing the Cox PH model to represent the survival process within a joint
modelling framework results in the underestimation of the standard errors due
to the semi-parametric nature of the model [11], which has motivated the devel-
opment of alternative representations of the survival process,
ii. Despite their intuitive interpretations, fully parametric representations of the
survival process are not readily employed within a joint modelling framework
due to limitations on the distributional shapes which they can represent [12],
bolstering the popularity of piecewise constant baseline hazards approaches, as
well as spline-based techniques, to model the survival process [19],
iii. When interest lies in making predictions on survival outcome from a joint model,
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previous literature has established parametric models to be advantageous in
comparison to spline based and piecewise constant approaches.
Within Chapter 3, the Coxian phase-type distributions, and the associated Coxian
phase-type regression model, is explored as a potential alternative representation of
the survival process. Whilst phase-type distributions offer a number of unique fea-
tures, overcoming these aforementioned limitations, they also constitute a growing
area of statistical research themselves, and their incorporation within a joint models
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This chapter begins by introducing the standard methodology of phase-type distribu-
tions and exploring previous literature within this area of statistical research. Par-
ticular attention is paid to the Coxian phase-type distribution due to its suitability
for representing typical flow patterns and its previously established applicability to
typical survival analysis problems. Phase-type regression models, an extension to
standard phase-type distributions which allow for covariates to be incorporated, are
also introduced and an overview of their previous applications is presented.
Within Section 3.3, a new methodological approach to fitting phase-type regression
models is detailed. This introduces an EM algorithm approach which is utilised due to
its increased stability when fitting standard phase-type distributions, compared to pre-
viously applied fitting procedures such as the Nelder Mead (NM) and Quasi-Newton
(QN) algorithms. Further methodological developments to this new EM algorithm
approach are discussed within Section 3.4, detailing alternative formulations of the
model which allow more in-depth inferences to be drawn regarding the covariates’
effects on the system. Finally, within Section 3.5, the phase-type regression method-
ology is extended to allow for the inclusion of time-varying covariates, significantly
increasing the scope of the models which, in current literature, cannot handle such
covariates. Simulation studies are presented throughout, validating each of the new
methodological advancements.
3.2 Phase-type Distributions
Phase-type distributions are a diverse family of distributions which describe the ab-
sorption times of a finite state Markov process in continuous time with a single absorb-
ing state [22], formulated by a convolution of exponential distributions, either in series
or parallel. As described by Neuts [124], phase-type distributions are a mathemati-
cally tractable way to approximate any positive distribution to an arbitrary degree of
accuracy, which makes them a potentially attractive approach to represent survival
data. In fact, such an advantage has been previously noted by Faddy [125], who re-
marked that phase-type distributions are advantageous in their ability to represent
a greater variety of hazard shapes, particularly compared to the standard exponen-
tial and Weibull distributions which are limited to constant or monotone hazards,
respectively.
Consequently, phase-type distributions are explored within this research as a po-
tential alternative representation of the survival process within a joint model formu-
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lation. Their fully parametric nature overcomes the previously discussed limitations
experienced with semi-parametric survival models, while their ability to represent any
positive distribution to an arbitrary degree of accuracy overcomes the noted constraints
of alternative fully parametric approaches. Further, as shall be explored within this
chapter, phase-type distributions have a number of unique advantages, compared to
standard survival models, in terms of the inferences which can be made on the system
that they represent, providing further insight into the process under investigation.
With that said, the application of phase-type distributions to typical survival anal-
ysis problems, in comparison to their more common usage within queueing theory
and flow modelling, remains relatively novel, with little exploration beyond that of
Aalen [28], who first proposed their applicability to biostatistics survival problems. As
such, extensions to phase-type distributions to facilitate such implementations have
occurred more recently within their history. For instance, they were adapted to handle
censored individuals in 1996 [31], and the phase-type regression model, developed to
incorporate covariate effects, was first proposed in 2012 [30].
As such, this chapter begins by reviewing standard phase-type distributions, be-
fore exploring advancements to the methodology so as to overcome some of the more
inhibiting limitations of the models. Through this, phase-type distributions can be es-
tablished as a more suitable approach to represent the survival process within a joint
model, later explored fully within Chapter 4.
3.2.1 Background
The practice of fitting phase-type distributions began in 1917, when Erlang [23], inter-
ested in modelling the service times within a telephone exchange system, considered
that the overall time spent within a queue could be represented by a series of n iden-
tical exponential distributions, defined by rate parameter λ. Conceptually, this is
tantamount to assuming that the individuals within the queue progress through an
underlying Markov chain of n transient states, before service, where they are then
considered to enter the single absorbing state of the system, denoted state 0. This
idea is represented diagrammatically within Figure 3.1
Erlang’s so called ‘method of stages’ forms the basis of modern queueing theory [24],
and the idea of utilising a convolution of exponential distributions, in series or other-
wise, has subsequently been generalised in many ways to define a highly versatile class
of probability distributions, referred to as phase-type [22]. For example, the hypo-
exponential distribution is one such generalisation which relaxes the assumption that
















Figure 3.1: An illustrative representation of the Erlang distribution, where λ rep-
resents the rates of transition through the states of the underlying Markov process.
rates to vary across the underlying states, or ‘phases’ [126]. The Coxian phase-type
distribution is a further generalisation which allows individuals to enter the absorbing
state from any of the n transient states of the system, not just the final nth state.
In general, phase-type distributions are therefore considered to represent the dis-
tribution of the absorption times of any continuous time, finite state Markov process
with a single absorbing state, where the phase-type distribution is defined by the un-
derlying Markov process which it represents. Consequently, there is a certain duality
to the parameters of a phase-type distribution; while they can be considered holisti-
cally to represent the overall distributional shape of the absorption times, they can
also be considered individually to represent the rates of flow through the underlying
states of the Markov process which they represent.
Exploring these ideas mathematically, let us consider a continuous time Markov
process,
{
St, t ≥ 0
}
, defined on a state space
{
0, 1, ..., n
}
, where 0 is absorbing
and 1, ..., n are transient. For each pair of states j and k, there exists an associated
transition intensity, representing the instantaneous risk of transitioning from state j
into state k, which is given by:
qjk = lim
δt→0







where δt represents an infinitesimal time increment.
These transition intensities can be represented within a transition intensity matrix,
Q, which can be block partitioned to specify T, a sub-generator matrix representing the
instantaneous risk of transitioning among the transient states within the system, and t,
an exit vector representing the state-specific failure rates, or the rates of transitioning
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where the zero terms along the top row indicate that state 0 is absorbing.
Additionally, a transition probability matrix, P(t), whose jkth entry represents the
probability of the process being in state k at time t, given that it was in state j at time











The absorption times, τi, of such a Markov process with a single absorbing state
are thus distributed according to a phase-type distribution, defined by two parameters:
p, a (1× n) row vector indicating the probability of beginning the Markov process in
each of the n transient states, and T, the (n× n) sub-generator matrix of the system,
as shown:
τi ∼ PH(p,T).
The probability density function of the phase-type distribution is given by:





where t is the exit vector given by t = −T1, 1 is an (n × 1) vector of ones and θτ
represents the set of unknown parameters of the distribution; θτ = {p,T}. Similarly,
the survival probability of the phase-type distribution is given by:












Whilst there are clear similarities between phase-type distributions and Markov
models, specifically in that they are both concerned with estimating the unknown
transition parameters of the sub-generator matrix T, they are different both in terms
of the scenarios in which they can be utilised and in their primary target of inference.
When fitting a standard Markov model:
• the number of states within the system, as well as the criteria for determining
to which state an individual belongs, is typically set out and defined in advance,
based upon prior knowledge of the system under investigation,
• repeated measures are required, through time, to explicitly observe the current
state of the system, where the likelihood is given by the product of the transition
probabilities at all observation times over all individuals [128,129],
• the objective of the model is to accurately represent the rates of flow amongst
each of the states of the system; whilst the overall distribution of the absorption
times can subsequently be represented by the estimated transition intensity ma-
trix, the distribution is not considered during the parameter estimation process.
In comparison, when fitting a phase-type distribution:
• the number of states within the underlying Markov model is typically unknown
and determined based upon that number which provides the best fit to the
distribution of the absorption times, where likelihood ratio tests can be used to
compare fits with increasing numbers of phases to identify the optimal number
[130],
• no criteria is imposed upon the system to specify to which state an individual
belongs; instead the fit, and number of underlying phases, is solely influenced by
the data,
• only the single observation on an individual’s absorption time is utilised to fit
the model,
• the primary objective is to estimate the parameters which best represent the
distributional shape of the absorption times, where making inferences from these
parameters on the rates of flow of individuals through the underlying Markov
process is a secondary additional benefit.
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Phase-type distributions are therefore beneficial when employed to represent a
process where there is an assumed but unobserved underlying Markov process, where
interest may lie in making inferences regarding the rates of flow through this process
in the absence of the repeated observations. For example, applying phase-type distri-
butions to survival data can potentially uncover stages of a disease’s progression and
allow inferences to be made regarding how quickly individuals deteriorate through the
stages of the disease. This uncovered information can provide insight into a patient’s
future quality of life, and can help inform treatment interventions; an individual who
spends the majority of their survival time in the early stages of a disease before quickly
transitioning through the more severe stages just before death will require different
medical interventions than someone who will conversely spend the majority of their
survival time in the more severe stages of the disease. Previously, Faddy and Mc-
Clean [131], for example, have employed phase-type distributions to represent patient
length of stay in hospital, utilising the uncovered states in this way to identify short,
medium and long stay patients.
3.2.2 The Coxian Phase-type Distribution
The Coxian phase-type distribution [127], as previously mentioned, is a generalisation
of the Erlang distribution which allows individuals to either (i) transition sequentially
through the transient states of the underlying system with phase-specific intensities,
denoted λj , or (ii) to transition from any transient state into the absorbing state, again





















Figure 3.2: An illustrative representation of the Coxian phase-type distribution,
where µj represents the rate of absorption from state j and λj represents the rate
of transition from state j into state j + 1.
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The corresponding sub-generator matrix and exit vector of the Coxian phase-type
distribution are given by:
T =

−(λ1 + µ1) λ1 0 . . . 0
0 −(λ2 + µ2) λ2 . . . 0

















where it is assumed that all individuals begin the process within the first state of the
system, i.e. p = (1, 0, 0 . . . , 0).
The Coxian phase-type distribution is of particular interest within this research
due to the fact that the typical flow patterns of a queue or survival process are well
represented by the underlying Markov process of the Coxian. For example, when
employing the Coxian to represent a failure process, the sequential transitions through
the transient states can represent ageing, whilst the absorption transitions represent
failure, with the uncovered phases representing different stages of the process [125].
When applied to the survival times of individuals suffering from some disease, it can
be possible to map the uncovered states of the Markov model onto distinct stages
of the disease’s evolution, allowing meaningful inferences regarding the rates of flow
through these stages to be obtained.
Previously, the Coxian phase-type distribution has been employed extensively to
represent patient length of stay in hospital, where the transient phases of the system
represent different stages of care, and patients can ‘absorb’ (i.e. leave the hospital) from
any stage within the system [131–133]. They have also been employed, for instance,
to represent operating and repair times of a device [134] and to fit heavy-tailed data
within finance and insurance risk [135], to give just a few examples.
From a fitted Coxian phase-type distribution, Faddy [125], along with Marshall
and McClean [133], previously considered estimating the proportion of failures which
occur from each phase. The probability of experiencing the event of interest from each
transient state, denoted ρj , is calculated by multiplying the probability of first surviv-
ing until the jth state by the probability of absorbing from that state. A generalised













, for j = 1, ..., n (3.9)




The ordered event times can then be subdivided into the ratio ρ1 : ρ2 : ... : ρn,
making it possible to determine n length of stay groups, Wj ,:
Wj =
{
τ (i) : M
j−1∑
g=1






where τ (1), ..., τ (M) are the ordered absorption times of the M individuals. This allows
the identification of which individuals leave the system from which states, subdividing
the data into groups with similar survival distributions. Further study of these groups
can potentially provide more insight into what characteristics influence how individuals
move through the system. This approach, however, imposes the assumption that all
individuals who are absorbed from the first phase do so before any individuals are
absorbed from the second phase, and so on. It does not allow for a scenario whereby
one individual may quickly deteriorate through the system and absorb from the final
phase faster than another individual may absorb from the first phase, for example.
Conversely, within the EM algorithm approach to fitting phase-type distributions,
discussed in detail later, the expected time each individual spends within each state
is approximated within the E-step of the algorithm, overcoming this limitation.
Employing the forward Kolmogorov equation [136] to calculate the matrix expo-
nential of the probability density function, given by Equation 3.5, whilst utilising the
probabilities of absorption from each state, allows an analytic expression for the prob-

























and where λn = 0.
3.2.2.1 Fitting Procedure
Phase-type distributions, in general, are well documented to suffer from identifiability
issues; the same shape of distribution can be represented by multiple combinations
of parameters, i.e. the distribution is non-singular [39], and the high number of un-
known parameters which need to be estimated can often result in convergence to a
local rather than global maximum [138]. Lang and Arthur [40], for instance, have
previously investigated various approaches to evaluate the quality of the estimated
parameters from both maximum likelihood and moment matching fitting procedures.
Within their research, they noted the non-singular nature of phase-type distributions,
showing that simulated distributions could be approximated by subsets of the phase-
type distribution, and they concluded that a superior parameter estimation technique
does not yet exist.
Coxian phase-type distributions, in comparison to more generalised phase-type
distributions which allow transitions amongst all states within the underlying Markov
process, alleviate this problem somewhat by reducing the number of parameters from
n2 − n to 2n − 1, whilst still retaining the ability to fit any positive distribution
to an arbitrary degree of accuracy [33]. However, accurate methods for estimating
their parameters is still considered an open problem [39, 40, 130] which, as noted by
Marshall and Zenga [138], is caused by “the non-linear problem of fitting, the number
of parameters to be simultaneously optimised and the non-unique representations of
phase-type distributions”. To date, various fitting procedures have been explored
within the literature, with varying levels of success.
The Nelder-Mead (NM) algorithm is perhaps the most common approach, utilised
by Faddy [130], Fackrell [139] and Marshall and McClean [140], for example, to
maximise the likelihood of the model. Moment matching techniques have also been
used [141], although Riska et al. [142] noted them to be ineffective at capturing the long
tails of the distribution. Faddy [143] has also previously employed simple least squares
along with a Quasi-Newton (QN) minimisation algorithm to estimate the unknown
transition parameters, whereas Marshall and Zenga [138] have used the QN algorithm
to instead perform maximum likelihood estimation. Marshall and Zenga [144], along
with Payne et al. [145] have further discussed and compared different fitting procedures
for the Coxian phase-type distribution, with Marshall and Zenga noting that whilst
the QN algorithm is more effective computationally, the NM produces average param-
eter estimates which are closer to the simulated values. Asmussen et al. [33] instead
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used the EM algorithm to estimate the unknown parameters within phase-type distri-
butions, treating the single observations made on the individuals’ absorption times as
an incomplete observation on the full Markov process.
It has been extensively shown within phase-type literature that the maximisation of
the likelihood is strongly influenced by the starting values of the unknown parameters;
occasionally the problem converges towards a local maxima rather than the global
maximum [146]. As the number of phases increases, so too does the number of unknown
parameters and, consequently, the complexity of the maximisation problem, often
increasing the number of initialisations which either fail to converge within the pre-
specified criteria, or converge to a local maxima. Such convergence issues are symptoms
of the previously discussed identifiability issues which are associated with fitting phase-
type distributions and the extent of these failed convergences can vary depending on
the algorithm employed to maximise the likelihood. Therefore, in order to determine
the true best fit to the data, it is necessary to make multiple initialisations of the
starting parameters, where the best fit is subsequently chosen based on a combination
of the log-likelihood value, the shape of the estimated probability density compared
to the empirical data and, where possible, clinical or professional input regarding
expected rates of flow through the system under investigation.
3.2.3 The Coxian Phase-type Regression Model
Due, in part, to recent applications of the Coxian phase-type distribution within more
conventional survival analysis settings, it has become of increased interest to incorpo-
rate covariates within the distribution so as to make inferences regarding their effects
on the rates of flow through the underlying Markov process. However, a limited num-
ber of approaches to do so have been explored within the literature. Faddy [147], in
2009, considered the mean length of stay in the system to be dependent on various
covariates using the log-link exp
{
α + w ′iγ
}
, where w i is a vector of covariates with
corresponding regression parameters γ. A fully Bayesian approach to this method
was adopted by McGrory [148]. In 2012, Tang et al. [30] proposed the Coxian phase-
type regression model, where instead the transition rate parameters were regressed on
various covariate effects:
qjk = q0jk exp{−w ′iγ} (3.13)
where q0jk is the baseline intensity of transitioning from state j to k and w i is a vector
of covariates with corresponding regression parameters γ. Theoretically, this same
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approach can be taken to any phase-type distribution, not only one which is Coxian,
where the probability density function is then given by:




t exp{−w ′iγ} (3.14)
where an AFT parameterisation is adopted, as shall be the case for the remainder of
the novel research within this thesis.
This methodology, however, makes some restrictive constraints, specifically im-
posing the assumption that a covariate will have the same effect on each transition
intensity. Consequently, within this model set-up, γ is interpreted as the accelera-
tion effect of the covariate on the rate of flow through the entire system as a whole,
where this effect is assumed to remain fixed over time. Whilst this is a standard as-
sumption within conventional survival AFT models, it is in contrast to the standard
approaches taken to estimating the effect of covariates within a Markov model, where
transition-specific inferences regarding a covariate’s effect can be made [149].
3.2.3.1 Comparison to Standard Survival Regression Models
As previously mentioned, one of the advantages of the Coxian phase-type distribu-
tion which is of particular interest within this research is its ability to represent any
positive distribution to an arbitrary degree of accuracy [33,124]. In comparison, alter-
native survival distributions are noted within the literature to be restricted in terms
of the distributional shapes which they can represent [125], limiting the scope of fully
parametric survival models to cases where the data is known to observe a certain base-
line distribution. The Coxian phase-type regression model, on the other hand, does
not suffer from this same limitation, and instead can suitably represent any distribu-
tional shape by increasing the number of phases until the inclusion of an additional
phase does not significantly improve the fit of the distribution. This idea can be best
illustrated by way of an example.
Survival data was simulated according to an inverse-gamma distribution (chosen
for its less-typical shape) with a single covariate effect. Subsequently, standard survival
models which assume (i) an exponential, (ii) a Weibull, (iii) a log-normal and (iv) a log-
logisic distribution were fitted to the data, with the estimated baseline distributions
plotted alongside the simulated distribution within Figure 3.3. As can be observed, the
Weibull and exponential distributions did not capture the true shape of the simulated

































Figure 3.3: Estimated probability density functions from fitting (i) exponential,
(ii) Weibull, (iii) log-normal and (iv) log-logistic survival models to the simulated
data.






























Figure 3.4: Estimated probability density functions from fitting the Coxian phase-
type regression model with increasing numbers of phases to the simulated data.
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Subsequently, the Coxian phase-type regression model was fitted to the same data,
and by increasing the number of underlying phases it can be observed from the plotted
density functions within Figure 3.4 that the fit of the Coxian distribution continued
to improve until convergence towards the true simulated density. Thus, employing the
Coxian phase-type regression model is beneficial within survival analysis as no prior
knowledge of the baseline distribution of the data is necessary; its shape can always
be captured by the Coxian.
3.2.3.2 Fitting Procedure
Beyond the research of Tang et al., there has been little published within the literature
regarding the estimation of covariate effects within phase-type distributions; Faddy et
al. [147] used built-in Matlab functions such as fminsearch to maximise the likelihood
of their covariate dependent mean model. Tang et al. [30] instead extended a Bayesian
approach, previously used by Ausin et al. [150], to fit the Coxian phase-type regression
models.
To date, an EM algorithm approach to estimate the parameters of the phase-
type regression model has not been investigated, despite the EM algorithm’s increased
stability compared to the NM and QN algorithms when fitting standard phase-type
distributions. Consequently, within this research, such an EM algorithm approach is
developed and, subsequently, the increased stability of the approach is leveraged so
as to relax the restrictive assumptions made regarding the covariate effects. As such,
this new EM algorithm approach significantly advances both the work of Asmussen et
al. [33], which does not account for covariate effects, and previous phase-type regression
models which do not allow transition-specific inferences of the covariate effects.
3.3 A New EM Algorithm Approach to Fitting Phase-
type Regression Models
The EM algorithm, as formalised by Dempster et al. [76], is an iterative two step ap-
proach to obtain maximum likelihood estimates when handling data which is in some
way incomplete. Whilst this missingness typically stems from incomplete observations
in the traditional sense, the methodology is also applicable to cases where there exists
some unobserved latent variable within the likelihood which must first be approxi-
mated [151], as is the case with the latent random effects within the LME model,
for example. Similarly, when fitting phase-type distributions, the single observation
on an individual’s absorption time can be regarded as an incomplete observation on
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the individual’s full path through the underlying Markov process, where the missing
data is comprised of the states the individual visits, and the time spent within these
states [152].
The contribution to the complete likelihood of individual i is given by the product
of the probability densities for all possible transitions through the underlying Markov
model, as shown:








fijk(Eij ;θτ ) (3.15)
where Eij is the expected time individual i spends in state j, and fijk(Eij ;θτ ) is the
probability density of individual i transitioning from state j into state k at this time.
The parameters which maximise this likelihood also maximise the likelihood of the
phase-type distribution which corresponds to the density function given by Equation
3.14. The density of fijk(Eij ;θτ ) can be expressed as the product of the hazard and
survivor functions:
fijk(Eij ;θτ ) = Sijk(Eij ;θτ )hijk(Eij ;θτ )
Nijk (3.16)
where Nijk represents the probability of transitioning from state j into state k.
The hazard of this transition is given by:
hijk(Eij ;θτ ) = q0jk exp{−w ′iγ} (3.17)
and the corresponding survivor function (where ‘failure’ in this case is exiting the
state) is given by:













where the vector of covariates, w i, is assumed time-invariant.
Equation 3.16 is comparable to Equation 2.13, where the density function of a
typical fully parametric survival model is given by the product of the survivor function
and hazard function taken to the power of the event indicator, δi. Therefore, when
an individual is censored, δi = 0 and only the survivor function contributes to the
58
3.3. A New EM Algorithm Approach to Fitting Phase-type Regression
Models
density, whereas if the event is explicitly observed, δi = 1 and both the survivor and
hazard functions contribute to the density. On the other hand, when fitting a phase-
type distribution using the EM algorithm approach, the individuals’ paths through
the underlying Markov process are unknown and it is not explicitly observed whether
or not an individual makes each transition from state j to state k. This uncertainty
is incorporated within the model via Nijk, the probability of the transition from state
j into state k occurring during the observation period.
For instance, if an individual is censored it is known that they do not enter the
absorbing state during the observation period, i.e. Nij0 = δi = 0 for all j. Conversely,
if an individual is observed to experience the event of interest, it is known for certain
that they absorb from one of the transient states in the system, i.e.
n∑
j=1
Nij0 = δi = 1.
Taking the survivor function to the power of Nijk ensures the correct estimation of
the density, where Nijk are approximated within the E-step.
The contribution to the overall likelihood of individual i transitioning from state
j into state k is thus given by:
exp
{





and after incorporating the probability of beginning the process in each of the under-
lying states, given by p
Bij
j , the overall likelihood of the complete Markov process for
an n-phase type regression model can be expressed as:



























q0jk is the jk
th element of the baseline transition intensity matrix, Q =
(




representing the transition intensities when w ′iγ = 0 ,
pj is the j
th element of the phase-type initialisation vector, p, representing the overall
probability of beginning the Markov process in state j,
Bij is the individual-specific probability that individual i begins the Markov process
in state j,
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Eij is the total time individual i spends in state j,
Nijk is the probability that individual i will make a transition from state j into state
k at some point during the time for which they are in the system,
Nij0 is the probability that individual i belongs to state j at the moment before they
experience the event of interest and transition into the absorbing phase,
w i is a vector of covariate values for individual i, with corresponding regression pa-
rameters γ, and,
m is the total number of observed individuals.
The approach taken to handle censored individuals extends upon that discussed
by Olsson [31] for the incorporation of censored individuals within an EM algorithm
approach to fitting standard phase-type distributions without covariate effects. It has
been adapted within this research for the phase-type regression model.
The corresponding log-likelihood is given by:

























where the EM algorithm approach to maximising this likelihood is detailed below.
3.3.1 E-Step
When fitting phase-type distributions, the observed event times, i.e. τi = min(τ
∗
i , Ci),
along with the event indicator, δi, and covariate values, w i, comprise the observed
information for each individual. This means that the ‘missing’ data to be approximated
for each individual within the E-step of the algorithm consists of:
i. the probability of beginning the process in each of the underlying states, Bij ,
ii. the total time spent within each underlying state, Eij ,
iii. the probability of a transition occuring between each pair of states, Nijk, and
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iv. the probability of absorbing from each of the underlying states, Nij0.
Consequently, on any given iteration of the EM algorithm, the expected values
of these latent variables are calculated, based on the current best estimates of the
unknown parameters, θτ = {p, T, γ}. It should be noted that, for some specific
phase-type distributions, such as the Coxian, it is assumed that all individuals start
the process within the first state of the underlying system, meaning that both Bij and
p are known in advance, and are therefore not required to be predicted or estimated.
For completeness, and to illustrate the methodology for the general case, the prediction
and estimation of Bij and p, applicable in cases where this assumption is not made,
is discussed here, however they shall not be required within subsequent applications
which utilise the Coxian phase-type distribution.
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cijk(τi | θτ )q0jk exp{−w ′iγ}
pdi(τi | θτ ) (3.24)







aij(τi | θτ )q0j0 exp{−w ′iγ}
pdi(τi | θτ ) (3.25)
where Nij0 = 0 for censored individuals. The values of aij(τi | θτ ) and cijk(τi | θτ ),
as well as the elements of the vector di(τi | θτ ), denoted dij(τi | θτ ), are given by:






























where ej is the j





= 1, where 1 is a vector of ones. The derivation of
these expected values are presented within Appendix A. The Runge-Kutta numerical
approximation can be utilised to predict aij(τi | θτ ), dij(τi | θτ ) and cijk(τi | θτ ), as
implemented by Asmussen [152] for phase-type distributions without covariate effects,
or aij(τi | θτ ) and dij(τi | θτ ) can be calculated analytically using the current best
estimates of θτ , and cijk(τi | θτ ) can be numerically approximated using the Gauss-
Kronrod rule [123].
3.3.2 M-Step
Within the M-step of the algorithm, the log-likelihood is maximised and closed form





















, for j = 1, . . . , n. (3.30)
As closed form estimates of the covariate parameters can not be obtained, a one-step
Newton Raphson process is used on the (l+1)th iteration to obtain updated estimates
of γ:
γ̂(l+1) = γ̂(l) −H(γ̂(l))−1S(γ̂(l)) (3.31)
where the score vector, S(γ), and Hessian matrix, H(γ), are given by:
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−q0jkw iw ′i exp{−w ′iγ}Eij
}
. (3.32)
3.3.3 Simulation Study One
A simulation study was conducted to validate the new EM algorithm approach to
fitting phase-type regression models and to compare the new methodology to previ-
ously employed NM and QN algorithm approaches. Within the study, to illustrate
each of the three algorithm’s robustness, or lack thereof, to an increasing number of
phases and covariates, four scenarios were considered, where datasets were generated
consisting of:
i. two underling phases, defined by baseline transition parameters q010 = 0.05,
q020 = 0.10 and q012 = 0.30, influenced by a single continuous covariate generated
from a uniform distribution, wi ∼ unif(−3, 3), with corresponding regression
parameter γ = 0.2,
ii. two underlying phases, defined by baseline transition parameters q010 = 0.05,
q020 = 0.10 and q012 = 0.30, influenced by two covariates, one continuous:
wi1 ∼ unif(−3, 3), and one binary: wi2 ∼ unif{0, 1}, with corresponding regres-
sion parameters γ1 = 0.3 and γ2 = −0.4,
iii. three underlying phases, defined by baseline transition parameters q010 = 0.02,
q020 = 0.10, q030 = 0.20, q012 = 0.15 and q023 = 0.25, influenced by a single
continuous covariate, wi1 ∼ unif(−3, 3), with corresponding regression parameter
γ = 0.6, and,
iv. three underlying phases, defined by baseline transition parameters q010 = 0.02,
q020 = 0.10, q030 = 0.20, q012 = 0.15 and q023 = 0.25, influenced by two covari-
ates, one continuous: wi1 ∼ unif(−3, 3), and one binary: wi2 ∼ unif{0, 1}, with
corresponding regression parameters γ1 = 0.6 and γ2 = −0.2.
The parameters for this simulation study were carefully selected to generate data
which observes the shape of a typical survival distribution; i.e. positively skewed with a
63
3.3. A New EM Algorithm Approach to Fitting Phase-type Regression
Models
long tail, in line with previous simulation studies conducted on the Coxian phase-type
distribution [145].
For each scenario, 100 datasets were simulated using the ‘actuar’ package within R
software [153], each consisting of 400 observations with approximately 20% censoring.
A single initialisation was performed for each dataset using the NM, QN and EM
algorithms, where convergence was considered to be achieved when the difference in
the log-likelihood between two successive iterations was less than 1 × 10−4 and a
maximum of 1000 iterations were permitted.
Within previous literature, a number of performance measures have been employed
to evaluate the success of different algorithms at fitting phase-type distributions [138,
154], two of which are of interest here:
a. Rate of convergence (ROC)
This is a measure of the number of initialisations which satisfy the convergence





b. Rate of algorithm’s success (RAS)
This is a measure of the number of convergences which produce acceptable re-
sults, given by:
RAS =
number of acceptable results
number of convergences
× 100 (3.34)
where an “acceptable result” is one for which the estimated parameters fall
within an acceptable range (here considered to be between 0 and 10), as defined
by Marshall and Zenga [138]. That is to say, not all convergences will suitably
estimate the parameters of the distribution, where some may have converged at a
local maxima rather than the global maximum. Additionally, certain approaches
may be more prone to converging to a subset of the true phase-type distribution,
as discussed by Lang and Authur [155]. The RAS, therefore, gives an indication
of what proportion of those initialisations that converged resulted in a set of
parameters which appropriately represents the true distribution of the data.
For further insight and ease of interpretation, these performance measures are com-
bined within this research to introduce a third metric, the rate of successful conver-
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gence (ROSC), which is a measure of how many acceptable fits are produced, relative
to the total number of initialisations, which is given by:
ROSC =
number of acceptable fits
number of initialisations
× 100 (3.35)
This gives the more intuitive interpretation of the percentage of initialisations, rather
than convergences, which result in an acceptable fit.
3.3.3.1 Results
The ROC, RAS and ROSC scores from the NM, QN and EM algorithm fits for the
four simulated scenarios are given in Table 3.1.
The ROC scores indicate that the EM algorithm successfully satisfies the conver-
gence criteria more often than either the NM or the QN algorithms for each of the
four scenarios, suggesting it to be the most stable method of fitting Coxian phase-
type distributions. In terms of convergence, the NM is both the poorest performing
algorithm and the algorithm which is most affected by increasing number of phases
and/or covariates. For instance, for the three-phase two covariate scenario, only 21%
of the NM initialisations resulted in convergence, compared to 69% for the two-phase
one covariate scenario; the addition of three extra parameters, resulted in more than
a 66% decrease in the number of convergences. The QN algorithm, in contrast to the
NM, seems largely unaffected by the inclusion of additional phases, whilst showing
a slight decrease in ROC with additional covariates. The EM algorithm, conversely,
appears more robust to the inclusion of additional covariates, but exhibited a slight
decrease in ROC with additional phases.
From the RAS scores it can be observed that, for the two phase simulations, both
the EM and QN algorithms have scores of 100%, indicating that all of those initiali-
sations which resulted in convergence provided acceptable parameter estimates. The
NM algorithm, on the other hand, has lower RAS scores, indicating that this approach
is more susceptible to false convergence. Whilst the EM algorithm is more robust to
increasing phases, maintaining its score of 100% for the three phase simulations, the
QN begins to also suffer false convergence, although not to the same extent as the
NM.
The ROSC score combines the ROC and RAS scores to reveal what percentage
of the initialisations resulted in acceptable results, making it easier to infer which
algorithm performs best overall. So, for example, whilst the QN algorithm may be
least affected by increasing the number of phases in terms of ROC, considering this
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along with the RAS scores, which suggest that the QN begins to experience problems
with the quality of its convergences, provides a better insight. It can be observed
that the EM algorithm overall performs significantly better than its competitors, with
ROSC scores which are at least 20% higher than the next best algorithm for each of
the simulated scenarios.
To illustrate how well each of the approaches uncover the true distribution of the
absorption times, the mean probability density of the acceptable fits for the three phase
simulations with one and two covariates are plotted in Figures 3.5 and 3.6 respectively.
For the three phase simulation with one covariate, it can be observed that the mean
of all three algorithms suitably captured the shape of the distribution, although this
was only the case for the NM and QN when the false convergences had been identified
and removed. For the three phase simulation with two covariates, the QN and EM
both captured the shape, with the EM performing marginally better with slightly
smaller confidence intervals. On the other hand, those fits of the NM algorithm which
were retained as “acceptable” did not suitably represent the shape; suggesting this
approach requires more initialisations to yield results which accurately represent the
distribution.
The mean estimates of the covariate parameters for the acceptable results are
given within Table 3.2. It can be observed that the acceptable results of all three
approaches were close to the simulated values, with the EM algorithm having the
smallest standard errors. The EM algorithm is also superior in the sense that further
investigation into those initialisations which converged is not required as they were all
deemed acceptable. In comparison, even after further intervention to remove the false
convergences, the QN and NM still had larger standard errors compared to the EM
algorithm.
Whilst not a primary focus of this simulation study, it can be noted that the
improved accuracy of the EM algorithm comes at the expense of longer computational
times. Previously Payne et al. [145] noted that the timings for a single convergence
of the Coxian phase-type distribution varied significantly depending on the software
employed to fit the models, with MATLAB functions taking approximately 529 seconds
(8.8 minutes) to reach convergence for a three-phase Coxian. Whilst the EM algorithm
approach takes longer for a single initialisation, it has the advantage of not needing as
many initialisations to produce an ‘acceptable result’.
Overall, the newly developed EM algorithm approach is shown to improve upon













































Table 3.1: Summary of the ROC, RAS and ROSC values over 100 simulations for the NM, QN and EM algorithms.
No. of Phases No. of Covs
ROC RAS ROSC
NM QN EM NM QN EM NM QN EM
2
1 69.00 76.00 99.00 88.41 100.00 100.00 61.00 76.00 99.00
2 56.00 67.00 95.00 73.21 100.00 100.00 41.00 67.00 95.00
3
1 38.00 77.00 84.00 18.42 74.03 100.00 7.00 57.00 84.00
2 21.00 69.00 89.00 9.52 84.06 100.00 2.00 58.00 89.00
ROC: Rate of convergence, RAS: Rate of algorithm’s success, ROSC: Rate of successful convergence
NM: Nelder-Mead, QN: Quasi-Newton, EM: Expectation-Maximisation
Table 3.2: Summary of the average parameter estimates and empirical standard errors of the acceptable fits over the 100 simulations
for the NM, QN and EM algorithms.
No. of Phases No. of Covs Parameter Sim
NM QN EM
Est. Std. Err. Est. Std. Err. Est. Std. Err.
2
1 γ1 0.200 0.206 0.005 0.206 0.004 0.201 0.003
2
γ1 0.300 0.306 0.004 0.305 0.004 0.302 0.003
γ2 -0.400 -0.383 0.018 -0.409 0.013 -0.384 0.010
3
1 γ1 0.600 0.605 0.015 0.603 0.003 0.598 0.002
2
γ1 0.600 0.580 0.410 0.602 0.003 0.601 0.002
γ2 -0.200 -0.198 0.140 0.217 0.010 -0.196 0.009
NM: Nelder-Mead, QN: Quasi-Newton, EM: Expectation-Maximisation
Acceptable fits: Those fits for which all parameters fall within an “acceptable range”; here considered to be between 0 and 10.
Est.: Mean parameter estimate, Std. Err.: Empirical standard error
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Figure 3.5: Mean baseline probability densities (and 95% confidence intervals)
of the convergences of the NM, QN and EM algorithm approaches to fitting a
three-phase Coxian with one covariate.
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Figure 3.6: Mean baseline probability densities (and 95% confidence intervals) of
the acceptable results of the NM, QN and EM algorithm approaches to fitting a
three-phase Coxian with two covariates.
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3.3.4 Summary








Step 2 Specify the latent variables which are to be approximated within the E-step
of the algorithm, given by Equations 3.22 − 3.25,
Step 3 Iteratively work through the Expectation and Maximisation steps of the EM
algorithm until a pre-defined convergence criteria is satisfied:
E-Step: Approximate the expected values of the latent variables using Equa-
tions 3.26 − 3.28,
M-Step: Differentiate the log-likelihood, given by Equation 3.21, with respect
to the unknown parameters and solve to generate updated parameter esti-
mates, given by Equations 3.29 − 3.31,
Step 4 Define the final parameter estimates based upon those from the final iteration
of the algorithm.
3.4 Alternative Representation of the Covariate Effects
As previously discussed, the standard formulation of phase-type regression models
imposes the restrictive assumption that a covariate will have a constant effect on all
transitions through the underlying Markov process. Whilst this is done to reduce the
number of additional parameters which are to be estimated by the already unstable
fitting procedures found in current literature, it does so at the expense of limiting
the information which can be gained regarding how a covariate impacts the system
under investigation. In comparison, standard Markov modelling techniques allow for
covariates to have a unique effect on each transition within the system.
A phase-type regression model which relaxes this assumption and instead allows
for the effect of a covariate to vary across transitions offers a number of advantages,
particularly in the cases of disease modelling. For example, many recent studies have
been conducted to evaluate the effect of antiretroviral therapy on the survival of HIV
patients, with a core interest in establishing when treatment intervention should com-
mence so as to ensure the most significant impact. Kitahata et al. [156], for example,
stratified their sample population based on the individuals’ disease progression and
were able to conclude that antiretroviral therapy had a much more significant effect
when administered to patients in the early stages of HIV, and had a much reduced
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impact on those in later stages. Fitting the standard phase-type regression model to
such a scenario may cause the drug’s significant impact on individuals’ deterioration
in the early stages of the disease to be masked by the insignificance in the later stages.
By instead allowing the effect of the drug to vary amongst transitions, it would be
possible to identify such a significant impact on only the earlier transitions through
the system, thus informing intervention strategies.
Within this section, the increased stability of the EM algorithm approach to fitting
phase-type regression models, developed within Section 3.3, is leveraged to relax this
single covariate effect assumption by allowing the covariates to have varying effects
across different transitions. It should be considered, however, that whilst the current
formulation of the model may be too restrictive, a fully flexible model within which
each covariate has a unique effect on each transition will introduce a large number of
additional parameters which may be too liberal and computationally intensive to fit.
To this end, three approaches of relaxing this limitation are considered:
i a state-specific (SS) approach, whereby a covariate is considered to have a single
effect on all transitions from the same state, but varying effects across the states,
as illustrated within Figure 3.7,
ii a direction-specific (DS) approach, whereby the effect of a covariate on the ab-
sorption transitions is considered to be different from the effect on the sequential
transitions through the transient states, illustrated within Figure 3.8 and,
iii a transition specific (TS) approach, whereby the covariates have a unique effect on
each transition within the system, illustrated within Figure 3.9.
These approaches are discussed in more detail within Sections 3.4.1 - 3.4.3 below and
are validated by a simulation study in Section 3.4.4.
3.4.1 State Specific Parameterisation
In order to investigate the potential of a covariate’s effect to vary depending upon
the state from which the transition occurs, a state-specific (SS) parameterisation was
developed within which the effect of the covariate is constant on all transitions from
a single state, but can vary across the states, as illustrated for the Coxian within Fig-
ure 3.7. Within a Coxian phase-type regression model, where backwards transitions
through the phases are not permitted, this parameterisation makes it possible to iden-
tify when a covariate has a significant impact. Under this formulation, the covariate
parameter γ is now dependent upon state j, as shown:
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qjk = q0jk exp{−w ′iγj} (3.36)
where w i is a vector of time-invariant covariate parameters as before and q0jk is the

























Figure 3.7: A Coxian phase-type distribution with state-specific covariate param-
eters, γj .
























and the EM algorithm approach, developed within Section 3.3, is employed to max-
imise the likelihood, where the E-step remains largely unchanged with only the ele-
ments of the sub-generator matrix, T, and exit vector, t, updated to observe the new















the initialisation vector remains unchanged and is given by Equation 3.30, and the
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covariate parameters are again given by a one-step Newton Raphson process where














































−q0jkw iw ′i exp{−w ′iγj}Eij
}
. (3.40)
3.4.2 Direction Specific Parameterisation
An alternative consideration is that a covariate may have a different effect on the event
of interest occurring (i.e on the absorption transitions) compared to on the evolution of
the disease (or transitions amongst the transient states of the system). For example, a
treatment intervention may slow down a diseases progression but have an adverse effect
on the individual’s overall health and increase the hazard of absorption from each of the
underlying states. For example, chemotherapy treatment in cancer patients may slow
down the progression of the disease but could have a negative effect on other aspects of
the individuals health, perhaps weakening the patient’s immune system and increasing
the risk of death from an associated comorbidity. Such a scenario can be evaluated
by allowing each covariate to have two associated parameters: γ0, representing the
effect of the covariate on the absorption rates, and γ1, representing the effect of the
covariate on the rates of transition amongst the transient states:
qjk = q0jk exp{−w ′iγ1} k = 1, . . . , n
qj0 = q0j0 exp{−w ′iγ0}
(3.41)
This parameterisation is illustrated within Figure 3.8, and the contribution to the
overall likelihood of individual i is given by:
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Figure 3.8: A Coxian phase-type distribution with direction-specific covariate pa-




































Again, the E-step of the EM algorithm remains largely unchanged with just the
elements of the sub-generator matrix, T, and exit vector, t, updated to observe the























the initialisation vector remains unchanged and is given by Equation 3.30, and the
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covariate parameters are again given by a one-step Newton Raphson process where



















































































3.4.3 Transition Specific Parameterisation
The final formulation to consider is a transition specific (TS) parameterisation whereby
the covariates have a unique effect on each transition, in the same way as within a
standard Markov model, as shown:
qjk = q0jk exp{−w ′iγjk} (3.49)
where γjk is the effect of the covariate vector wi on the transition from state j into
state k.
This parameterisation is shown diagramatically within Figure 3.9 and the contribution



















































Figure 3.9: A Coxian phase-type distribution with transition-specific covariate
parameters γjk.
The E-step of the EM algorithm is updated so as the elements of the sub-generator
matrix, T, and exit vector t, observe the new covariate parameterisation, as before.















the initialisation vector remains unchanged and is given by Equation 3.30, and the
covariate parameters are again given by a one-step Newton Raphson process where














































−q0jkw iw ′i exp{−w ′iγjk}Eij
}
.
3.4.4 Simulation Study Two
Within this simulation study, there are three primary targets of interest:
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• Firstly, to validate the SS, DS and TS formulations of the new EM algorithm
approach to fitting phase-type regression models,
• Secondly, to compare the performance of this new EM algorithm approach with
the standard NM and QN algorithms previously employed, similarly adapted for
the new covariate formulations,
• Finally, to investigate the loss of information when the constant effect formula-
tion is applied to data which does not truly obey this assumption.
As within the simulation study conducted in Section 3.3.3, four scenarios were
investigated whereby the number of underlying phases, as well as the number of co-
variates incorporated within the model, was increased to assess how well the different
algorithms handled an increasing number of unknown parameters. To this end, for
each of the covariate approaches under investigation, four datasets were simulated to
be Coxian phase-type distributed using the actuar package in R [153], consisting of:
i two underlying phases, defined by baseline transition parameters q010 = 0.05,
q020 = 0.10 and q012 = 0.30, where the effect of the single continuous covariate,
wi1 ∼ unif(−3, 3), on the transition intensities for each of the three approaches
under investigation is given by:
• SS parameterisation: γ1 = 0.2, γ2 = −0.4
• DS parameterisation: γ0 = −0.5, γ1 = 0.4
• TS parameterisation: γ10 = 0.3, γ20 = 0.7, γ12 = −0.5
ii two underlying phases, defined by baseline transition parameters q010 = 0.05,
q020 = 0.10 and q012 = 0.30, where the effect of the two continuous covariates,
wi1 ∼ unif(−3, 3) and wi2 ∼ unif(−3, 3), on the transition intensities for each of
the three approaches under investigation is given by:



































iii three underlying phases, defined by baseline transition parameters q010 = 0.02,
q020 = 0.04, q030 = 0.06, q012 = 0.10 and q023 = 0.20, where the effect of the single
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continuous covariates, wi1 ∼ unif(−3, 3), on the transition intensities for each of
the three approaches under investigation is given by:
• SS parameterisation: γ1 = 0.5, γ2 = −0.4, γ3 = 0.8
• DS parameterisation: γ0 = −0.3, γ1 = 0.2
• TS parameterisation: γ10 = −0.1, γ20 = −0.3, γ30 = −0.4, γ12 = 0.2,
γ23 = 0.4
iv three underlying phases, defined by baseline transition parameters q010 = 0.02,
q020 = 0.04, q030 = 0.06, q012 = 0.10 and q023 = 0.20, where the effect of the two
continuous covariates, wi1 ∼ unif(−3, 3) and wi2 ∼ unif(−2, 2), on the transition
intensities for each of the three approaches under investigation is given by:



















































Within this study, only one dataset was simulated for each of the approaches un-
der investigation, as opposed 100 different datasets, as was the case for Simulation
Study One. The reason for this change in procedure is that this simulation study aims
to investigate the impact of the starting values of the unknown parameters on the
performance of the algorithms under investigation. Using the same dataset for 100
different initialisations, where only the parameter starting values vary across initial-
isation, means that any differences observed can be attributed solely to the starting
values, and not to differences in the datasets used.
The datasets for each approach were simulated to consist of more observations than
previously, 1500 as opposed to 400, so as to minimise sample bias. To ensure that
each algorithm yielded enough convergences to analyse, enough initialisations were
performed on each algorithm so as to generate 100 successful convergences, instead
of performing just 100 initialisations as was done within Simulation One. The RAS
performance measure from the first simulation was retained, and two new measures
were introduced, based upon the mean relative distance to the maximum likelihood
estimates (MRD) measure, previously employed within the literature [138, 154]. The
MRD, along with the two adjustments that were employed here, are described below:
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a. Mean relative distance to the MLEs (MRD)
This is a measure of how close the estimated parameter values are to the true









where W is the number of estimated parameters, ζw is the true parameter value
and ζ̂w is the value estimated by the l
th convergence.







b. MRD of acceptable fits (MRDa)
Instead of calculating the MRD for all convergences, the MRD was instead calcu-
lated for only those fits which were deemed “acceptable”. Different algorithms
may be more prone to converging to local maxima, which results in an “un-
acceptable result”, therefore introducing bias to the MRD. However, the RAS
metric already identifies to what extent this occurs for each of the approaches.
Therefore, the MRDa controls for this bias by evaluating only the quality of





number of acceptable results
(3.54)
where A is the total number of acceptable results and MRDaq is the mean relative
distance calculated using Equation 3.52 for the qth acceptable result.
c. MRD of covariate parameters (MRDc)
As mentioned previously, phase-type distributions suffer from a non-singularity
problem whereby the same shape distribution can be represented by multiple sets
of parameters. This means that it is possible to accurately represent the shape
of the distribution with a set of parameters which are different from the simu-
lated values, resulting in a high MRDa value, despite the fact that they suitably
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represent the data. To remove this effect, and instead evaluate the MRD of only
the covariate parameters, the MRDc measure is introduced. The contribution
to the MRDc of the qth acceptable result can be given by Equation 3.52, where
ζw represents the w





number of acceptable results
(3.55)
3.4.4.1 Results
The RAS, MRDa and MRDc scores for the four approaches are given in Table 3.3.
Looking first a the RAS scores, it can be observed that the NM produces the fewest
acceptable results for each of the SS, DS and TS approaches, just as was observed
for the constant effect (CE) approach within Simulation One, with the EM algorithm
again performing best in terms of the RAS. Similarly, the MRDa and MRDc scores
also indicate the EM algorithm to be the superior of the three fitting procedures for
each of the approaches, as the scores for the EM algorithm are, in general, closest to
zero. It can be seen that as the number of unknown parameters increases, both the
MRDa and MRDc scores increase, indicating that the algorithms begin to increasingly
suffer from the aforementioned identifiability issues.
The higher MRDc scores within Table 3.3 suggest that not all acceptable fits
successfully estimate the true covariate parameter values. Looking more closely at the
SS scenario, the estimated covariate parameters from each of the acceptable fits for the
two-phase simulation, for example, are plotted within Figure 3.10. It can be seen that
the EM algorithm has the highest success rate, as it has the most fits which estimate
the true values of the parameters, which is further validated by the EM algorithm




































Table 3.3: Summary of the RAS, MRDa and MRDc scores over the 100 simulations for the NM, QN and EM algorithms for the
four approaches to incorporating covariates within the Coxian phase-type distribution.
Approach
No of No of RAS MRDa (MRDc)
Phases Covariates
NM QN EM NM QN EM
SS
2
1 91.00 93.00 100.00 1.034 (1.055) 0.269 (0.215) 0.234 (0.145)
2 71.00 100.00 100.00 2.543 (3.302) 0.511 (0.457) 0.126 (0.091)
3
1 35.00 80.00 100.00 4.992 (5.393) 2.864 (1.094) 0.874 (0.944)
2 36.00 91.00 100.00 10.13 (13.19) 1.830 (1.041) 1.605 (1.262)
DS
2
1 73.00 100.00 100.00 1.925 (3.463) 0.718 (0.556) 0.684 (0.610)
2 82.00 100.00 100.00 13.817 (23.079) 0.588 (0.712) 1.018 (1.200)
3
1 45.00 96.00 96.00 4.042 (1.290) 3.183 (1.348) 1.881 (0.403)
2 39.00 92.00 100.00 4.749 (5.293) 2.400 (0.941) 1.416 (1.021)
TS
2
1 81.00 100.00 100.00 3.346 (5.778) 1.405 (1.101) 0.438 (0.400)
2 65.00 100.00 100.00 6.680 (9.139) 1.722 (1.639) 0.544 (0.397)
3
1 38.00 90.00 100.00 7.245 (10.274) 2.989 (1.975) 1.340 (1.279)
2 46.00 79.00 100.00 6.873 (7.982) 3.114 (2.632) 1.842 (2.000)
RAS: Rate of algorithm’s success, MRDa: Mean relative distance of all unknown paramaters utilising the acceptable fits, MRDc:
Mean relative distance of all unknown covariate parameters utilising the acceptable fits
NM: Nelder-Mead algorithm, QN: Quasi-Newton algorithm, EM: Expectation-Maximisation algorithm
SS: State-specific approach, DS: Direction specific approach, TS: Transition specific approach
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For the DS scenario, it can be observed, once again, that not all of the acceptable
fits resulted in an accurate estimate of the ‘true’ simulated covariate parameter value.
Figure 3.11, for example, shows the results of the two phase simulation with one
covariate where it can be observed, similarly to before, that the EM algorithm provides
more accurate estimations of the true effect than the NM and QN.
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True Value: γ22 = 0.4
Figure 3.10: Comparison of the ordered covariate parameter values from the 100
simulations, estimated by employing the NM, QN and EM algorithm approaches to
data simulated according to a two phase Coxian distribution with two covariates,
observing the SS parameterisation.
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True Value: γ1 = 0.4
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True Value: γ0 = −0.5
Figure 3.11: Comparison of the ordered covariate parameter values from the 100
simulations, estimated by employing the NM, QN and EM algorithm approaches
to data simulated according to a two phase Coxian distribution with one covariate,
observing the DS parameterisation.
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Finally, for the TS scenario it can be inferred from the overall higher MRDc values
that fewer of the acceptable fits result in successful estimations of the true covariate
effects, particularly for the NM algorithm. This is shown visually, for example, for the
two phase simulation with one covariate in Figure 3.12, where it can be observed that
the EM algorithm once again proved to generate the most successful estimations of
the covariate effect.
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Figure 3.12: Comparison of the ordered covariate parameter values from the 100
simulations, estimated by employing the NM, QN and EM algorithm approaches
to data simulated according to a two phase Coxian distribution with one covariate,
observing the TS parameterisation.
The final aim of the simulation study is to investigate how successful the constant
effect (CE) approach is at representing the behaviour of the model when the true effect
of the covariate is not constant across all transitions. In order to investigate this, the
standard approach which assumes a constant covariate effect was used to fit a phase-
type distribution to the four datasets simulated to follow the TS approach. The true
simulated values of the covariates on each transition rate, along with the estimated



































Table 3.4: Table showing the estimated covariate parameters when a Coxian phase-type regression model which assumes a CE
approach is fitted to data simulated according to a TS approach.
Simulated Parameter Values Under the TS Assumption:
Two Phases Three Phases
One Covariate Two Covariates One Covariate Two Covariates
γ110 = 0.300 γ110 = 0.100 γ210 = −0.600 γ110 = −0.100 γ110 = −0.300 γ210 = 0.300
γ120 = 0.700 γ120 = 0.500 γ220 = −0.200 γ120 = −0.300 γ120 = −0.200 γ220 = 0.100
γ112 = −0.500 γ112 = 0.300 γ212 = −0.300 γ130 = −0.400 γ130 = −0.400 γ230 = 0.200
γ112 = 0.200 γ112 = 0.500 γ212 = −0.200
γ123 = 0.400 γ123 = 0.100 γ223 = −0.500
Estimated Parameter Values Assuming a CE Approach:
γ1·· = 0.461 γ1·· = 0.416 γ2·· = −0.285 γ1·· = −0.175 γ1·· = −0.125 γ2·· = 0.044
TS: Transition specific, CE: Constant effect
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It can be observed that the estimated effect by the CE approach serves as an almost
pseudo-average of the overall effect and so, in cases where the covariate has a similar
effect on all transitions it may be sufficient to employ the CE approach. For example,
for the two phase simulation with two covariates it can be observed that the true effect
of the first covariate on each transition is always positive; γ110 = 0.100, γ120 = 0.500
and γ112 = 0.300, which is reflected in the estimated effect under the constant effect
assumption, γ1·· = 0.416.
However, in cases where the effect of the covariate varies more extremely across
the transitions, the CE estimate may not provide information which reflects the true
effect of the covariate. For example, for the three phase simulation with two covari-
ates, the second covariate has a positive effect on each of the absorption transitions;
γ210 = 0.300, γ220 = 0.100 and γ230 = 0.200, and a negative effect on the sequential
transitions; γ212 = −0.200 and γ213 = −0.500. The estimated ‘overall’ effect by the CE
approach is 0.044, which is much weaker than the true transition-specific effects, giving
the false impression that the covariate is not strongly associated with the individuals
rates of flow through the system.
3.5 Inhomogeneous Coxian Phase-type Regression Model
Within standard Coxian phase-type literature, the transition intensities which define
the distribution are assumed to be constant over time, reflecting the assumption that
the underlying Markov process is time homogeneous. However, if interest lies in incor-
porating a time-varying covariate within a Coxian phase-type regression model, such
as a longitudinal response, this homogeneity assumption is violated as the transition
intensity now varies with time, as shown:
qjk(t) = q0jk exp
{− wi(t)γ} (3.56)
where wi(t) is an observation on a covariate value at time t and q0jk is the baseline
transition intensity, representing the rate of transition from state j into state k when
wi(t) = 0.
Within this section, the EM algorithm approach to fitting phase-type regression
models, developed within Section 3.3, is further extended to allow for the incorpo-
ration of time-varying covariates within the specific case of the Coxian, something
which has never previously been explored within the literature. Doing so significantly
extends the scope of Coxian phase-type regression models, particularly within medical
statistics, where longitudinal biomarkers and time-varying endogenous covariates are
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regularly of interest within time-to-event studies. Before adapting the density func-
tion and discussing the fitting procedure, let us conceptually discuss the progress of
an individual through an n-phase Coxian distribution when the transition intensities
are influenced by a time-varying covariate.
At time zero, individual i belongs to the first state of the underlying Markov
process, where their initial rates of transitioning into the absorbing and second state













If Ei1 is the expected time individual i spends in state one, the rate of transitioning




































If individual i makes the transition into the second state at time Ei1, their rate of













and if Ei2 is the expected time spent within this second state, the rates of transitioning
into either the absorbing or third states at their expected transition time are given by:
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{− wi(Ei1 + Ei2)γ} (3.66)























and so on until the nth state from which the individual can only absorb.





























where Fi is a vector denoting the cumulative time spent within each state for individual
i, where Fij =
j−1∑
j∗=1
Eij∗ , where j 6= 1 and Fi1 = 0, i.e:
Fi =
(
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The corresponding log-likelihood is given by:





























Within the E-Step of the time inhomogeneous Coxian phase-type regression model it
is necessary to approximate Nijk and Nij0 as before, where the time-varying nature
of the covariate must be taken into consideration. However, instead of approximating




{ − wi(s)γ}ds, along with the first
and second derivatives with respect to γ. As such, the expected values of the latent






q0jkcijk(τi | θτ )





{− wi(s)γ}ds | τi] = cijj(τi | θτ )





{− wi(s)γ}ds | τi] = g2ijj(τi | θτ )






{− wi(s)γ}ds | τi] = g3ijj(τi | θτ )
pdi(τi | θτ ) (3.75)






aij(τi | θτ )q0j0 exp{−wi(τi)γ}
pdi(τi | θτ ) (3.76)
where Nij0 = 0 for censored individuals. The values of aij(τi | θτ ), dij(τi | θτ ),
cijk(τi | θτ ), g1ijj(τi | θτ ), g2ijj(τi | θτ ) and g3ijj(τi | θτ ) are given by:
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{− wi(s)γ}ds}(t exp{− wi(τi)γ})δi (3.78)

















{− wi(u)γ}du}(t exp{− wi(τi)γ})δi ds
(3.79)

















{− wi(u)γ}du}(t exp{− wi(τi)γ})δi ds
(3.80)

















{− wi(u)γ}du}(t exp{− wi(τi)γ})δi ds
(3.81)
3.5.2 M-Step
Within the M-step of the algorithm, updated estimates for the unknown transition




















































































This chapter began with a review of the methodology and current applications of both
phase-type distributions and phase-type regression models. Through this, a number
of features of the Coxian phase-type regression model which make it an attractive ap-
proach to represent survival data within a joint modelling framework were highlighted.
In particular:
i through the latent phases uncovered during the fitting process, the Coxian phase-
type distribution provides further insight into the failure process which it repre-
sents, in comparison to standard survival models. By mapping these uncovered
states onto distinct stages of the survival process, inferences can be made regard-
ing the rates of deterioration through these stages and, thus, the quality of life
individuals will experience for their remaining survival time.
ii the Coxian phase-type distribution is capable of representing any positive distri-
bution to an arbitrary degree of accuracy, overcoming the limitations associated
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with alternative parametric survival models which are limited in terms of the dis-
tributional shapes which they can suitably fit [125],
iii Coxian phase-type regression models are fully parametric, alleviating previously
identified limitations which are encountered when a semi-parametric survival model
is incorporated within a joint model, resulting in the underestimation of the stan-
dard errors [11],
iv the fully parametric nature of the Coxian phase-type regression model is also ad-
vantageous compared to semi-parametric approaches in terms of making survival
predictions from the fitted joint model [12].
Despite their advantages, however, there are some limitations associated with
phase-type regression models, well documented within the literature. A number of
these limitations were highlighted within this research, and new methodology was de-
veloped to overcome them, improving the suitability of phase-type distributions for
representing the survival process within a joint model. Specifically:
a. a new EM algorithm approach to fitting phase-type regression models was de-
veloped, and shown to be more stable, both in terms of its rate of successful
convergence and in its precision when estimating covariate effects, compared to
previously employed NM and QN algorithm approaches,
b. this new EM algorithm approach, evidenced through its high RAS scores, also
showed a significant reduction in the number of false convergences, well doc-
umented to plague the fitting of phase-type distributions through alternative
approaches, meaning excessive initialisations are no longer necessary as signifi-
cantly more successful convergences resulted in an acceptable fit,
c. the increased stability observed within this newly developed EM algorithm ap-
proach was leveraged to relax the restrictive assumption that covariates have
a constant effect on all transitions through the underlying Markov model. In-
stead, new formulations of the model were presented which allow state-specific,
direction-specific and transition-specific inferences to be drawn from the data,
where the NM and QN were shown to struggle with these adaptions,
d. the new EM algorithm approach was also extended to allow for the incorpo-
ration of time-varying covariates, not previously investigated within phase-type
literature, broadening the scope and applicability of the models.
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Within Chapter 4, new methodology for incorporating the Coxian phase-type re-
gression model within a joint likelihood, alongside a LME model, is developed. This
novel joint model is subsequently applied to a dataset collected on individuals suffering
from chronic kidney disease within Chapter 5.
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Chapter 4
Joint Modelling of Longitudinal and





This chapter details the development of a new joint modelling approach to the anal-
ysis of longitudinal and survival data, within which the Coxian phase-type regression
model is employed to represent the survival process. This new joint model observes
the standard shared parameter formulation, found within the literature, where the
association between the longitudinal and survival processes is represented by latent
random effects.
Preliminarily, a two-stage approach is explored, similar to that of the early two
stage procedures proposed by Tsiatis et al. [5] and Self and Pawitan [6] to incorporate
unbiased estimates of a repeatedly observed covariate within a survival model. Subse-
quently, the joint likelihood approach to this new methodology is detailed, where two
common joint modelling parameterisations are developed:
i the random effects (RE) parameterisation, where the individuals’ latent random
effects are incorporated within the survival submodel, and,
ii the true longitudinal response (TLR) parameterisation, where an unbiased predic-
tion of the individual’s longitudinal response is incorporated within the survival
submodel.
Finally, a simulation study is conducted both to validate the new methodology and
to compare the approach with the commonly employed exponential and Weibull AFT
joint models, available through the JM package within R software [14].
4.2 Motivation
Employing the Coxian phase-type distribution to represent the survival process within
a joint modelling framework offers a number of advantages to both these previously in-
dependent areas of statistical research, broadening their applicability and scope. Previ-
ously, Coxian phase-type distributions have been utilised extensively to model patient
flow through hospital, favoured for their ability to uncover underlying stages of the
process which they represent [25,26,131,132,139,140]. They have also been employed,
although somewhat less commonly, to model heavy tailed distributions [157–159], here
valued for their ability to represent any positive distribution to an arbitrary degree
of accuracy, and they have been applied within the area of risk theory to estimate
ruin probabilities, favoured for their mathematical tractability [160]. The utilisation
of phase-type distributions within more typical survival analysis-type problems, on
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the other hand, remains novel, with limited investigation beyond that of Aalen [28],
who first discussed their possible applicability to biostatistics survival problems. The
incorporation of covariates within such models, allowing their effect on the tranitiion
intensity parameters to be evaluated, is similarly under-investigated, with only a lim-
ited number of techniques discussed within the literature [30, 147, 148]. Further, in
order to aid successful convergence, these covariate approaches impose the restrictive
assumption that a covariate will have the same effect across all transition intensi-
ties, limiting the depth of the information which can be ascertained regarding how
covariates affect the system under investigation.
The first stage of this research, detailed within Chapter 3, targeted some of the
more impeding limitations of phase-type regression models, with the aim of improving
their suitability for representing the survival process within a joint modelling frame-
work. Specifically, a newly developed EM algorithm approach to fitting phase type-
regression models was developed, detailed within Section 3.3, improving both the rate
of successful convergence of the model, along with the accuracy of the parameter es-
timates themselves, when compared to previous estimation approaches, as illustrated
through a simulation study within Section 3.3.3. Additionally, the restrictive assump-
tion that covariates have a constant effect across all transitions was relaxed within
this new EM algorithm approach, discussed within Section 3.4, increasing the level
of insight which can be obtained pertaining to how the covariates affect the system
represented by the phase-type distribution.
Incorporating this improved phase-type regression model within a joint modelling
framework, as shall be detailed within this chapter, extends the scope of the Coxian
phase-type distribution to scenarios where there exists some association between the
survival or queueing process under investigation and a related longitudinal marker of
interest. Currently, phase-type regression models have not been developed to allow for
the inclusion of time-varying covariates, limiting their applicability to time-invariant
scenarios, which is particularly detrimental within the medical field where it is often
of interest to consider the effect of time-varying covariates on survival.
In turn, joint models can benefit from the distributional advantages of phase-type
distributions, which can overcome some of the previously documented limitations of
standard joint modelling approaches [19]. Namely, the ability of the Coxian to suit-
ably represent any positive distribution to an arbitrary degree of accuracy overcomes
the limitation of the more commonly employed parametric distributions, such as the
exponential and Weibull, which have been noted by Gould [12], for example, to “re-
strict the range of baseline hazard functions that can be captured accurately”. Indeed,
this limitation has influenced the development of alternative spline-based [7, 161] and
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piecewise constant [162] hazard representations, which can be more conceptually and
computationally complex. Further, the fully parametric nature of the Coxian phase-
type regression model means that the standard errors of the parameters within the
joint likelihood are not underestimated, as they are when representing the survival
process with a Cox PH model, due to its unspecified baseline [11]. It has additionally
been highlighted within the literature that a fully parametric survival model is more
convenient when interest lies in obtaining individualised predictions of survival out-
come [12], which is attractive within the medical field due to the increasing popularity
of ‘personalised medicine’.
The Coxian phase-type distribution is also advantageous in comparison to alter-
native survival representations due to the additional information it can provide about
the survival process, as previously discussed. That is to say, when modelling survival
of a chronic condition, the latent phases which are uncovered during the model fitting
can be considered to represent distinct stages of the disease under investigation. From
these uncovered states, and the estimated rates of flow between them, invaluable in-
sight can be obtained pertaining to how individuals behave before their failure time.
For instance, within the E-step of the EM algorithm approach to fitting phase-type re-
gression models, developed within Section 3.3, personalised approximations are made
of the expected time each individual will spend in the underlying states of the system,
providing information on how long individuals can expect to remain in the earlier
stages of the disease, informing intervention strategies.
4.3 Two-stage Approach
Mirroring the first steps in the development of the standard joint modelling methodol-
ogy, a two-stage approach was initially considered, similar to that of Tsiatis et al. [100]
and Pawitan and Self [101], where the Coxian phase-type regression model was instead
utilised to represent the survival process, in place of the standard Cox PH model. Con-
sequently, within stage one, the longitudinal response is modelled to generate unbiased
estimates of each individual’s longitudinal response trajectory and, within stage two,
features of this trajectory are incorporated within a survival model to quantify the
association between the two processes.
Different parameterisations of the model can be formulated depending upon the fea-
tures of the longitudinal trajectory which are incorporated within the survival model.
The two most common parameterisations, (i) the random effects (RE) and (ii) the true
longitudinal response (TLR), are detailed here. For illustration, the random effects
parameterisation was further applied to data collected on individuals suffering from
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chronic kidney disease, as detailed by Donnelly et al. [29].
4.3.1 Stage 1: Linear Mixed Effects Model
Within both parameterisations, the first stage of the model building procedure com-
prises of fitting a LME model to the repeated measures of the time-varying longitudi-
nal response of interest, estimating population-level fixed effects parameters, as well
as individual-specific deviations from these parameters, referred to as random effects.
Most commonly, two random effects are incorporated within the model, representing
deviations from the population-average intercept and slope, allowing individuals to
have unique initial values of the longitudinal marker, and unique rates of change over
time.
Fitting a LME model to the repeated observations of a periodically observed
biomarker of interest makes the endogenous covariate fully observable, allowing a
‘true’ estimate to be calculated for each individual at their respective event times, free
from contamination of unexplained variance.
The LME model, discussed in full within Section 2.2.3, is given by:
yi(t) = x i(t)β + bi0 + bi1t+ i(t)
= y∗i (t) + i(t)
(4.1)
where bi0 and bi1 are the random effects and y
∗
i (t) is the unbiased estimate of the true
longitudinal response at time t.
4.3.2 Stage 2: Coxian Phase-type Resgression Model
Employing the Coxian phase-type regression model to represent the survival process,
replacing the standard Cox PH representation, allows additional information regarding
the behaviour of the individuals before they experience their event of interest to be
ascertained. That is, the phases of the Coxian phase-type distribution, and the rates of
transition between them, provide insight into how quickly individuals will deteriorate
through the underlying stages of the disease before experiencing their event of interest.
The two parameterisations of the Coxian phase-type regression model are detailed
below, where, for simplicity in terms of the notation, the covariates are assumed to
have a constant effect on each of the transitions through the Coxian. In practice,
this assumption can be relaxed to make state-specific, direction-specific or transition-
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specific inferences regarding the covariates’ effects by alternatively utilising one of the
formulations developed within Section 3.4.
4.3.2.1 Random Effects Parameterisation
Under the RE parameterisation, features of the individuals’ longitudinal trajectories,
represented by the latent random effects, are incorporated within the Coxian phase-
type regression model, given by:



























Bij log(pj), from the generalised log-likelihood of phase type distributions,
given by Equation 3.21, is not included within the likelihood due to the assumption of
the Coxian that all individuals begin the process within the first phase of the underlying
system, meaning Bij log(pj) = 0 for all i and j. The random effects parameterisation
allows inferences to be made regarding the effect of deviating from the population
average trajectory, in terms of both the intercept and slope, on the survival process,
as was originally proposed by Tsiatis et al. [100].
4.3.2.2 True Longitudinal Response Parameterisation
Under the TLR parameterisation, the ‘true’ estimate of each individual’s longitudi-
nal response is incorporated as a covariate within the Coxian phase-type regression
model, thus allowing its effect on the survival process to be evaluated, where additional
baseline covariates can also be included, as shown:






















log(q0jk)−w iγ − ŷ∗i (τi)α
)} (4.3)
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From the fitted model, it is therefore possible to make inferences on the effect of a
one unit increase in the longitudinal response on the rates of flow through these latent
stages of the survival process.
Some extensions within the literature have investigated the possibility of incorpo-
rating different representations of y∗i (τi) within the survival model, which can similarly
be extended to the Coxian phase-type regression model. For example, Crowther et
al. [163] incorporated the first differential of the longitudinal response with respect to
time, y∗i (τi)
′, in order to make inferences regarding the effect of the rate of change of
the longitudinal response on survival.
4.4 Joint Likelihood Approach
As previous research has shown, bias can be introduced to the estimated parameters
from a two-stage joint modelling approach as no consideration is given to the potential
impact of the survival process upon the longitudinal process, discussed fully within
Section 2.4.1. Consequently, within this section, the parameters of both the longitudi-
nal and survival processes are estimated simultaneously from a single joint likelihood,
where the latent association between the two processes is represented by the random
effects, as within the shared parameter formulation of joint models. Both the RE and
TLR parameterisations are detailed within 4.4.1 and Sections 4.4.2 below, with the
application of the TLR parameterisation to chronic kidney disease data illustrated
within Chapter 5.
4.4.1 Random Effects Parameterisation
Under the RE parameterisation, the joint probability density of the longitudinal and
survival processes, represented by a LME model and Coxian phase-type regression
model respectively, is given by:































































Note that, once again, the contribution to this density of the Coxian phase-type
regression model, f(τi|bi;θτ ), no longer includes the pj or Bij terms from the density
of the standard phase-type regression model due to the assumption that all individuals
begin the process within the first phase of the distribution, meaning p
Bij
j = 1 for all i
and j.
The corresponding log-likelihood of this probability density is given by:







































log(q0jk)−w iγ − bi0α1 − bi1Fi(j+1)α2
)}
(4.8)
where the EM algorithm is employed to maximise the likelihood and estimate the
unknown parameters of the model, as detailed below.
4.4.1.1 E-Step
Within the E-step of the algorithm, the expected values of various functions of the
random effects are approximated in a way similar to that outlined for standard joint
models by Wulfsohn and Tsiatis [4] and Henderson et al. [9]. That is, on each iteration
of the algorithm, the expected value of any function of the random effects, denoted
r(bi), is given by:
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E
[














where f(y i|bi;θy), f(τi|bi;θτ ) and f(bi;θb) are as defined in Equations 4.5, 4.6 and















− bi0α1 − bi1uα2
}
. (4.10)
The integrals with respect to the random effects can be approximated using the
Gauss Hermite quadrature approach, or the pseudo-adaptive Gauss Hermite approach,
detailed by Rizopoulos [17]. Within this research, the pseudo-adaptive approach was
adopted.
The latent variables of the Coxian phase-type regression model are also calculated
within the E-step, in a way that is similar to the standard phase-type regression model
presented within Section 3.3.1, where additional derivatives of the log-likelihood with
respect to α and γ are required for the M-step of the algorithm. The expected values
of the latent Coxian phase-type regression variables are given by:
E
[
Nijk | y i τi, bi;θ
]
=
q0jkcijk(τi | θτ )
pdi(τi | θτ ) (4.11)
E
[




aij(τi | θτ )q0j0 exp
{
−w iγ − bi0α1 − bi1τiα2
}
pdi(τi | θτ ) , if δi = 1
0, if δi = 0
(4.12)
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−w iγ − bi0α1 − bi1uα2
}
du | τi, w i
]
=
cijj(τi | θτ )






−w iγ − bi0α1 − bi1uα2
}
du | τi, w i
]
=
h2ijj(τi | θτ )







−w iγ − bi0α1 − bi1uα2
}
du | τi, w i
]
=
h3ijj(τi | θτ )
pdi(τi | θτ )
(4.15)
where aij(τi | θτ ), cijk(τi | T), h2ijk(τi | θτ ), h3ijk(τi |θτ ) and the elements of the
vector di(τi | θτ ), denoted dij(τi | θτ ), are given by:



























−w iγ − bi0α1 − bi1τiα2
})δi
(4.17)





































−w iγ − bi0α1 − bi1τiα2
})δi
du (4.18)







































−w iγ − bi0α1 − bi1τiα2
})δi
du (4.19)






































−w iγ − bi0α1 − bi1τiα2
})δi
du. (4.20)
where the integrals with respect to time are numerically approximated using the Gauss-
Kronrod approach [123].
4.4.1.2 M-Step
By differentiating the log-likelihood with respect to the parameters of interest and
solving, updated estimates of the fixed effects parameters, β, the variance of the











































where the features of the random effects are approximated within the E-step.
Similarly, updated estimates of the baseline transition intensity parameters, q0jk,
are given by:
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w iγ + bi0α1 + bi1uα2
}
du is approximated within the E-step, given
by Equation 4.13.
Closed form estimates of the survival parameters, α1, α2 and γ, cannot be obtained,
meaning a one-step Newton Raphson is implemented to updated these parameters,
which, on the (l + 1)th iteration are given by:











































where S(·) and H(·) denotes the score vector and Hessian matrix, respectively.
The score vector and Hessian matrix of the baseline survival parameters, denoted






















































du is approximated within the E-step, given
by Equation 4.13.
The score and Hessians of the α1 and α2 parameters, representing the effects of


















































































































du, are again approximated within the
E-step, given by Equations 4.14 and 4.15.
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4.4.1.3 Summary
Input 1: Fit independent LME
model to generate initial longi-
tudinal parameter estimates:
β(0), D(0) and σ2(0)
Input 2: Fit independent Cox-





• Define the log-likelihood: logL(θ;y i, τi) = Eq. 4.8
• Identify: all unknown functions of the random effects: r(bi) = Eq. 4.10,
all ‘missing’ Coxian phase-type distribution variables = Eq. 4.11− 4.15






• Initialise the EM algorithm: l = 1
E-Step: Calculate the expected values of the unknown functions of
the random effects by solving:
E
[






Approximate the latent variables of the Coxian phase-type regres-
sion model using Eq. 4.16 − 4.20
M-Step: Differentiate the log-likelihood with respect to the un-










τ − θ(l−1)τ )
(|θ(l−1)τ |+ tol1)
< tol2
l = l + 1
Set Final Parameter Estimates:
θτ =
{
β = β(l), D = D(l), σ2 = σ2(l), T = T(l), α0 = α0
(l), α1 = α1
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4.4.2 True Longitudinal Response Parameterisation
Under the TLR parameterisation, the joint probability density of the longitudinal and
survival processes, represented by a LME model and Coxian phase-type regression
model respectively, is again given by Equation 4.4, where f(y i|bi;θy) and f(bi;θb)
remain unchanged from the RE parameterisation, given by Equations 4.5 and 4.7
respectively. However, under this parameterisation, the contribution of the survival



























−w iγ − y∗i (Fi(j+1))α
})Nijk
, (4.34)
where y∗i (·) = x i(·)β + z i(·)bi. The corresponding log-likelihood of this complete
probability density function is thus given by:







































log(q0jk)−w iγ − y∗i (Fi(j+1))α
)}
(4.35)
and the EM algorithm approach is again utilised to maximise this likelihood, as de-
scribed within the next two sections below.
4.4.2.1 E-Step
Within the E-step, similarly to the RE parameterisation, the expected values of var-
ious functions of the random effects, r(bi), are approximated utilising the method of
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Wulfsohn and Tsiatis [4], given by Equation 4.9, where the required functions of the
















−w iγ − y∗i (u)α
}
. (4.36)
The latent variables of the Coxian phase-type regression model are also calculated
within the E-step, in the say way as within the RE parameterisation discussed in
Section 4.4.1, where additional derivatives of the log-likelihood with respect to β are
required for the M-step of the algorithm. The expected values of the latent Coxian
phase-type regression variables are given by:
E
[
Nijk | y i τi, bi;θ
]
=
q0jkcijk(τi | θτ )
pdi(τi | θτ ) (4.37)
E
[




aij(τi | θτ )q0j0 exp
{
−w iγ − y∗i (τi)α
}
pdi(τi | θτ ) , if δi = 1







−w iγ − y∗i (u)α
}
du | τi, w i
]
=
cijj(τi | θτ )






−w iγ − y∗i (u)α
}
du | τi, w i
]
=
h2ijj(τi | θτ )







−w iγ − y∗i (u)α
}
du | τi, w i
]
=
h3ijj(τi | θτ )






−w iγ − y∗i (u)α
}
du | τi, w i
]
=
h4ijj(τi | θτ )







−w iγ − y∗i (u)α
}
du | τi, w i
]
=
h5ijj(τi | θτ )
pdi(τi | θτ )
(4.43)
where aij(τi | θτ ), cijk(τi | θτ ), h2ijk(τi | θτ ), h3ijk(τi | θτ ), h4ijk(τi | θτ ), h5ijk(τi | θτ )
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and the elements of the vector di(τi | θτ ), denoted dij(τi | θτ ), are given by:

























−w iγ − y∗i (τi)α
})δi
(4.45)








































































































































































































Updated estimates of the variance of the random effects parameter, D, and the variance
of the residual errors parameter, σ2, can be calculated similarly to the RE parameteri-
sation, utilising Equations 4.22 and 4.23. Similarly, updated estimates for the baseline

























− w iγ − y∗i (u)α
}
du is approximated within the E-step, given by
Equation 4.39.
As the longitudinal fixed effects parameters, β, are now contained within the sur-
vival portion of the probability density, closed form estimates can no longer be ob-
tained. Instead, estimates of β, along with the survival parameters α and γ, are
obtained through a one-step Newton Raphson update:
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The score and Hessian of the fixed effects parameters, denoted S(β) and H(β)









































































du, are approximated within the E-step
of the algorithm and are given by Equations 4.42 and 4.43.
The score vector and Hessian matrix of the baseline survival parameters, denoted
S(γ) and H(γ), are given by:
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−w iγ− y∗i (u)α
}
du is approximated within the E-step,
given by Equation 4.39.
The score vector and Hessian matrix of the association parameter of the true



































































are estimated within the E-step and are given by Equations 4.40 and 4.41.
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4.4.2.3 Summary
Input 1: Fit independent LME
model to generate initial longi-
tudinal parameter estimates:
β(0), D(0) and σ2(0)
Input 2: Fit independent Cox-
ian to generate initial survival
parameter estimates:
T(0), α(0) and γ(0)
• Define the log-likelihood: logL(θ;y i, τi) = Eq. 4.35
• Identify: all unknown functions of the random effects: r(bi) = Eq. 4.36,
all ‘missing’ Coxian phase-type distribution variables = Eq. 4.37− 4.43




• Initialise the EM algorithm: l = 1
E-Step: Calculate the expected values of the unknown functions of
the random effects by solving:
E
[






Approximate the latent variables of the Coxian phase-type regres-
sion model using Eq. 4.44 − 4.50
M-Step: Differentiate the log-likelihood with respect to the un-
known parameters and solve Eq. 4.22, 4.23 and 4.51 − 4.54 to gen-









τ − θ(l−1)τ )
(|θ(l−1)τ |+ tol1)
< tol2
l = l + 1
Set Final Parameter Estimates:
θτ =
{





4.4. Joint Likelihood Approach
4.4.3 Simulation Study Three
A simulation study was implemented to validate the TLR parameterisation of the new
joint likelihood approach which utilises the Coxian phase-type regression model to
represent the survival process, as developed within Section 4.4.2. Within this study,
two scenarios are considered. In the first scenario, the survival process is simulated
from a two-phase Coxian, whilst in the second scenario the survival process is simulated
from a three-phase Coxian, with 20% censoring in each. In doing so, the ability of the
model to handle an increasing number of underlying phases (and thus an increasing
number of unknown parameters) is illustrated. Censoring times were simulated for
each individual from a similar survival distribution, appropriately adjusted to ensure
the correct proportion of censoring, where the earliest event time (death or censor)
was taken for each individual. In order to demonstrate the potential error that occurs
within the estimates of the survival parameters when the underlying distribution is
misspecified, joint models which assume an exponential and Weibull distribution, the
standard within the JM package, are also fitted to the simulated datasets.
For both the two- and three-phase simulations, 100 datasets were produced, and
each of the joint model formulations under investigation (i.e. the Coxian, exponential,
Weibull AFT joint models) were fitted to the data. The average parameter estimates
of these 100 fits, along with their standard errors and empirical confidence intervals
(CI), are then compared to the true simulated values of the parameters. Convergence
was considered to be achieved if either of the following conditions, previously employed
within the JM package, was satisfied [14]:
i L(θ
(l)
τ )− L(θ(l−1)τ ) < tol3 ×




τ − θ(l−1)τ )
(|θ(l−1)τ |+ tol1)
< tol2,
where tol1 = 1 × 10−3 and tol2 = 1 × 10−4, and tol3 = 1 × 10−8, and a maximum of
1000 iterations of the algorithm were permitted.
4.4.3.1 Two-Phase Simulation
For the two-phase simulation study, 100 datasets were generated, each comprised of
400 individuals with an average of 13.19 repeated measures per individual, randomly
distributed between time zero and the individuals’ event times. For each individual,
the observed longitudinal response of interest at time tij was calculated by:
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yi(tij) = (β0 + bi0) + (β1 + bi1)tij + xi2β2 + xi3β3 + ij (4.61)
where:
tij is the j
th observation time for individual i, where the observation times were ini-
tially generated uniformly between 0 and the 99th percentile of the distribution,
and subsequently truncated based upon the simulated event time,
xi2 is a continuous covariate generated from a uniform distribution bounded between
-3 and 3: xi2 ∼ unif(−3, 3),
xi3 is a binary covariate generated from a discrete uniform distribution bounded
between 0 and 1: xi3 ∼ unif{0, 1},
β0, β1, β2 and β3 are the population level regression parameters corresponding to the
fixed effects, given by β =
(
−10.00 2.10 −0.40 0.50
)′
,
bi0 and bi1 are the random effects, representing the individuals’ deviations from the
















ij represents the residual error on the j
th observation from the ith individual, gen-
erated from a normal distribution: ij ∼ N (0.00, 0.30).
For the survival process, the individuals’ event times were simulated according
to a two-phase Coxian distribution with baseline transition parameters q010 = 0.0,
q012 = 0.1 and q020 = 0.3, influenced by two covariates:
qijk(t) = q0jk exp
{− yi(t)∗α} exp{− wiγ},
where:
yi(t)
∗ is the true value of the longitudinal response of interest at time t, given by:
y∗i (t) = (β0 + bi0) + (β1 + bi1)t+ xi2β2 + xi3β3 (4.62)
with corresponding association parameter α = 0.60, and,
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wi, a continuous baseline survival covariate generated from a uniform distribution,
wi ∼ unif(−3, 3), with corresponding regression parameter γ = −0.25.
The mean parameter estimates from the fits of the three joint models which assume
an underlying two-phase Coxian, exponential and Weibull distribution, along with
their standard errors, CIs and bias, are given within Tables 4.1 and 4.2.




Est. Std Err. 95% CI Bias (%)
β0 -10.000 -9.987 0.006 -10.065, -9.894 +0.013 (0.130)
β1 2.100 2.102 0.002 2.069, 2.140 +0.002 (0.095)
β2 -0.400 -0.404 0.002 -0.441, -0.363 −0.004 (1.000)
β3 0.500 0.490 0.005 0.378, 0.584 −0.010 (2.000)
σ2 0.300 0.301 0.001 0.289, 0.315 +0.001 (0.333)
D(1,1) 0.800 0.797 0.006 0.659, 0.918 −0.003 (0.375)
D(1,2) 0.300 0.298 0.002 0.244, 0.344 −0.002 (0.667)
D(2,2) 0.150 0.149 0.001 0.127, 0.169 −0.001 (0.667)
α 0.600 0.621 0.004 0.550, 0.679 +0.021 (3.500)
γ -0.250 -0.263 0.005 -0.365, -0.188 −0.013 (5.200)
Par: Parameter, Sim: True Simulated Value, Est.: Mean Estimated Value,
Std. Err.: Standard Error, CI: Empirical Confidence Intervals
Bias = Mean Estimated Value − True Simulated Value
Red: Difference between Mean Estimated Value and True Simulated Value when Est.<Sim
Blue: Difference between Mean Estimated Value and True Simulated Value when Est.>Sim
From these results it can be observed that, for each of the three models, the lon-
gitudinal and variance parameters were estimated with no significant bias. However,
the estimates of the survival parameters can be seen to be influenced by the choice
of survival distribution, where the exponential and, to a lesser extent, Weibull models
produced biased estimates which overestimated the covariate effects. In comparison,
the two-phase Coxian showed no significant bias in the estimates of the survival pa-
rameters.
The estimated baseline survival probability densities of the three parametric models
are plotted within Figure 4.1, alongside that of the simulated density, illustrating that
only the two-phase Coxian successfully uncovered the true shape of the distribution.
This highlights how the exponential and Weibull distributions struggle when the true






















Table 4.2: Parameter estimates from the two-phase Coxian joint model fitted to the simulated datasets.
Par Sim
Exponential Weibull
Est. Std Err. 95% CI Bias (%) Est. Std Err. 95% CI Bias (%)
β0 -10.000 -9.990 0.006 -10.081, -9.888 +0.010 (0.100) -10.001 0.006 -10.082, -9.889 −0.001 (0.010)
β1 2.100 2.100 0.002 2.069, 2.137 0.000 (0.000) 2.098 0.002 2.069, 2.137 −0.002 (0.095)
β2 -0.400 -0.405 0.002 -0.439, -0.365 −0.005 (1.250) -0.402 0.002 -0.439, -0.365 −0.002 (0.500)
β3 0.500 0.491 0.008 0.370, 0.586 −0.009 (1.800) 0.507 0.008 0.370, 0.535 +0.007 (1.400)
σ2 0.300 0.301 0.001 0.290, 0.315 +0.001 (0.333) 0.301 0.001 0.290, 0.315 +0.001 (0.333)
D(1,1) 0.800 0.799 0.007 0.692, 0.918 −0.001 (0.125) 0.798 0.006 0.688, 0.914 −0.002 (0.250)
D(1,2) 0.300 0.298 0.002 0.256, 0.341 −0.002 (0.667) 0.298 0.003 0.255, 0.341 −0.002 (0.667)
D(2,2) 0.150 0.148 0.001 0.128, 0.168 −0.002 (1.333) 0.148 0.001 0.129, 0.169 −0.002 (1.333)
α 0.600 0.840 0.003 0.782, 0.912 +0.240 (40.00) 0.647 0.024 0.414, 1.159 +0.047 (7.83)
γ -0.250 -0.353 0.009 -0.454, -0.252 −0.103 (41.20) -0.276 0.012 -0.409, -0.152 −0.026 (10.40)
Par: Parameter, Sim: True Simulated Value, Est.: Mean Estimated Value, Std. Err.: Standard Error, CI: Empirical Confidence Intervals
Bias = Mean Estimated Value − True Simulated Value
Red: Difference between Mean Estimated Value and True Simulated Value when Est.<Sim
Blue: Difference between Mean Estimated Value and True Simulated Value when Est.>Sim
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Figure 4.1: Plot showing the estimated baseline probability density functions when
the survival process is represented by an exponential, Weibull, and two-phase
Coxian distribution.
4.4.3.2 Three-Phase Simulation
For the three-phase simulation study, 100 datasets were generated, comprised of 450
individuals with an average of 5.09 repeated measures per individual. The observed
longitudinal response of interest at time tij , denoted yi(tij), was again defined by four
fixed effects: (i) an intercept, (ii) the time of observation, (iii) a continuous covariate
generated from a uniform distribution, xi2 ∼ unif(−3, 3), and (iv) a binary covariate
also from a uniform distribution, xi3 ∼ unif{0, 1}. The corresponding fixed effects
regression parameters are given by: β =
(
2.00 3.50 0.20 −0.60
)
.
Similarly to the two phase simulation, random individual-level variation was in-
troduced to the longitudinal response through two multivariate normally distributed
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and observation level residual errors, ij , were also introduced, generated from a normal
distribution: ij ∼ N (0.00, 0.40).
For the survival process, the individuals’ event times were simulated according to
a three-phase Coxian distribution with baseline transition parameters q010 = 0.00,
q020 = 0.40, q030 = 0.02, q012 = 0.14 and q023 = 0.40. As before, the individual-specific
transition intensities are influenced by the longitudinal process, with association pa-
rameter α = 0.20, and a continuous baseline covariate with regression parameter
γ = 0.10.
The mean parameter estimates from the fits of the joint model assuming a three-
phase Coxian, an exponential, and a Weibull distribution, along with their standard
errors, CIs and bias, are given within Tables 4.3 and 4.4. For the three-phase Cox-
ian, it can be observed that all parameters were estimated with minimal bias. For
the exponential and Weibull joint models however, it can be seen that whilst these
formulations successfully estimated the longitudinal parameters, they once again did
not appropriately uncover the true simulated values of the survival parameters γ and
α, as was the case within the two-phase simulation.




Est. Std Err. 95% CI Bias (%)
β0 2.000 1.995 0.005 1.912, 2.097 −0.005 (0.250)
β1 3.500 3.503 0.002 3.473, 3.546 +0.003 (0.086)
β2 0.200 0.201 0.002 0.169, 0.232 +0.001 (0.500)
β3 -0.600 -0.612 0.006 -0.707, -0.492 −0.012 (2.000)
σ2 0.400 0.400 0.001 0.372, 0.421 0.000 (0.000)
D(1,1) 0.600 0.595 0.006 0.489, 0.759 −0.005 (0.833)
D(1,2) 0.100 0.103 0.001 0.080, 0.131 +0.003 (3.000)
D(2,2) -0.200 -0.203 0.003 -0.277, -0.160 −0.003 (1.500)
α 0.200 0.180 0.006 0.106, 0.272 −0.020 (10.000)
γ 0.100 0.091 0.005 0.012, 0.178 −0.009 (9.000)
Par: Parameter, Sim: True Simulated Value, Est.: Mean Estimated Value
Std. Err.: Standard Error, CI: Empirical Confidence Intervals
Bias = Mean Estimated Value − True Simulated Value
Red: Difference between Mean Estimated Value and True Simulated Value when
Est.<Sim
Blue: Difference between Mean Estimated Value and True Simulated Value when
Est.>Sim
Interestingly, in this case, it was the exponential rather than the Weibull distribu-






















Table 4.4: Parameter estimates from the standard exponential and Weibull AFT joint models fitted to the simulated datasets.
Par Sim
Exponential Weibull
Est. Std Err. 95% CI Bias (%) Est. Std Err. 95% CI Bias (%)
β0 2.000 2.000 0.005 1.902, 2.096 0.000 (0.000) 2.007 0.005 1.907, 2.104 +0.007 (0.350)
β1 3.500 3.499 0.002 3.467, 3.539 −0.001 (0.029) 3.492 0.002 3.456, 3.533 −0.008 (0.229)
β2 0.200 0.203 0.002 0.174, 0.242 +0.003 (1.500) 0.203 0.002 0.173, 0.242 +0.003 (1.500)
β3 -0.600 -0.599 0.005 -0.708, -0.488 +0.001 (0.167) -0.598 0.005 -0.706, -0.488 +0.002 (0.333)
σ2 0.400 0.400 0.001 0.374, 0.424 0.000 (0.000) 0.400 0.001 0.374, 0.424 0.000 (0.000)
D(1,1) 0.600 0.604 0.006 0.389, 0.698 +0.004 (0.667) 0.604 0.006 0.494, 0.716 +0.004 (0.667)
D(1,2) 0.100 0.103 0.001 0.070, 0.133 +0.003 (3.000) 0.103 0.001 0.078, 0.131 +0.003 (3.000)
D(2,2) -0.200 -0.205 0.003 -0.249, -0.122 −0.005 (2.500) -0.205 0.003 -0.264, -0.157 −0.005 (2.500)
α 0.200 0.154 0.001 0.136, 0.173 −0.046 (23.00) 0.030 0.002 -0.006, 0.061 −0.170 (85.00)
γ 0.100 0.077 0.004 -0.002, 0.167 −0.023 (23.00) 0.040 0.002 -0.001, 0.087 −0.060 (60.00)
Par: Parameter, Sim: True Simulated Value, Est.: Mean Estimated Value, Std. Err.: Standard Error, CI: Empirical Confidence Intervals
Bias = Mean Estimated Value − True Simulated Value
Red: Difference between Mean Estimated Value and True Simulated Value when Est.<Sim
Blue: Difference between Mean Estimated Value and True Simulated Value when Est.>Sim
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This is not unsurprising as the estimated baseline density of the exponential distri-
bution is closer to that of the true simulated density than the Weibull distribution, as
can be seen within Figure 4.2. However, as was the case for the two-phase simulation,
only the Coxian fit uncovered the true shape of the distribution.




























Figure 4.2: Estimated baseline probability density functions when survival is rep-
resented by an exponential, Weibull, and three-phase Coxian distribution.
4.5 Summary
Within this chapter, a new joint modelling framework was developed within which
the longitudinal process is represented by a LME model and the survival process by
a Coxian phase-type regression model. Initially, a two stage approach was explored,
motivated by the early approaches to incorporate unbiased estimates of a time-varying,
endogenous biomarker within a survival model. Subsequently, the joint likelihood
approach to simultaneously estimate the parameters of both submodels, under both
the random effects (RE) and true longitudinal response (TLR) parameterisations, was
detailed in full.
A simulation study was then performed utilising the TLR parameterisation, illus-
trating the suitability of the Coxian to represent the survival process within such a
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joint modelling framework, where the simulated parameters were successfully uncov-
ered by the new model. Further, the simulation study also demonstrates the potential
bias which can be introduced to the estimates of the survival parameters when the
underlying distribution is misspecified, as joint models which assumed an exponential
and Weibull distribution were shown to not properly uncover the true covariate effects.
The novel joint model developed within this chapter contributes significantly to
both the areas of joint modelling and phase-type distributions in a number of ways:
i Employing the Coxian phase-type regression model to represent survival within a
joint likelihood enables joint models to uncover latent stages of the survival process,
meaning more insight can be obtained regarding the process under investigation.
As mentioned previously, within a disease modelling context, such insight can be
utilised to predict rates of deterioration of patients through the uncovered stages of
the disease, informing treatment interventions and providing predictions on quality
of life.
ii As the Coxian phase type distribution can represent any positive distribution to
an arbitrary degree of accuracy, it is not subject to the misspecification issues
associated with the exponential and Weibull distributions, which are limited by the
distributional shapes which they can represent. As illustrated within the simulation
study, miss-specifying the distribution can cause bias within the estimates of the
survival parameters, which the Coxian was shown to overcome.
iii Incorporating the Coxian phase-type distribution within a joint framework sig-
nificantly extends the scope of the Coxian phase-type regression model, allowing
the incorporation of time-varying, endogenous covariates as predictors for the first
time within the literature. Consequently, phase-type distributions now constitute a









Within this chapter, the newly developed approach to incorporate the Coxian phase-
type regression model within a joint modelling framework, developed within Chapter
4, is applied to a dataset collected on individuals suffering from chronic kidney disease
(CKD), illustrating its applicability within disease modelling. Section 5.2 first provides
some biological background on CKD and outlines the targets of this investigation, with
the dataset subsequently introduced within Section 5.3 and some preliminary data
analysis presented. Within Section 5.4, the process of fitting the model to the data
is discussed and the results are presented. The new methodology is also compared to
standard joint modelling approaches currently found within the literature, highlighting
its advantages and ability to overcome limitations of the previous techniques.
5.2 Biological Background
5.2.1 Chronic Kidney Disease
The kidneys are responsible for the cleaning and regulation of the body’s blood supply,
where their primary function is to filter waste products from the blood and convert
the waste into urine which is expelled from the body [164]. They are also responsible
for maintaining blood pressure, producing erythropoietin (EPO); a chemical which
stimulates the production of red blood cells, and for maintaining the correct level of
chemicals within the blood [165]. The filtration of the body’s blood supply takes place
inside tubular structures located within the kidneys called nephrons. At the beginning
of each nephron there is a network of capillaries known as the glomerulus; blood
travels through these capillaries at high pressure and plasma is filtered out through
the capillary walls into a surrounding structure called Bowman’s capsule. The rate
at which at which blood is filtered through the glomeruli in this way is known as the
glomerular filtration rate (GFR), and it is this which serves as one of the primary
markers for overall renal function [166].
Kidney disease arises when, for some underlying reason, the kidneys have a reduced
ability to carry out their functions, and it can occur in both an acute state or as
a chronic condition. Acute kidney disease is a short term illness whereby kidney
function is lost quickly, typically as a result of injury. However, when the underlying
cause is treated, kidney function typically returns to normal with no lasting impacts.
In contrast, chronic kidney disease is a long term, irreversible condition whereby an
individual’s kidney health gradually deteriorates over time [169].
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Cross-section of a kidney highlighting
a single nephron [167]
The structure of a single
glomerulus [168]
Figure 5.1: Structure of the kidney, a single nephron and Bowman’s capsule
In the United Kingdom, it has been estimated by a National Health Service (NHS)
Kidney Care Report [170] that there are currently 1.8 million people diagnosed with
CKD in England, costing the NHS approximately £1.45 billion. This is more than
double the cost from 2002/2003, making CKD a prevailing challenge for healthcare
providers [35]. The report also highlights that 95% of this cost can be attributed
to secondary care of CKD patients, particularly renal replacement therapies, such
as dialysis treatment. Consequently, it is mutually beneficial to both patients and
healthcare providers to more accurately model the behaviour of CKD so as to provide
treatment interventions with greater accuracy in a more cost-efficient manner.
Clinicians consider there to be five stages of CKD, and individuals are categorised
into one of these five stages based on their estimated glomerular filtration rate (eGFR)
as shown in Table 5.1.
Table 5.1: Stages of CKD
Stage eGFR Description
1 ≥ 90 Normal
2 60-89 Mild reduction
3a 45-59 Mild - moderate reduction
3b 30-44 Moderate - severe reduction
4 15-29 Severe reduction
5 <15 Kidney failure
The eGFR is a measure of how well the kidneys filter waste from the blood, which
can be difficult to assess accurately in routine clinical practice. One approach to
estimate the GFR is to add an exogenous marker, such as iothalmate [171], to the
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blood and to measure how much remains after the blood has passed through the
kidneys. However, estimating GFR in this way can be complex and expensive, so
instead it is more common for an endogenous marker, i.e. a waste product naturally
produced by the body, to be used. The most common maker utilised is creatinine, a
breakdown by-product of muscle metabolism found in the blood. Routine blood tests
can give a measure of the level of creatinine found in the blood which is then used to
calculate an estimate of the eGFR using the MDRD equation, which is given by [172]:
eGFR = 175× standardised S−1.154Cr ×Age−0.203
× (1.210 if Black)× (0.742 if Female)
(5.1)
where SCr is serum creatinine.
The individuals considered within this research are in end-stage renal failure and
are receiving regular haemodialysis (HD) treatment. HD is a common intervention
performed on end-stage CKD patients, which typically involves diverting the patients
blood out of their body through a machine which filters waste products and excess
fluid from the blood, artificially fulfilling the function of the ailing kidneys.
5.2.2 Anaemia
It is commonly observed that individuals suffering from CKD are also prone to suffer
from anaemia, a condition characterised by a reduction in the oxygen-carrying capacity
of the blood [173], typically as a result of fewer red blood cells or a decreased volume
of haemoglobin (Hb) [174]. Anaemia is common within CKD patients due to the
disease hindering the kidneys’ normal secretion of EPO, the hormone responsible for
regulating the production of red blood cells.
As CKD progresses, the production of EPO typically decreases and anaemia be-
comes increasingly prevalent within individuals suffering from severe kidney disease
[175, 176]. As such, within this research, Hb is investigated as a potential marker for
CKD, where interest lies in modelling the association between the dynamic nature of





The dataset analysed within this research was provided by the Northern Ireland Renal
Information Service and it contains 27,113 observations collected on 1,340 individuals
within Northern Ireland who are suffering from CKD and receiving haemodialysis
(HD) treatment. The data was collected from eight treatment centres across Northern
Ireland between April 2002 and December 2011, with a maximum survival followup
until September 2012. Repeated measures were collected on the individual’s Hb levels,
where the average number of observations per individual is 20.2, with a maximum of
133.
Within this analysis, the individuals’ repeatedly observed Hb levels are regressed
upon various baseline biomarkers, and the association between the dynamic nature of
Hb and survival time is investigated. An overview of the key variables observed within
the dataset is discussed below.
Observation Time
Observation time was recorded in months from when patients commenced HD treat-
ment. The maximum observed time spent on HD was 138.4 months (11.5 years), with
a mean of 29.6 months (2.5 years) and median 22.4 months (1.9 years).
Age
The mean age of patients when they began HD treatment was 66.9 years old, with a
median of 70, suggesting a slight negative skew which can be observed in the plotted
distribution within Figure 5.2, suggesting CKD to be more common amongst older
people. This is consistent with renal literature which highlights the disease as being
particularly problematic within an ageing population [38,177].
The youngest person observed within the dataset is 19 years old, and the oldest is
97, with the majority of patients (54.9%) aged between 65 and 85 years old. Within the
analysis, age is measured per 10 years, where the baseline was set to 7, corresponding
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Figure 5.2: Histogram showing the distribution of age at commencement of HD
treatment.
Gender
The dataset contained 523 (39%) females, who are defined as the baseline, and 817
(61%) males. This is again consistent with renal literature where it has been suggested
that, despite a higher proportion of females being diagnosed with CKD, end-stage renal
failure is more common in men [178].
Ethnicity
Whilst ten ethnic categories were recorded within the dataset (including ‘Other’), there
exists a major imbalance amongst the classes as 1278 patients (95.4%) were recorded
as ‘White’. There were 42 individuals (3.1%) for whom ethnicity was not recorded,
leaving the remaining 20 individuals (1.5%) spread across nine categories, as shown in
Table 5.2.
In order to overcome this imbalance, within all subsequent analysis only two ethnic
groups were considered; ‘White’ and ‘Other’, where ‘Other’ is redefined to include all
non-white ethnicities and is set as the baseline within the analysis.
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Mean corpuscular haemoglobin concentration (MCHC) is a measure of the average
concentration of haemoglobin in a given volume of packed red blood cells, measured
in grams per deciliter (g/dL) [173]. The healthy adult range is between 33− 36 g/dL,
where lower values can indicate anaemia due to iron deficiency. The observed mean
(and median) within the data is 32.4 g/dL, indicating that the CKD patients have
MCHC values slightly below the healthy range, as would be expected. The minimum
observed value was 28.3 g/dL and the maximum was 38.2 g/dL, giving a small overall
range of 9.9 g/dL, and interquartile range of 1.6 g/dL. Within the analysis, the baseline
was redefined as 32 g/dL.
MCV
Mean corpuscular volume (MCV) is a measure of the average red blood cell size,
recorded in femtoliters (fL), where the healthy adult range is between 80−96 fL [173].
The mean (and median) observed within the data is 95 fL which lies close to the
upper boundary of the acceptable levels. This is consistent with literature which has
suggested that normocytic anaemia due to renal and chronic diseases has less impact
on MCV levels, which typically remain within the normal range, in comparison to
anaemia due to other causes [175]. The minimum observed value was 77.9 fL and the
maximum was 128.8 fL, giving an overall range of 50.9 fL, with a small interquartile
range of 8.2 fL. Within the analysis, MCV was measured per 10 fL, where the baseline




Creatinine is a waste product produced by the body’s muscle metabolism which is
filtered from the body by the kidneys. It is a common endogenous marker used to
calculate the eGFR of the kidneys and it is measured in micromoles per litre (µM/L),
where the healthy adult range is between 60 − 110 µM/L. Within the dataset the
observed mean was 625.7 µM/L (median 605 µM/L) with a large overall range from
73 µM/L to 1567 µM/L, and a large interquartile range of 288.5. Due to its large
scale, creatinine was analysed per 100 µM/L, where the baseline was defined as 6,
corresponding to 600 µM/L.
Ferritin
Ferritin is a protein responsible for storing and releasing iron. Measured in nanograms
per milliliter (ng/ml), the healthy range is 500 − 2000 ng/ml [179]. Within the NI
dataset, the overall mean ferritin level is slightly below the healthy range at 496.27
ng/ml, with a median of 403.5 ng/ml. The minimum observed level within the dataset
was 15 ng/ml and the largest was 18030 ng/ml, giving an overall range of 18015
ng/ml, with and interquartile range of 403.35. Again due to its large scale, ferritin
was analysed per 100 ng/ml, and the baseline was set to 4, corresponding to 400 ng/ml.
Urea
Urea is a waste product produced by the body and removed from the blood by the
kidneys. Whilst higher levels than average can indicate reduced kidney function, urea
is generally considered a poor marker for CKD as it is strongly influenced by diet
and hydration levels at the time of observation [180]. Measured in millimoles per litre
(mmol/L), the healthy range is between 2.5− 7.1 mmol/L, where the observed mean
within the data is 18.0 mmol/L, which is set as the baseline, with a median of 17.7
mmol/L. The minimum observed value was 3.7 mmol/L and the maximum was 46.8
mmol/L, giving an overall range of 43.1 mmol/L, with a small interquartile range of
7.0 mmol/L.
Iron and EPO Treatments
The individuals observed within the NI Renal dataset received drug treatment inter-
ventions to improve their iron and EPO levels. The prescribed treatments, along with




Tables 5.3 and 5.4 provide summaries of the key continuous and categorical variables
observed within the NI Renal dataset, respectively.
Table 5.3: Summary of the continuous variables observed within the CKD dataset
under investigation
Variable Mean Median Min Max
Age 66.9 70.0 19.0 97.0
MCMC 32.4 32.4 28.3 38.2
MCV 95.0 95.0 77.9 128.8
Creatinine 625.7 605.0 73.0 1567.0
Ferritin 496.3 403.5 15.0 18030.0
Urea 18.0 17.7 3.7 46.8
Table 5.4: Summary of the categorical variables observed within the CKD dataset
under investigation









Iron Hydroxide 269 20.1
Venofer 755 56.3







5.3.2 Preliminary Data Analysis
Longitudinal Response of Interest: Haemoglobin
Haemoglobin (Hb) is an iron-rich protein found within red blood cells to which oxygen
binds so as to be transported around the body. As discussed previously, anaemia is
a common CKD comorbidity, where individuals can suffer from a reduced volume of
both red blood cells and/or Hb. As such, Hb can be considered a marker for the
individuals’ anaemic condition, which varies in a way that reflects the underlying
health of their kidneys. Measured in grams per deciliter (g/dL), deviations outside




The caterpillar plot in Figure 5.3 shows the mean and interquartile ranges of the
(ordered) individuals’ Hb levels. It can be observed that there exists considerable
variation amongst the individuals’ mean Hb levels, suggesting that the repeated mea-
sures are clustered by individual, as would be anticipated. This is further validated










where σ2b represents the individual level variance and σ
2
 is the observation level vari-
ance, where these values are obtained by fitting a null LME model with a random
intercept term to the data. From this ICC it can be inferred that, of the total varia-












Figure 5.3: A caterpillar plot showing a large amount of individual-level variation
amongst Hb levels observed within the sample.
This variation can be further observed by examining the trajectories of the indi-

















Figure 5.4: Spaghetti plot showing the Hb trajectories for those individuals who














Figure 5.5: Spaghetti plot showing the Hb trajectories for those individuals who
are censored within the dataset.
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From these plots, it can be observed that not only does there exist a large amount
of individual-level variation, but also a high level of variation amongst the repeated
measures per individual, evidenced by the large fluctuations observed within the high-
lighted individuals’ trajectories. Whilst it is difficult, within these plots at least, to
identify much difference between the two strata, it can be seen that the censored in-
dividuals were observed for a longer period of time, with 298 observations made after
100 months on the censored individuals, compared to only 9 observations on those
who die.
5.3.2.1 Survival Outcome: Time to death since commencement of HD
Within the dataset 585 (43.66%) individuals died during the observation period and
755 (56.34%) were censored. The distribution of the observed death times is shown in
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Figure 5.6: Histogram showing the distribution of the observed event times within
the dataset.
Further, based upon advice from a clinician, the individuals’ initial Hb levels were
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discretised into 4 categories, as shown:
• Extremely Low Hb: < 9 g/dL
• Low Hb: 9− 10.5 g/dL
• Desired Hb: 10.5− 12.5 g/dL
• High Hb: > 12.5 g/dL
and KM survival plots for these four categories are given in Figure 5.8.
From Figure 5.8, it can be observed that individuals with low levels of Hb when
commencing HD have worse survival probabilities compared to those with desired or
high Hb levels. Fitting a Cox PH model utilising the individuals’ initial Hb levels
as the sole predictor of survival further suggest a possible association, where a one
unit increase in Hb results in a hazard ratio (HR) of 0.891 (p-value: < 0.001), i.e.
the hazard of death decreases as Hb increases, which is consistent with previous renal
literature [182]. Of course, this test is prone to various sources of bias and error; it
only utilises the individuals’ initial Hb levels, which are prone to measurement error,
and does not incorporate any of the subsequent longitudinal measurements, which are
possibly informative of survival. Additionally, the effect of other significant variables
is not controlled for within the model. However, the model serves to give an idea of
the possible association which exists between Hb and survival, motivating subsequent
analysis utilising more appropriate techniques, explored in full within Section 5.4.
5.4 Application of Statistical Models to NI Dataset
5.4.1 Independent Analysis of Longitudinal and Survival Data
Preliminarily, independent longitudinal and survival models were fitted to the NI data,
providing an indication of the variables which significantly influence each of the pro-
cesses, as well as supplying suitable initial values for the parameters within the joint
model. It can also be of interest to compare the parameter estimates from the in-
dependent models with those from the joint model to identify which parameters are
most prone to the bias which results from the naive assumptions of the independent
models.
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Figure 5.8: A KM plot showing the different survival probabilities for each of the
four Hb categories.
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5.4.1.1 LME Model for the Longitudinal Response
As discussed previously, LME models are employed when there exists significant clus-
tering amongst the repeated measures of some longitudinal response of interest, vio-
lating the independent assumption of ordinary linear regression. Whilst the caterpillar
plot in Figure 5.3, along with the ICC value given from Equation 5.2, does suggest
that there exists significant clustering amongst the repeated observations of Hb per
individual, this can be validated by fitting both a null linear model and a null LME
model with a random intercept and comparing them via a likelihood ratio test (LRT).
An observed significant difference in these models can be attributed to the inclusion
of the random intercept, therefore confirming that the observations are significantly
clustered.
Similarly, the significance of a random slope can be corroborated by conducting a
LRT comparing a null LME with a random intercept to a null LME with a random
intercept and slope. In this case, a significant difference in the models can be attributed
to the inclusion of the slope, certifying that the rate of change of the Hb levels within
the CKD patients varies significantly across the individuals. The results of these LRTs
are shown in Table 5.5, confirming the significance of the two random effects.
Table 5.5: Likelihood ratio tests showing the significance of the random effects for the
NI dataset
Log Likelihood DF
Model 1: Ordinary linear model -47034.75 2
Model 2: Random intercept model -45141.17 3
Model 3: Random intercept and slope model -44612.21 5
Chi Sq. p-value
Test 1: Model 1 and Model 2 3787.15 < .0001
Test 2: Model 2 and Model 3 1057.92 < .0001
To evaluate the effect of the observed baseline covariates on Hb, a LME model
with a random intercept and slope was fitted to the NI data using the ‘nlme’ package
within R software [183] and backward selection was used to identify the variables which
had a significant effect on the individuals’ Hb levels. The estimates of the significant
parameters within the final model, along with their standard errors and p-values, are
given in Table 5.6.
The covariance parameters of the random effects indicate a negative association
between the random intercept and slope; individuals with a higher intercept typically
have a more-negative slope, and thus a faster decline over time.
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Table 5.6: Table showing the parameter estimates of the LME model for the NI data








Intercept 11.065 0.120 < 0.001
Time (Months) -0.008 0.001 < 0.001
Age (per 10) 0.072 0.016 < 0.001
MCV (per 10) -0.084 0.037 0.022
Creatinine (per 100) 0.032 0.011 0.003
Ferritin (per 100) -0.043 0.006 < 0.001
Ir
o
n Iron Hydroxide -0.139 0.070 0.047
Venofer 0.051 0.056 0.365





ce Random Intercept 0.876 - -
Random Slope 0.001 - -
Covariance -0.018 - -
Residual Error 1.378 - -
*Baseline
This negative correlation is illustrated by the plotted random effects within Figure













Figure 5.9: Scatter plot of the individuals’ random intercepts and slopes.
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To exemplify the variation that exists amongst the individuals’ repeated measures
trajectories, and to illustrate the fitted LME model’s suitability at representing them,
the estimated trajectories of nine randomly selected individuals, overlaid upon their
observed Hb measures, have been plotted within Figure 5.10.
ID: 10 ID: 14 ID: 24
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Figure 5.10: Personalised estimates of the individuals’ longitudinal trajectories
overlaid upon their observed values.
From these plots, it can be observed that different individuals can have very dif-
ferent Hb trajectories, where, for example, individual 27 has Hb levels which increase
over time, compared to individual 69, whose Hb levels decrease with time. The plots
also highlight different features of the data, namely that different individuals are ob-
served for different periods of time (with different numbers of observations), and that
the repeated measures per individual are similarly distributed around each individual’s
personalised trajectories.
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5.4.1.2 Exponential, Weibull and Coxian Models for the Survival Process
Independent AFT models, assuming underlying exponential, Weibull and Coxian phase-
type distributions were also fitted to the data. For fair comparison between the mod-
els, this Chapter explores only the constant effect (CE) parameterisation of the Cox-
ian phase-type distribution, meaning all models impose the same assumption that
haemoglobin has a constant effect on survival through time. The exponential and
Weibull distributions were chosen for comparison due to their being the only AFT ap-
proaches currently available to represent the survival process of a joint model within
the JM package in R. Baseline covariates were incorporated so as to identify those
which significantly impact the survival process and to obtain initial estimates of their
parameters for the joint likelihood fitting procedure (Model 1). As with the LME
model, backwards selection was employed, and the final models are displayed within
Tables 5.7 and 5.8, where it was found that only the individuals’ baseline ages signifi-
cantly impacted survival.
To investigate the impact of making naive assumptions regarding the dynamic
nature of the individuals’ Hb levels, two further survival models were also fitted (for
each distributional assumption), incorporating an estimate of each individual’s Hb
level at their event time as an additional covariate within the model. Within Model
2, the individuals’ Hb was estimated using LOCF and, in Model 3, the LME model
previously fitted in Section 5.4.1.1 was utilised to calculate ‘unbiased’ estimates of the
individuals’ Hb at their event times, constituting a two-stage approach to the joint
analysis of longitudinal and survival data. The parameter estimates from these models,
adjusted for all other significant covariates, are also given in Tables 5.7 and 5.8. The
exponential and Weibull models, interestingly, estimate that whilst the LOCF estimate
of Hb, contaminated with error, does significantly affect survival, the predicted Hb
levels from the LME model were not found to have a significant association. For the
Coxian fits, however, both the LOCF and LME prediction of Hb were found to be
significant.
As the shape parameter of the Weibull distribution is significant within the model,
it can be inferred that the baseline distribution of the survival times is not sufficiently
represented by the exponential distribution. Similarly, BIC scores show that the two-
phase Coxian provides a more suitable fit than the Weibull distribution (6209.42 vs
6241.40), and that the three-phase Coxian provides a slight improvement upon the
































Table 5.7: Parameter estimates from independent exponential and Weibull AFT survival models fitted to the CKD data, incorpo-
rating covariates (i) Model 1: Age, (ii) Model 2: Age and LOCF Hb and (iii) Model 3: Age and Predicted Hb.
Exponential Weibull
Parameter Est. Std. Err. p-value Est. Std. Err. p-value
Model 1:
Age (per 10) -0.267 0.033 < 0.001 -0.205 0.026 < 0.001
Intercept 6.289 0.242 < 0.001 5.740 0.196 < 0.001
log(Shape) - - - 0.259 0.033 < 0.001
Model 2: LOCF Hb∗ 0.118 0.027 < 0.001 0.095 0.021 < 0.001
Model 3: Predicted Hb∗ 0.045 0.056 0.445 0.023 0.042 0.582
∗ Adjusted for Age, Est.: Estimate, Std. Err.: Standard Error
Table 5.8: Parameter estimates from independent two, three and four phase Coxian phase-type regression models fitted to the CKD
data, incorporating covariates (i) Model 1: Age, (ii) Model 2: Age and LOCF Hb and (iii) Model 3: Age and Predicted Hb.
Two-phase Coxian Three-phase Coxian Four-phase Coxian
Parameter Est. Std. Err. p-value Est. Std. Err. p-value Est. Std. Err. p-value
Model 1:
Age (per 10) -0.217 0.023 < 0.001 -0.213 0.012 < 0.001 -0.209 0.010 < 0.001
q010 0.000 0.000 - 0.000 0.000 - 0.000 0.000 -
q012 0.032 0.005 - 0.077 0.007 - 0.102 0.008 -
q020 0.003 0.001 - 0.000 0.000 - 0.000 0.000 -
q023 - - - 0.071 0.006 - 0.099 0.007 -
q030 - - - 0.003 3× 10−4 - 0.000 0.000 -
q034 - - - - - - 0.181 0.014 -
q040 - - - - - - 0.003 3× 10−4 -
Model 2: LOCF Hb∗ 0.103 0.018 < 0.001 0.100 0.013 < 0.001 0.101 0.010 < 0.001
Model 3: Predicted Hb∗ 0.063 0.032 0.050 0.075 0.024 0.002 0.066 0.027 0.015
∗ Adjusted for Age, Est.: Estimate, Std. Err.: Standard Error
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The inclusion of a fourth phase, however, does not significantly improve the fit
(6214.48 vs 6207.01), meaning it can be concluded that the three-phase Coxian pro-
vides the best fit to the data. The estimated densities of these models are plotted
within Figure 5.11, highlighting the variability which exists amongst the models. It
can also be seen visually that the addition of the fourth phase within the Coxian did
not significantly change the shape of the distribution, indicating that the inclusion of
additional Coxian phases eventually results in conversion to a single density shape.






































Figure 5.11: Estimated baseline probability densities from an exponential, Weibull,
two-, three- and four-phase Coxian distribution.
Looking at the parameter estimates from the fitted models for the survival covariate
Age, it can be observed that different specifications of the underlying distribution has
a slight impact on the estimates of the survival parameter, with values ranging from
−0.267 to −0.209, suggesting that a decade increase in age results in an acceleration
factor between exp{−α} = exp{0.267} = 1.306 and exp{0.209} = 1.232.
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5.4.2 Joint Analysis of Longitudinal and Survival Data
Within this section, the parameters of the longitudinal and survival processes are
estimated simultaneously through the single joint likelihood approach. As interest lies
in modelling the association between survival and the Hb levels themselves, the true
longitudinal response (TLR) parameterisation of the joint likelihood is employed. As
before, survival parameters are estimated according to the AFT parameterisation.
Within the JM package in R software [14], there are only two available AFT rep-
resentations for the survival process: one which assumes an underlying exponential
distribution and an other which assumes an underlying Weibull distribution. However,
the independent survival models, fitted within Section 5.4.1.2, have already suggested
that the Weibull distribution does not sufficiently represent the shape of the CKD data,
meaning that the parameter estimates from a joint model which assumes the Weibull
distribution are likely to be biased due to the misspecification of the survival process.
Whilst alternative approaches exist for fitting PH models with atypical survival dis-
tributions, such as the piecewise constant baseline hazards model or the PH model
which utilises splines to approximate the log baseline hazard, no such alternatives are
currently available for the AFT model. This research aims to overcome this restric-
tion by utilising the Coxian phase-type distribution to represent the survival process,
where its ability to suitably represent any positive distribution to an arbitrary degree
of accuracy should alleviate the possibility of miss-specification. As such, within this
section, the two available AFT approaches within the JM package, along with the
newly developed joint model which utilises the Coxian phase-type distribution, were
fitted to the CKD data and their results compared.
The parameter estimates from the exponential and Weibull AFT representations
are given in Table 5.10, where it can be observed that little variation is observed
amongst the estimates of the longitudinal and variance parameters. The parameters
associated with the survival process, however, are considerably influenced by the choice
of survival model. For example, the exponential representation predicts that a one unit
increase in Hb results in an acceleration factor of exp{−0.658} = 0.518, compared to
exp{−0.525} = 0.591 from the Weibull model.
When fitting the joint model which assumes an underlying Coxian phase-type
distribution, it is necessary to again determine the number of underlying phases which
provide the best fit to the data, as it will not necessarily be the same number of phases
as within the independent survival model. In order to do this, models were once again
fitted with an increasing number of phases and the BIC was employed to compare the
models and determine which provides the most suitable fit to the data. For the NI
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dataset, the BIC values of the fitted models are given within Table 5.9, where it can be
observed that a three-phase Coxian provides the best fit, as was the case when fitting
the independent survival models.
Table 5.9: Table showing the BIC values of the fitted joint models utilising the Coxian
phase-type distribution




*Optimal number of phases.
The estimated parameters from this three-phase Coxian joint model are given in
Table 5.10, alongside those from the exponential and Weibull AFT models. From
these parameter estimates, it can again be observed that there exists little variation
in the estimates of the longitudinal and variance parameters across the three models.
That is to say, these parameters are not drastically affected by the representation
of the survival process. But, again, substantial differences exist in the estimates of the
survival parameters, as is consistent with what has been observed previously within
Simulation Study Three. Within the three-phase Coxian representation of the survival
process, the acceleration factor of a one unit increase in Hb is given by exp{−0.345} =
0.708, highlighting that the extent of this acceleration effect is overestimated by the
joint models which assume an exponential or Weibull distribution.
It is interesting to note that the estimates of the Hb survival parameters from the
three distributions vary significantly when compared to those of the same distribution
estimated utilising a two-stage approach, displayed within Tables 5.7 and 5.8. As the
two-stage approach only incorporates point estimates of the individuals’ Hb levels at
their death time, in comparison to the joint likelihood approach which incorporates
the individuals’ complete Hb trajectories, it can be concluded that the individuals’
Hb medical history significantly impacts the estimates of the parameters, hence the
difference in the parameter estimates.
Comparing the estimates of the effect of Hb on survival from the joint models with
those from the independent survival models fitted within Section 5.4.1.2 highlights
that both the LOCF Hb and predicted Hb from the LME model resulted in an under-
estimation of the true effect of Hb; highlighting the necessity of using joint modelling
































Table 5.10: Table showing the parameter estimates of the standard joint models available within the JM package in R applied to
the NI renal data.
Exponential Weibull Three-phase Coxian













Intercept 11.084 0.116 < 0.001 11.078 0.118 < 0.001 11.073 0.039 < 0.001
Time (Months) -0.010 0.001 < 0.001 -0.010 0.001 < 0.001 -0.010 3× 10−4 < 0.001
Age (per 10) 0.074 0.016 < 0.001 0.073 0.016 < 0.001 0.073 0.005 < 0.001
MCV (per 10) -0.093 0.035 0.008 -0.097 0.036 0.007 -0.092 0.012 < 0.001
Creat. (per 100) 0.039 0.010 2× 10−4 0.038 0.011 3× 10−4 0.037 0.003 < 0.001
Ferritin (per 100) -0.043 0.006 < 0.001 -0.043 0.006 < 0.001 -0.043 0.002 < 0.001
Iron Hydroxide -0.139 0.069 0.044 -0.134 0.070 0.054 -0.137 0.023 < 0.001
Venofer 0.055 0.054 0.311 0.056 0.055 0.309 0.055 0.018 0.002








e Intercept 0.879 - - 0.886 - - 0.888 - -
Slope 0.001 - - 0.001 - - 0.001 - -
Covariance -0.018 - - -0.018 - - -0.019 - -









Age (per 10) -0.316 0.034 < 0.001 -0.246 0.027 < 0.001 -0.231 0.027 < 0.001
Association 0.658 0.063 < 0.001 0.525 0.053 < 0.001 0.345 0.019 < 0.001
Intercept 0.716 0.698 - 0.125 0.577 - - - -
Scale 1 - - 1.304 - - - - -
q010 - - - - - - 1.8× 10−117 6.4× 10−61 -
q020 - - - - - - 8.2× 10−32 1.9× 10−17 -
q030 - - - - - - 2.740 0.869 -
q012 - - - - - - 0.147 0.047 -
q023 - - - - - - 2.738 0.870 -
Log Likelihood -47634.57 - - -47608.75 - - -47586.83 - -
BIC 95377.14 - - 95332.70 - - 95310.46 - -
Est.: Estimate, Std. Err.: Standard Error
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A plot of the estimated baseline density corresponding to the rate parameters from
the three-phase Coxian is given within Figure 5.12, and the underlying Markov process
which defines the Coxian phase-type distribution uncovered by the fitted joint model
is shown diagrammatically within Figure 5.13.



































Figure 5.13: Illustration of the uncovered Markov process from the NI dataset
with baseline transition intensities.
As is typical within Coxian phase-type distribution literature, it is often of interest
to map these latent states onto the survival process, where in this case they can
represent distinct stages of progression within end-stage renal patients. From the
baseline transition intensities, it can be inferred that individuals spend the majority
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of their time within the first state, with a small rate of transition into the second state
of only 0.147. From this second state individuals deteriorate much faster, transitioning
into the third state with rate 2.738, from which they then absorb relatively quickly,
with rate 2.740. Such a rate of flow pattern suggests that the individuals within the
dataset spend a prolonged period of time within relatively good health, before a rapid
decline through the later diseases stages just before death. This pattern is consistent
with what has been identified within previous literature [184], where, for example,
Figure 5.14 shows some common health trajectories of CKD patients, which suggest
that a rapid decline after an extended period of health can be typical.
As discussed previously, an advantage of employing the EM algorithm approach
to fit the Coxian phase-type regression model is that, within the E-step, the expected
time spent within each state is approximated for each individual, providing additional
insight into how their condition evolves. For example, looking at the personalised
approximations of the percentage of the individuals’ survival times spent within each
state, it can be identified that individuals exhibited different deterioration rates, as
illustrated for three patients within Figure 5.15. Within this Figure it can be observed
that, Individual 27 spent the majority of their survival time within State 1, before
experiencing a rapid decline through the last two states before death, reflecting the
trajectory within panel A in Figure 5.14. Conversely, Individual 42 experienced a
more gradual decline towards the end of their survival time, perhaps reflecting the
trajectory within panel B in Figure 5.14. Finally individual 69 spent an even more
reduced proportion of time within State 1, and longer in States 2 and 3, perhaps
moving toward the trajectory observed within panel C of Figure 5.14. Comparing this
survival information with the individuals’ Hb trajectories, plotted previously within
Figure 5.10, it can be observed that Individual 27’s increasing Hb levels correspond to
a greater proportion of time spent in good health (i.e. State 1), whereas Individual 69’s
decreasing Hb trajectory corresponds to an increased time within the poorer health
states.
These personalised approximations of time spent within each state can be invalu-
able to clinicians when determining patient intervention and making predictions re-
garding survival outcome; in fact, they can not only make explicit predictions on overall
survival time, but also individualised predictions on the time patients will spend in
each state, and thus their quality of life.
Within the CKD dataset analysed within this research, the estimated mean time
spent within state one is 33.47 months, in state two is 1.58 months and state three is
1.45 months. Figure 5.16 shows three histograms of the distribution of the percentage
of the individuals’ survival times spent within each state, with the majority (764
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Figure 5.14: Illustration of four typical trajectories of decline within CKD patients.
Source: NHS Kidney Care [184].
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Figure 5.15: Illustration showing the estimated percentage of overall survival time
spent in each state for three individuals.
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individuals) spending more than 95% of their survival time in state one.










































Figure 5.16: Histograms showing the percentage time spent within each of the
uncovered stages of the Coxian.
5.5 Summary
Within this chapter, the newly developed joint modelling approach which utilises the
Coxian phase-type regression model to represent survival was illustrated through an
application to data collected from end-stage renal patients within Northern Ireland.
Initially, the dataset was introduced and some preliminary analysis was presented,
highlighting the possible association which exists between the haemoglobin levels of
CKD patients and their survival. Subsequently, independent longitudinal and survival
models were fitted to the data, before the joint likelihood approach was implemented.
The newly developed approach was compared favourably to the standard joint mod-
elling approaches available within the JM package.
Finally, some of the advantages of employing the Coxian to represent the survival
process within a joint model were highlighted, such as the meaningful interpretations
of the uncovered stages, and the personalised approximations regarding the times





6.1. Summary of Conclusions
6.1 Summary of Conclusions
This research introduces a new fully parametric joint modelling approach for the anal-
ysis of longitudinal and survival data, which utilises the Coxian phase-type regression
model to represent the failure process. In doing so, this new model offers a number of
advantages:
i The applicability of the Coxian phase-type regression model is extended, where
it can now be employed in scenarios where interest lies in modelling the associa-
tion between a survival process and a related time-varying endogenous covariate
of interest. In previous literature, the Coxian phase-type regression model was
restricted in terms of its scope, as it was only capable of handling time-invariant
covariates, reducing its relevance within the medical field, for example, where lon-
gitudinal biomarkers are of increasing interest.
ii Within this new joint model, the Coxian phase-type distribution is highly flexible in
terms of the distributional shapes that it can represent, overcoming the restrictions
of alternative, fully parametric representations of the survival process, which are
limited in terms of the distributional shapes they can suitably fit [7,12,125]. This
was highlighted within Simulation Study Three in Section 4.4.3, where misspeci-
fying the survival distribution by incorrectly employing an exponential or Weibull
AFT model resulted in biased estimates of the survival parameters, which the Cox-
ian was shown to overcome. Further, employing a fully parametric approach to
represent the survival process is beneficial if interest lies in making predictions of
outcome for individual patients [12], which is often a focus within medical statistics.
iii The uncovered phases of the Coxian phase-type distribution provide a new, more
in-depth perception of the survival process under investigation, where inferences
can be made not only on how covariates affect the survival process as a whole,
but insight can also be gained into how the individuals’ quality of life will evolve
during their remaining survival time.
Before embarking on the development of this novel joint modelling framework, this
research first focused on addressing some of the limitations of phase-type distributions,
which impede their performance when representing typical survival problems. Firstly,
motivated by the well documented convergence issues of phase-type distributions [39,
40, 130], a new EM algorithm approach to fitting phase-type regression models was
detailed within Section 3.3. Through a simulation study, presented within Section
3.3.3, this new approach was shown to have improved accuracy in the parameter
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estimates compared to previously utilised NM and QN algorithm approaches, as well
as a higher rate of successful convergence, as illustrated within Figure 6.1.












































Figure 6.1: Plot showing the rate of successful convergence (ROSC) of the newly
developed EM algorithm approach to fit phase-type regression models, compared
with previously employed NM and QN approaches.
A further advantage of this EM algorithm approach is that, within the E-step of
the model’s fitting procedure, the expected time each individual spends within the
different underlying states is approximated, along with the probability of visiting each
state, providing insight into how individuals behave before experiencing their event of
interest. This is of particular importance in the analysis of diseases in which patients
experience differing qualities of life during different stages of the disease’s development.
For example, this is a documented issue for CKD patients, where previous research
has established the importance of considering quality of life [185] and the benefits of
appropriately modelling the time until end of life care is required [184].
Secondly, this research investigated relaxing a commonly made restrictive assump-
tion regarding covariate effects within phase-type regression models, where previous
approaches impose the potentially unrealistic assumption that the effect of a covariate
151
6.1. Summary of Conclusions
is constant across all transition intensities. Whilst this is done to minimise the number
of covariates to be estimated by the already unstable fitting procedures, it does so at
the expense of limiting the information which can be gained from the model. De-
tailed within Section 3.4, the increased stability of the newly developed EM approach
to fitting Coxian phase-type regression models was leveraged to introduce three new
parameterisations of the model which allowed (a) state-specific, (b) direction-specific
and (c) transition-specific inferences to be made. Through a second simulation study,
presented within Section 3.4.4, it was shown that the newly developed EM algorithm
approach to these three parameterisations again outperformed the previous NM and
QN approaches both in terms of the ROSC and accuracy of the parameter estima-
tion, whilst providing detailed insight into how covariates affect different aspects of an
individuals survival process.
Thirdly, in order to consider incorporating the Coxian phase-type regression model
within a joint modelling framework, Section 3.5 introduced novel methodology to
amend the model to allow the rate of transition between the underlying phases of the
distribution to evolve over time. Where previously the underlying Markov process
was considered time homogeneous, the inclusion of time-varying covariates relaxes
this assumption to specify a time inhomogeneous Markov process, with baseline time-
invariant hazards.
This development paved the way for the new methodological approach to fit joint
models, utilising the Coxian phase-type regression model to represent the survival
process. This was then detailed within Chapter 4 for the two commonly used pa-
rameterisations of the joint model, the true longitudinal response (TLR) and random
effects (RE) parameterisations. A further simulation study was presented within Sec-
tion 4.4.3, illustrating this new model’s ability to represent more flexible distributional
shapes than those joint models which assume an underlying exponential or Weibull dis-
tribution. Within the study it was also seen that bias was introduced to the estimated
survival parameters when an exponential and/or Weibull distribution was assumed for
data which had a more complex distributional shape, which the Coxian was shown to
overcome.
This is a major advantage in the analysis of real world observational data where
complicated survival densities are likely to be encountered, as illustrated by the mo-
tivating example presented within Chapter 5. Within this chapter, the new joint
modelling methodology was applied to data collected from 1,340 renal patients within
Northern Ireland, who received haemodialysis treatment for end-stage CKD. Through
the model fitting procedure, it was determined that a three-phase Coxian provided
the best fit to the data, improving upon those fits of the exponential and Weibull
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distributions available within the JM package in R, through comparisons based upon
the models’ BIC values. From the uncovered phases of the Coxian, and the estimated
rates of flow through them, it was observed that the individuals spent the majority
of their survival time within the first phase of the distribution, representing the least
sever stage of the disease. After transition into the second phase, individuals begin
to deteriorate much more quickly, with a much higher rate of progression into the
final phase, from which they were quickly absorbed. The uncovered flow pattern was
found to be consistent with the anticipated behaviour of end-stage renal patients [184].
This added insight into patient behaviour, alongside the aforementioned ability to pro-
vide individualised rates of flow, as well as personalised predictions of the time spent
within each state, has the potential to better inform patients and to aid clinicians in
the establishment of targeted treatment plans for their patients.
6.2 Potential Further Work
Joint modelling is a rapidly-evolving area of statistical research, and as such there
exists much scope for developing and improving the methodology of joint models,
depending upon the desired inferences of an investigation. A particularly active as-
pect of this research area concerns the various procedures and techniques which can
be employed to fit joint models, where the computational issues are a well discussed
drawback [19]. Whilst an aspect of this research focused upon improving the issues
associated with fitting the Coxian phase-type regression model through a conventional
maximum likelihood approach, a potential avenue of future research could be the al-
ternative use of Bayesian analysis in the estimation of the novel joint model which
utilises the Coxian. Recent years have seen an increase in the number of Bayesian
approaches employed within the field of joint modelling, beneficial due their ability
to alleviate some of the computational burden of the complicated joint modelling fit-
ting procedure [186]. Indeed, the recent publication of the ‘JMBayes’ package within
R [20] has no doubt increased the popularity of this approach. Whilst the research
presented within this thesis has explored the method of maximum likelihood to esti-
mate the unknown parameters of the newly developed joint model, employing recent
recommended approaches such as the pseudo-adaptive Gauss Hermite, it could alter-
natively be possible to employ Bayesian statistical approaches to compare whether
an improvement in the efficiency of the model’s fitting procedure could be achieved.
Indeed, further investigation into the computational timings of different fitting proce-
dures would be beneficial for both the Coxian phase-type regression model and for the
newly developed joint model which utilises the Coxian.
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Within this research, a LME model was employed to represent the longitudinal
process, where interest was instead focused upon investigating alternative representa-
tions of the survival process. It may therefore be of interest in future work to consider
previously adapted approaches explored within the literature to fit non-linear trends
for the longitudinal profile, such as spline based longitudinal models [187], or a LME
model with a stochastic component [188], which could be integrated alongside the
Coxian within a joint modelling framework. Additionally, it could be of interest to
model multiple longitudinal responses alongside a survival process, and as such it may
be beneficial to consider a multivariate joint model which utilises the Coxian for the
survival process.
A further extension of this work could be to investigate the commonly accepted
normality assumption for the distribution of both the random effects and the residual
errors within the LME model, as previous research has shown that such assumptions
can be restrictive in the presence of outliers. To combat this, robust joint modelling
techniques have been developed, which assume the wider-tailed t-distribution in place
of normality assumptions so as to better accommodate outliers. This has been shown to
improve the estimates of the longitudinal parameters [189]. As such, applying a Coxian
representation of the survival process alongside a robust LME model within a joint
modelling framework would reduce the bias which can occur within both processes.
Whilst the work presented within this thesis focused specifically on the application
of the Coxian phase-type distribution to model survival, due to its underlying Markov
process suitably representing the expected flow of individuals suffering from a chronic
or degenerative condition, it could be beneficial to explore different phase-type distri-
butions with alternative underlying Markov structures. For example, recovery from a
disease could be incorporated within the model by allowing individuals to transition
backwards through the underlying system, as illustrated within Figure 6.2. However,
such a model, with its increased parameters, could exacerbate the identifiability issues
of phase-type distributions.
As the application of the Coxian phase-type regression models to standard survival
problems is a relatively novel application, it has not yet been fully explored within the
literature. As such, the common adaptations to typical survival models, designed to
model more complicated real-life survival situations, have not been implemented within
the Coxian. For example, a competing risks scenario cannot currently be modelled
using phase-type regression models. As such, there exists scope for various extensions
to the Coxian phase-type regression model and thus to the novel joint model presented
in this work.
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Figure 6.2: Diagram showing a Coxian phase-type distribution which allows re-




























Figure 6.3: Diagram showing an underlying Markov process with two absorption
states.
One possibility could be to allow individuals who experience a competing risk to
transition into a second absorbing phase, as depicted within Figure 6.3. This way, all
individuals who are suffering from the disease can contribute to the estimates of the
rates of flow through the n transient states, representing the stages of the disease. An
application of this model to a CKD scenario could be considered, where individuals
often receive a kidney transplant before experiencing their event of interest. Such a
model can provide insight into which event individuals are most at risk of experiencing
during each stage of the disease.
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Appendix A
E-Step of the Coxian Phase-type
Regression Model
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A.2. Expected time spent within each state, E ij
A.1 Expected probability of beginning the process in each
state, Bij
Whilst the initialisation vector, p, represents the overall population-average proba-
bility of beginning the process within each phase of the underlying Markov process,
i.e. p = Pr(X0), personalised predictions can be obtained by considering the indi-
viduals observed event times and covariate vectors. By manipulating this conditional







































































pjdij(τi | θτ )
pdi(τi | θτ ) .
(A.5)
A.2 Expected time spent within each state, E ij
The expected total time spent within state j of a Markov process by individual i is
calculated by integrating the probability of belonging to state j with respect to time,
bounded between 0 and the total time spent within the system as a whole, as shown:
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cijj(τi | θτ )
pdi(τi | θτ )
(A.9)
where the Runge-Kutta or Gauss-Hermite approaches can be utilised to numerically
approximate this integral.
A.3 The expected probability of transitioning between
each pair of states, N ijk
The probability of transitioning between any pair of states j and k within a Markov
model in an infinitesimal time increment, δu, conditional upon the event time is given
by: Pr(Xu = j, Xu+δu = k | τi). It follows that the probability of this transition
occurring at some point during the time period for which the individual is known to
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A.3. The expected probability of transitioning between each pair of
states, N ijk
be in the system is given by the sum of the probabilities of the transition occurring
at each infinitesimal time increment. This can be approximated by integrating the
infinitesimal transition probability over the total time the individual spends within
























































Xu+δu = k |Xu = j
)
= q0jk exp{−w iγ} (A.12)
Pr
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τi |Xu = j, Xu+δu = k













is given by Equation A.4. This means that the expected value of






























cijk(τi | θτ )q0jk exp{−w iγ}
pdi(τi | θτ ) as δu→ 0.
(A.14)
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A.4. Expected probability of absorbing from each state, N ij0
A.4 Expected probability of absorbing from each state,
N ij0
The expected probability of absorbing from state j, i.e the expected probability of
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